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ABSTRACT 
Substantial evidence now exists for two distinct vascular circuits within skeletal muscle. 
The nutritive capillary circuit directly nourishes skeletal myocytes, whereas another 
slightly larger set of non-nutritive vessels is probably interspersed within connective 
tissue of the septa and tendons. The fluctuation of flow between these two circuits 
allows sensitive control of nutrient delivery, which is often independent of changes in 
total flow. These innate flow patterns can be manipulated in vitro by the infusion of 
vasoactive agents into the perfused rat hindlimb. Certain vasoconstrictors (including 
serotonin) increase connective tissue flow at the expense of muscle capillary flow, 
denying access of glucose and insulin to the myocytes and inducing acute insulin 
resistance. In vivo, insulin itself causes increased flow to the muscle capillaries, and this 
insulin-mediated capillary recruitment is often blocked in insulin resistant states. 
This thesis primarily investigates the uptake of blood-borne metabolites during serotonin 
infusion in the perfused rat hindlimb, including glucose, fatty acids (FFA, both albumin-
bound and derived from chylomicron-triglyceride) and amino acids. In addition, the 
effect of elevated plasma FFA on the action of insulin to recruit capillaries was 
investigated in the euglycaemic, hyperinsulinaemic clamp in vivo, from the metabolism 
of 1-methyl xanthine. 
When the ratio of non-nutritive to nutritive flow was increased in the perfused rat 
hindlimb, the insulin-mediated uptake of glucose, Na-palmitate (albumin-bound) and a-
aminoisobutyric acid were reduced. Unlike the other fuels tested, with high non-nutritive 
flow the uptake of FFA from chylomicron-triglyceride hydrolysis was increased. It was 
therefore reasoned that non-nutritive flow was accessing a population of adipocytes 
within the muscle connective tissue, most likely in the perimysium. This perimysial 
adipose tissue is responsible for muscle 'marbling'. 
In the experiments determining the effect of FFA on insulin-mediated glucose uptake in 
vivo, FFA inhibited both insulin-mediated capillary recruitment and glucose uptake, thus 
elevated FFA in vivo were able to induce a state of insulin resistance, likely to be partly 
mediated by reduced capillary recruitment or nutritive flow. Accordingly, elevated FFA 
prevent perfusion of the nutritive capillaries to some degree, resulting in predominantly 
non-nutritive flow. This likely results in the reduced access and uptake of insulin, 
glucose, amino acids and albumin-bound fatty acids by myocytes, contributing to their 
buildup in the plasma. However, increased flow through the non-nutritive vessels of the 
muscle connective tissue, increased the exposure of lipoproteins to lipolytic enzymes. 
Thus, non-nutritive flow probably nourishes connective tissue adipocytes and increases 
the potential for fat accretion within the muscle. 
The results within this thesis offer important insights into nutrient access in skeletal 
muscle, in particular with elevated FFA in vivo. A reduction in nutritive flow, caused by 
elevated plasma FFA, is likely to reduce the uptake of glucose, amino acids and FFA 
into the myocytes, however increase fat deposition in the muscle connective tissue. This 
xi 
may contribute to the reduction in oxidative capacity, and accelerated 'marbling' and 
insulin resistance of human muscle, 
CHAPTER 1 
1 Introduction 
1.1 Skeletal muscle fuel metabolism and the whole body: a perspective 
Skeletal muscle (SM) makes up approximately 38% of the entire human body 
mass and therefore largely influences whole body substrate uptake and utilization (127). 
Lipid and carbohydrate are the predominant fuels for SM metabolism, however the 
carbon chains from amino acid catabolism may contribute up to 15% of the muscle 
energy during exercise (273). In addition, SM utilizes 25% of the whole body oxygen 
consumption during rest, which can exceed 90% during intense exercise (reviewed in 
(90)). 
1.1.1 Vasoconstrictors affecting fatty acid, amino acid and glucose uptake 
1.1.1.1 Skeletal muscle lipid uptake 
In vivo, FFA oxidized by SM are obtained from a number of sources. These 
include albumin-bound fatty acids, circulating lipoproteins or cytoplasmic deposits 
within the cell. More recently the presence of adipocytes interlaced between muscle 
fibres has been suggested as an alternative source, however their importance remains to 
be determined (283). 
TG may be transported to peripheral tissues as micellar lipoproteins (including 
very low-density lipoproteins (VLDL) and chylomicrons). VLDL are mainly released 
from the liver during fasting, and are thus assembled from endogenous TG. Post-
prandial delivery of FFA occurs via chylomicrons assembled in the enterocytes 
(reviewed in (109)). FFA are released from the core of the lipoprotein by the enzyme 
lipoprotein lipase (LPL), situated in the capillary lumen (55) (68) (272). 
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During a period of elevated lipid requirements, FFA are mobilized from adipose 
tissue (AT) stores (interfibirillar or elsewhere). Albumin acts as a blood-borne carrier for 
the FFA. Due to their lipophilic nature, albumin-bound FFA and FFA derived from 
lipoprotein hydrolysis are firstly adsorbed onto the luminal surface of the capillary 
endothelial cell. A number of mechanisms have been postulated for FFA crossing the 
endothelium. FFA traverse the endothelium either unbound, bound to albumin, or bound 
to a fatty acid transport protein (283). Fatty acids may also pass between endothelial 
cells bound to albumin, however it has been reported that the albumin molecule is 
probably too big to pass through these clefts (reviewed in (283)). One postulated method 
for FFA to traverse the endothelial cell is the 'flip-flop' of un-ionized FFA. In this 
model FFA rapidly 'flip' from the luminal to the abluminal plasmamembrane (104) 
(103). However, whether FFA cross the endothelial cell (in particular through the 
cytoplasm) either unaided or via facilitated transport is a contentious issue. SM uptake 
of FFA from the blood has been reported to be a function of FFA concentration by some 
authors (67), however others have reported the uptake to be saturable (278) (279). 
Saturable uptake implies a carrier-mediated mechanism for transport into myocytes. 
Over ten putative membrane fatty acid transporters have been described, and the most 
important include fatty acid binding protein (FABP), fatty acid transport protein 
(FATPpm) and fatty acid translocase (FAT) (reviewed in (104) (31)). The 0-pleated 
sheets of all these transporters are thought to form a tertiary structure resembling two 
halves of a clam-shell that shield the hydrophobic FFA from the cytoplasm. FFA are 
then adsorbed from the outer leaflet of the endothelial cell and cross the interstitial space 
on an albumin carrier (reviewed in (283)). A similar transport mechanism to the 
endothelium is thought to occur across the sarcolemma and the membranes of other 
parenchymal tissues. Once adsorbed from this membrane, the FFA are thought to be 
bound by a cytoplasmic FABP which is the intracellular equivalent of albumin. This 
reduces the unbound FFA concentration, increasing the gradient from the extracellular 
FFA, and thus facilitating uptake. 
Approximately 90% of the FFA entering the resting myocyte are esterified into 
lipid droplets located adjacent to the mitochondria (272) (157). Thus, the myocyte has a 
ready reserve of FFA available for 0-oxidation within the mitochondria. The glycerol 
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moiety for TG synthesis is thought to be from glucose-derived dihydroxyacetone 
phosphate, which forms glycerol-3-phosphate (207). This has recently been challenged 
by Guo and Jensen (101) who demonstrated that the minute amounts of glycerol lcinase 
(the enzyme that phosphorylates glycerol into glycerol-3-phosphate) in rat and human 
SM are likely to substantially contribute to trigylceride synthesis (and therefore whole 
body glycerol uptake). Alternatively, glycerol-3-phosphate may be provided from lactate 
(297). However the most widely accepted hypothesis is that glycogen supplies 
dihydroxyacetone phosphate that is then converted to glycerol-3-phosphate (207). 
Alternatively fatty acids may be oxidized in the mitochondria (very-long chain fatty 
acids are first shortened, and often oxidized in the peroxisomes (reviewed in (283)) or 
used to synthesize phospholipids and other cell components (e.g. prostaglandins). 
1.1.1.2 Skeletal muscle carbohydrate uptake 
The hydrophilic property of glucose impedes transport across the plasma 
membrane, therefore facilitated transport is mandatory. By 1992 five SM glucose 
transporters (members of the GLUT family) of approximately 45IcDa were identified 
(reviewed in (13)). Since then more have been discovered, including GLUT9 in 
leukocytes and brain; however this transporter appears to be absent from SM (36). In 
SM, sarcolemmal GLUT1 transports glucose during the basal state while glucose uptake 
simulated by insulin is facilitated by GLUT4 (reviewed in (308)). Insulin binding to the 
a-subunit of the insulin receptor stimulates tyrosine kinase activity of the n-subunit 
(reviewed in (237) and (114)). This causes rapid phosphorylation and activation of 
insulin-receptor substrate-1 (IRS-1) (115). Wortmannin has been shown to inhibit 
insulin-stimulated glucose uptake (189), suggesting phosphatidyl inositol 3 kinase (PI3- 
Kinase) is also involved in one of the intracellular insulin signaling pathways. Insulin-
receptor substrate-1 (IRS-1) may thus stimulate P13-Kinase, which then may activate 
protein kinase B (PKB/Akt). PKB/Akt acts to transport GLUT4 from an intracellular 
pool to the membrane. The steps involved in the signaling pathway between PKB and 
GLUT4 translocation, as yet, remain unidentified, however much research has been 
done into the mechanism for GLUT4 translocation to the membrane. SNAP 23, Vamp 2 
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and syntaxin 4 form a complex in SM known as SNARE (soluble N-ethylmaleimide-
sensitive factor attachment protein receptor) that is required for vesicle-membrane 
fusion. Other ancillary proteins that may be involved have been identified, including 
Mune 18c, synip, VAP 33 and rab 4 (reviewed in (79) and (114)). While GLUT4 is 
considered to be the major glucose transporter that is activated by insulin, GLUT8 has 
recently also been identified to be insulin sensitive (36). 
The body has only a limited capacity for carbohydrate storage and is therefore 
readily converted to fat. Once inside the cell glucose is irreversibly phosphorylated by 
SM hexokinase to glucose-6-phosphate, which is then able to undergo glycolysis or 
glycogen synthesis. Insulin attenuates glycogen synthase kinase-3, therefore activating 
glycogen synthase (190). 
1.1.1.3 Skeletal muscle amino acid uptake 
Many of the amino acids are comparatively bulky and are hydrophilic, therefore 
also require facilitated transport. A number of SM amino acid transporters have been 
identified, and they vary in their sensitivity to insulin and their dependence on sodium 
(292). These transporters contain a cluster of membrane spanning regions that form a 
hydrophilic channel across the membrane, through which the amino acids can pass. 
Amino acids may be carried by multiple transporters, but selectivity is usually 
determined by the side chain. The A, L, NM and ASC systems are dominant in SM. 
System A is a uniporter that carries the amino acids alanine, serine, glutamine, 
methionine or glycine ((43), reviewed in (29) (42) (292)). System L carries the large, 
neutral amino acids valine, leucine, isoleucine, methionine, phenylalanine, tyrosine or 
tryptophan (reviewed in (292)). System NM  transports glutamine, asparagine or 
histidine, while the major substrates for the ASC transporters are alanine, serine or 
cysteine (2) (42). Insulin greatly affects systems A and NM  ((165) (29) reviewed in 
(56)), and the effects of insulin and exercise are additive (309). 
After entering the myocyte amino acids may be transaminated before entering 
the tricarboxcylic acid cycle for oxidation (reviewed in (273) (90)). In particular, valine 
and isoleucine are able to form the TCA intermediate succinyl-CoA, however leucine 
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and isoleucine can form acetyl CoA which can enter the TCA cycle (reviewed in (90)). 
While most essential amino acids undergo metabolism in the liver, the periphery 
(including SM and AT) is the major site of degradation of the branched chain amino 
acids (BCAA, valine, leucine and isoleucine). They may also be used for the synthesis 
of cell components, including enzymes and transporters, and often activate mRNA 
translation and gene expression. Amino acids are not stored as polymers in the body, 
however the largest pool of protein found in the body is in the myocyte. 66% of SM 
amino acids are components of the myofibrillar proteins actin and myosin (reviewed in 
(90)). Myofibrillar protein breakdown can be measured by detecting 3-methyl histidine 
(3-MH) release from muscle. 
1.1.2 Nutrient uptake is affected by delivery (blood flow) 
The delivery of nutrients to SM via the bloodstream is not only dependent on 
substrate concentration and flow rate, but is also largely influenced by the location of 
blood flow in SM. While it would appear likely that fuel uptake closely correlates with 
muscle total flow, we have shown that the uptake of nutrients is more closely associated 
with capillary flow than total flow to the muscle (209). Vasoactive agents such as insulin 
therefore may act to recruit capillaries without necessarily affecting total flow. For this 
to occur, flow must be drawn from another area within the muscle. There is now 
substantial evidence that two parallel circuits exist in the SM, and flow to each can be 
intimately regulated by the addition of certain vasoactive substances (reviewed in (46) 
(48)). Blood flow may therefore increase in one area (e.g. capillaries) at the expense of 
the other (possibly muscle septa and tendons). The uptake of glucose, amino acids and 
fatty acid (both albumin bound and free-fatty acid (FFA) derived from chylomicron-
triglyceride (TG)) therefore will depend on the extent of capillary perfusion. An 
imbalance between capillary recruitment and de-recruitment will affect nutrient uptake 
and storage and may therefore predispose to certain metabolic syndromes, including 
diabetes. Both vasoactive agents and fuels themselves may affect glucose uptake by 
muscle. While flow may influence substrate uptake, uptake may also has some effect on 
total flow (in particular a reduction in capillary recruitment with insulin in diabetes), 
however this remains to be determined. Clearly the two factors, uptake and both total 
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and capillary flow, cannot be separated, and both factors are crucial in understanding the 
haemodynamic actions of insulin and mechanisms of insulin resistance. 
1.1.2.1 Insulin acts to increase blood flow to muscle 
While insulin stimulates glucose, fatty acid and amino acid transport and 
metabolism, it is now widely accepted that insulin also produces significant 
complementary increases in blood flow (reviewed in (15)). This additional vasodilatory 
action of insulin is thought to be largely nitric oxide (NO) dependent (260) (37) (231). 
NO is formed from the enzyme nitric oxide synthase (NOS) during the conversion of L-
arginine to L-citrulline (reviewed in (17)). This reaction requires oxygen and NADPH as 
cofactors and is stimulated by a rise in cytoplasmic Ca2+ levels. Insulin acts on PKB/Akt 
in the endothelial cell via a P13-Kinase activated pathway, which is postulated to 
phosphorylate and activate PKB/Akt and then NOS (62). Insulin also promotes the 
association of calmodulin with NOS to disrupt the suppressive effect of calveolin on the 
enzyme's activity (250). NO diffuses to the vascular smooth muscle cells and stimulates 
cyclic guanosine monophosphate (cGMP) production and subsequent vasodilatation. 
NOS is found throughout the vasculature and myocytes of SM (250) and NO may thus 
be generated in the myocytes, endothelial cell or smooth muscle. 
Insulin has a haemodynamic action to increase capillary flow independently of 
changes to total flow 
Dissociation between total flow and skeletal muscle metabolism 
Insulin is believed to have a haemodynamic action in SM to increase total flow 
to the muscle and subsequently increase glucose uptake (148) (16) (4). Despite this well 
documented action, not all studies have shown increases in total flow with insulin (136) 
(200). Some researchers have shown increases in insulin-mediated glucose uptake 
(IMGU) with increased total flow (16) (83), but others have not (240) (177) (244) (124) 
(186). Pitkanen et al. (201) also infused the endothelium-dependent vasodilator sodium 
nitroprusside, and found increases in total leg flow and flow dispersion, but decreased 
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glucose extraction in resting muscle of healthy men. Moreover the increases in glucose 
uptake often precedes increases in total flow (83) (148). Similarly, oxygen consumption 
was unrelated to forearm blood flow in vivo (83). The uptake of glucose and oxygen by 
in vivo SM preparations therefore appear to be unrelated to total flow. 
Metabolism is associated with capillary flow - evidence for capillary recruitment 
Dissociation of the effects of insulin on glucose uptake and flow have also been 
shown in our laboratory in vivo. While total flow showed no clear relationship to IMGU, 
it was clearly proportional to capillary flow when determined by the conversion of the 
exogenous substrate 1-methyl xanthine (1-MX) to 1-methyl urate (1-MU), by the 
capillary-endothelial enzyme xanthine oxidase (209). Despite similar increases in total 
flow with both insulin and epinephrine, only insulin increased capillary flow (1-MX 
metabolism, (209)). In addition, collaborators of our laboratory in the U.S.A have 
reported no increase in total flow with 3 mU/mg/kg insulin, although an increase in 
capillary flow was evident (as determined by the distribution of albumin microbubbles) 
within 30 minutes of insulin infusion (287). Moreover, N(omega)-nitro-L-arginine 
methyl ester (L-NAME, an inhibitor of NOS) partially prevented insulin-stimulation of 
1-MX conversion (289). Therefore insulin acts to recruit capillaries independently of 
changes in total flow, and this process is partly mediated by NO. 
Definition of capillary recruitment 
Capillary recruitment is the opening of previously quiescent capillaries for 
increased filtration. Recruitment is therefore an additional mechanism to distension 
(increase in capillary lumen volume) for increasing capillary perfusion. Distension is 
controlled by the vasodilatation of smooth muscle high in the vascular tree coordinating 
flow to all capillaries, therefore increasing total flow to all distal capillaries (reviewed in 
(172)). Recruitment may only affect certain subsets of capillaries by accessing the 
preceding terminal arteriole, thereby reducing the area between perfused capillaries and 
maximizing the area of substrate diffusion (reviewed in (248) (172)). Arteriolar 
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resistance will therefore exert primary control over the exposed capillary surface area 
for the exchange of nutrients. 
Skeletal muscle resistance vessels 
SM generates substantial whole body arterial blood pressure due to a large 
resistance to increases in cardiac output. Flow through SM resistance vessels is 
demonstrated by the equation: 
Q = P/R 
Where: Q is the flow, P the pressure and R the resistance. Moreover, the 
resistance is related to the arteriole diameter by the equation: 
R= 1/r4 
Where: R is the vascular resistance and r is the arteriole diameter. Therefore, a 
small increase in the radius will produce a large decrease in vascular resistance, 
resulting in large increases in vessel flow. 
Classification of resistance vessels in the skeletal muscle microcirculation 
Precapillary arterioles can be classified according to their proximity to the feed 
arteriole. The arteriole directly downstream from the feed artery is usually designated as 
the 1 st order arteriole (1A, approximately 100 pm) (248). All subsequent arterioles are 
classified in increasing order. The next apparent diameter reduction down the vascular 
tree represents the beginning of the 2 nd order arteriole (2A). A transverse arteriole is 
usually a 3 rd order arteriole, and, depending on the classification system used, the more 
distal 4th  and 5th order arterioles (<151.im) directly precede the capillary modules 
(capillaries arising from a common arteriole). The 3 rd to 5 th order arterioles (<40 1.1m) are 
thought to be responsible for capillary recruitment, therefore recruitment occurs in 
multiple capillary modules (172). A similar classification method is used for the venular 
vessels, where the post-capillary venules are designated 4 or 5V. 1 st order venules (1V) 
are those leaving the muscle and often lie adjacent to the 1 st order arterioles. 
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Vasoactive agents 
The capillary endothelial surface area and hydrostatic pressure are of primary 
importance in determining capillary filtration, and these factors are largely influenced by 
the arterial and venular tone. Capillary filtration of the SM microcirculation can be 
manipulated by the use of vasoactive agents. Agents that constrict or dilate resistance 
vessels may alter both resistance and the distribution of blood flow within the SM. 
Topically applied serotonin (5-HT) to the microvasculature of the rat cremaster 
muscle elicits dose-dependent changes in vessel tone (298). Concentrations ranging 
from 10-8 to le M causes substantial dilation of 4 th  order arterioles (classified in this 
case as the arterioles just preceding the capillaries), while at 10 4 M, constriction of the 
1st order arterioles occurred (298). 
Despite the arterial vessels being classical 'resistance vessels', changes in venous 
resistance may also exert control over capillary hydrostatic pressure. It is now evident 
that circulating vasopressin, angiotensin (All) and catecholamines have constrictor 
effects on venules. The former two however produce only minor venular constriction 
compared to the arterioles. Norepinephrine (NE, 0.1 i_tM) increased arterial pressure and 
decreased venular pressure by a similar extent despite constriction in Al-A4 and V3-V1 
(9). No change in constriction of the V4 may be due to only minute amounts of smooth 
muscle in these vessels. NE had greater constrictor effects on more distal arterioles. As 
already stated insulin may increase arteriole diameter through the release of NO (260) 
(37) (231) (307). In addition, prostaglandins stimulated by AIL bradykinin (24) and 
insulin (310) (284) also have vasodilatory effects. Infusion of either a NOS inhibitor, or 
an inhibitor of prostaglandin synthesis, prevented insulin-mediated reductions in 
forearm vascular resistance, suggesting the co-release of both with insulin (284). 
Prostaglandin release from the perfused rat hindlimb, had no effect on glucose uptake, 
however the dilatory effect of prostaglandins may be absent in this preparation, as it 
appears to be with insulin (310). It is therefore generally thought that vasodilators 
increase capillary filtration and vasoconstrictors decrease capillary filtration, however 
our laboratory has identified vasoconstrictors that are able to both increase and decrease 
substrate uptake by the perfused rat hindlimb (as discussed later in this chapter). 
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It is widely thought that the arterioles determine the extent of capillary perfusion, 
however for this mechanism to occur, arterioles must predetermine which capillary 
modules are to be perfused before the blood reaches the capillaries themselves (an 
unlikely phenomenon). In addition, adjacent fibres from different motor units (the group 
of muscle fibres innervated by a single motor neurone) can be supplied by a common 
capillary therefore dilation of the preceding arteriole would potentially supply 
unworking muscle fibres (reviewed in (172)). Moreover, the smaller order arterioles 
(larger, generally 1st  and 2nd order) lie adjacent to the corresponding venules, allowing 
diffusion of muscle-derived substances into the arteriole. However, as discussed above it 
is the more distal arterioles that are responsible for capillary recruitment. 
The primary controlling unit of capillary recruitment has recently been suggested 
to be the capillaries themselves (248) (172). One recently suggested hypothesis is that 
substances released from metabolically active muscle act locally to hyperpolarize 
adjacent endothelial cells. The endothelial cell may then transmit this membrane 
potential along the endothelial walls via gap junctions (membrane low resistance areas) 
to preceding resistance vessels (reviewed in (241) (248) (249)). Maximal perfusion of 
highly active muscle then occurs via signal transmission from the small arterioles 
(regulating capillary perfusion) to feed arteries external to the muscle (reviewed in 
(248)). 
The direct application of NE, acetylcholine (ACh) and bradykinin (BK) to 
capillary endothelial cells of the rat extensor digitorum longus (EDL), constricted (with 
NE) or dilated (with ACh and BK) upstream arterioles (168). Super-perfusion 
experiments that were designed to omit the diffusion of released substances to the 
arterioles, led the authors to conclude that a dilatory signal was electronically conducted 
from the capillary to the arteriole via the endothelial cells. Therefore, a muscarinic 
receptor antagonist applied to the arteriole did not prevent vasodilatation after ACh 
administration to the capillary. Similarly K + caused depolarization of the endothelial cell 
membrane (reviewed in (172)). Substances released from the muscle fibres may cause 
local vasodilatation of post-capillary venules and subsequent vasodilatation in proximal 
arterioles. 
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It is also possible that capillary filtration is controlled by vasodilatation of the 
post-capillary venule by insulin. Endothelial NOS (eNOS) is distributed throughout the 
SM vasculature, including the venular vessels (250). A shear-stress related increase in 
NO release has been detected in the venules of SM with increased flow rates (142). A 
signal may then be transmitted up the vascular tree to the resistance vessels. Moreover, 
reduced oxygen tension and pH in the venule, with contraction, may stimulate RBC to 
release ATP. Direct application of ATP to venules results in dilation of upstream 
arterioles (52), and increases in venular ATP concentration cause dilation of adjacent 
arterioles (105). Moreover, the diffusion of oxygen via arterioles to adjacent tissue has 
been reported (70). Although capillary hydrostatic pressure is maximal with increased 
arteriole diameter and decreased venular diameter, it would seem logical that dilation in 
both would occur to allow removal of the extra flow and muscle metabolites. 
As discussed above, capillary flow may be influenced by both the arteriole and 
venular network, and these changes are not always dependent on total blood flow. It 
therefore follows that fuel partitioning and uptake in SM will not always follow total 
flow. Anomalies in SM substrate uptake and blood flow have been well documented. 
The differences have been attributed to SM flow heterogeneity (46) (48). 
Skeletal muscle capillaries 
In 1923 August Krogh observed that a large number of capillaries in resting SM 
in frogs and guinea pigs contained either no RBC, or contained RBC that were 
stationary (147). Either electrical stimulation or massaging of the muscle resulted in 
substantial capillary recruitment. This phenomenon had already been noted after the 
application of heavy metals (reviewed in (147)). Krogh's model for oxygen exchange, 
however, described the capillaries of SM to be of homogenous distribution, so that all 
areas received oxygen from the nearest capillary (146). Despite this, it is widely 
recognized that the vessels in most muscles have a more random anatomical spacing. 
Goldman and Popel (86) have recently published complex computational models for 
certain capillary arrangements in SM and found that maximal tissue oxygen occurs in 
tortuous capillaries with concomitant cross-connections to other capillaries. Therefore, 
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due to the tortuosity of capillaries in shortened SM, Krogh's model may not be 
applicable (203). 
1.1.3 History of anomalies of substrate delivery in skeletal muscle 
1.1.3.1 Isolated, incubated muscle preparations 
Insulin has been shown to increase 3-0-methylglucose uptake in the incubated 
soleus, however this was a smaller increment than obtained in hindlimb perfusion 
experiments (despite having a larger basal glucose uptake) (138). Although the creatine 
phosphate levels are comparable to fresh muscle, it is likely that in the soleus, the inner 
core may be anoxic, resulting in a higher basal glucose uptake, that is not apparent in 
muscles with less mitochondria (for example in the extensor digitorum longus (EDL)). 
The above effects are independent of the muscle vasculature, regulating flow patterns, 
and are often vastly different from in situ and in vivo preparations. During in vivo 
muscle preparations SM oxygen and nutrient supply is regulated by haematocrit, 
haemoglobin oxygen saturation, nutrient concentration and vascular delivery (reviewed 
in (116)). 
1.1.3.2 A dual skeletal muscle microcirculation 
In 1977 Grubb and Snarr (100) reported that IMGU was not further increased 
after a critical flow rate in perfused rat hindlimb. They suggested that the excess flow 
was escaping into another set of vessels that were "too thick" for optimal exchange. 
Individuals that were prone to psychological "nervous attacks" were noticed to have 
higher venous oxygen saturation than "less excitable" subjects (113). Similarly, infusion 
of NE to simulate this effect, resulted in increased flow however no change in calculated 
oxygen consumption (113). The bisphasic response of adrenaline on SM oxygen uptake 
was demonstrated in 1931 by von Euler (291) in the perfused hindleg of dogs. 
Adrenaline was found to both decrease and increase oxygen consumption (V02) at 
concentrations of 10 -8.5 and 10-9 — 10-10 M respectively. 
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A key paper in presenting the anomalies of blood flow and oxygen uptake was 
reported by Pappenheimer (192), where a reduction in blood flow during intravenous 
administration of adrenaline to the isolated perfused dog hindlimb, increased V02. 
Alternatively, in the isolated perfused dog gastrocnemius, increased flow caused by 
electrical stimulation of the associated tibial nerve, reduced the arterial/venous oxygen 
extraction. The transient increase in V02 noted after stimulation contributed to the 
complicated recovery period and suggested these vasoconstrictor nerves have different 
localities and responses. These experiments also suggested that vasoconstrictor nerves 
may allow alterations in innate flow patterns within SM to allow perfusion of different 
areas (with different endothelial surface areas), depending on muscle requirements. 
Importantly, these observations did not correlate with changes in total blood flow to the 
muscle; from this he proposed that a dual vascular system existed within SM (192). 
Alternative metabolic effects in a muscle with constant total flow, led Renkin to 
propose two metabolically and spatially distinct areas of the vasculature within SM 
(219). It appeared that certain vasomodulators were acting to increase capillary 
perfusion, while different doses or different vasoactive substances increased flow to the 
"escape" vessels that bypassed the capillary network. 
Failure to produce convincing evidence for the existence of true arteriovenous 
anastamoses in SM (199) (257) (106) (11) led to the search for other possible anatomical 
candidates to encompass the "escape" circulation. Barlow et al. (12) recorded an 
increase in the clearance of 24Na injected into the muscle bed during simultaneous 
infusion of intravenous epinephrine. The opposite response occurred with epinephrine 
infusion when the 24Na was injected into muscle septa and tendons. Lindbom and Arfors 
(156) noted that feeding arterioles of the tenuissimus muscle often supplied both muscle 
capillaries and vessels of the neighboring connective tissue (CT). This view was 
supported by Grant and Wright (95). Using intravital microscopy, Borgstrom et al. (32) 
showed that the rabbit tenuissimus muscle contained capillaries and adjacent CT that 
were supplied by the same feed arterioles. 
Our laboratory has produced mounting evidence to infer two distinct regions of 
SM blood flow (46) (48). The effects produced by the addition of certain 
vasoconstrictors cannot be explained simply by increases in oxygen consumption, due to 
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the energy used by smooth muscle (the proposed "hot pipes" theory). While this may 
contribute to some of the energy consumed during vasoconstriction, certain 
vasoconstrictors cause a decrease in SM oxygen consumption (211). In addition, the 
effects of vasoconstrictors on metabolism are absent in incubated muscle systems (211), 
implicating the importance of substances delivered via the vascular route. Moreover, 
these metabolic effects are not seen during concomitant infusion of a vasodilator, 
implying vascular effects of these agents. Changes in vascular permeability, and thus 
conditions for metabolic exchange, were ruled out, as the vasoconstrictor, 5-HT, that 
decreases oxygen uptake in the perfused rat hindlimb, is known to increase vascular 
permeability (reviewed in (167)). Taking these results into consideration, the most likely 
explanation for the two responses is the existence of two distinct, parallel pathways in 
SM in which blood can flow that are linked by a common transverse arteriole. One 
consists of the muscle capillaries and the other of a different set of vessels probably 
located in the muscle septa and tendons (181). 
Nutritive flow 
The pathway offering the greatest potential for nutrient exchange and therefore 
having the highest metabolic capacity (i.e. oxygen consumption), is paralleled by 
increases in the uptake of glucose, and the efflux of purines, pyrimidines and lactate 
(46). This occurs with no increase in total blood flow to the muscle. This vascular route 
has been termed nutritive due to the positive effect on metabolic rate, and is thought to 
consist of capillaries directly nourishing myocytes. Therefore, increasing access to this 
area is analogous to the capillary recruitment seen with insulin. The capillaries run 
parallel to the muscle fibres and are in close contact for nutrient exchange. Whether the 
increase in flow is the stimulus for increased metabolism, or visa versa, remains to be 
determined. Isolated SM was found to undertake a transient overcompensation in 
oxygen consumption after a period of oxygen deprivation. This oxygen payback was 
determined to be around 70% of the total oxygen lost during anoxia (76) (230) and 
suggested that oxygen can influence its own uptake. Therefore an increase in oxygen 
delivery (and that of other substrates) may increase its own metabolism. Another 
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possibility is that a shear stress-related paracrine signal, caused by the increased flow, is 
responsible for the increased metabolism (reviewed in (46)). It is important to note that 
increased metabolism by resting muscle (when exposed to appropriate vasoconstrictors) 
is always associated with increased perfusion pressure. As eluded to earlier, insulin does 
not affect pressure or oxygen uptake by the perfused hindlimb; this may be significant. 
Manipulating the degree of capillary recruitment allows almost instantaneous 
alterations of exchange efficiency. Until now, insulin has been discussed as a major 
effector of capillary recruitment, however other vasoactive substances are able to 
manipulate the micovasculature for maximal perfusion. These have been termed Type A 
vasoconstrictors and include low frequency sympathetic nerve stimulation (102), a 1 - 
adrenergic agonists (including NE (<0.1p,M) (180)), All (53), vasopressin (53) and low 
doses of various vanilloids (98). 
The infusion of type A vasoconstrictors into the perfused rat hindlimb causes 
substantial red blood cell (RBC) washout (180), indicative of the recruitment of nutritive 
capillaries that are not perfused at rest. Vascular corrosion casting revealed higher flow 
dispersion throughout the hindlimb after infusion of the Type A vasoconstrictors, 
despite no increase in cast weight. Moreover, these vasoconstrictors increased the 
amount of fluorescent dextran that could be trapped in these capillaries after removal of 
the constriction (180). Nutritive flow in SM is currently determined using a variety of 
techniques including laser doppler flowmetry (45) (44), the conversion of 1-MX by the 
capillary endothelial enzyme xanthine oxidase (209) and following the intravascular 
pathway of albumin microbubbles (287). 
Vasoconstrictors (Type A) thought to increases the perfusion of this area, 
probably act by impeding perfusion of a second area (termed non-nutritive). Flow can 
then only pass through the capillaries. Maximal perfusion of this nutritive area is 
thought to occur during stages of increased metabolic requirement, for example during 
exercise. 
It is of interest to determine whether capillary recruitment with the Type A 
vasoconstrictors acts via similar mechanisms to insulin-mediated capillary recruitment 
(as discussed earlier). Diversion of flow to the capillary network (after the addition of a 
Type A vasoconstrictor) and an associated pressure increase, appears to stimulate 
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metabolism (oxygen and glucose uptake, lactate output etc.). Increased metabolism may 
therefore produce a signal molecule that is released from the myocyte, which may then 
cause vasodilatation (along with that from shear-stress) to further promote access to this 
pathway. In preparations such as the perfused rat hindlimb however, the vasculature is 
already fully dilated, so no complementary dilatory effect of the Type A 
vasoconstrictors would be seen. Type A vasoconstrictors may also cause some 
constriction of the post-capillary venules, increasing capillary hydrostatic pressure and 
thus facilitating exchange. These two factors thus suggest that increased uptake is from 
increased delivery, which can be manipulated via vasoactive agents through either 
constriction or dilation). 
Non -nutritive flow 
Blood diverted to the non-nutritive shunt vessels accesses an area within the SM 
with poor potential for nutrient exchange. Vasoconstrictors accessing this area are 
termed Type B and include 5-HT (211), high doses of NE (2.511M (180)), and high 
doses of vanilloids (98). A significant reduction in oxygen consumption with no 
decrease in total flow is observed in perfused hindlimb muscles, that is not apparent in 
incubated muscle systems (211). 
Less than half of the blood flowing into SM is thought to access this area in 
resting muscle (108). These non-nutritive vessels are located within individual muscles, 
as fluorescent microspheres remain trapped in dissected muscle after selective perfusion 
of non-nutritive sites. In addition, there appears to be a reduction in surface muscle flow 
as recorded by a decrease in the external laser doppler signal with 5-HT (measuring non-
vectorial movement of RBC). Whether this is due to a decrease in flow dispersion or 
whether the non-nutritive vessels are not on the muscle surface remains unresolved. 
Using internal probes, non-nutritive sites can be detected within the muscle, but are not 
as frequent as nutritive sites (45). Other researchers suggest that these vessels are on the 
edge of muscles (311) and our laboratory has made convincing measurements of non-
nutritive flow in muscle tendons (181). The tendon vasculature is connected to vessels 
present in the muscle perimysium (CT surrounding the fibre bundles). This CT may 
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therefore house the non-nutritive vessels. If so, the tendon may reflect non-nutritive flow 
changes on a smaller scale. 
Studies using microsphere entrapment have shown that the non-nutritive vessels 
are slightly larger than the true muscle capillaries, and are thus produce less resistance to 
flow (288). As discussed earlier, 5-HT constricts larger arterioles or possibly even feed 
arteries, therefore it is likely that during 5-HT infusion the flow passes down the 
pathway of least resistance (the non-nutritive vessels). High doses of NE similarly 
constrict larger arterioles and/or feed arteries. This too would attenuate capillary flow, 
thus redirecting blood through non-nutritive vessels. 
Non -nutritive flow and insulin resistance 
5-HT infusion decreased IMGU in the perfused rat hindlimb (211) and decreased 
conversion of the exogenous substrate 1-MX to 1-MU (209). In addition, an analogue of 
5-HT (a-methyl 5-HT) caused insulin resistance in vivo with diminished metabolism of 
1-MX due to insulin (210). Non-nutritive flow therefore produces an acute state of 
muscle insulin resistance, probably by denying access of glucose and insulin to the 
capillaries. During long stages of physical inactivity and enhanced non-nutritive flow, 
changes in gene expression may lead to detrimental glucose tolerance and ultimately 
contribute to insulin-resistance (reviewed in (47)). Reports on SM blood flow with 
insulin resistance have been conflicting. It has been reported that NIDDM patients have 
a lower basal leg blood flow that remains unstimulated with insulin (149). Others have 
found no change (258). While there is no clear association between total flow and 
insulin resistance, it is likely that insulin resistance is associated with decreased capillary 
flow. 
1.1.4 Mechanisms of fuel metabolism and insulin resistance 
Insulin resistance may be loosely defined as a diminished insulin response 
(reviewed in (34)), resulting in decreased IMGU by SM, which is largely due to 
attenuated translocation of GLUT4 to the plasma membrane (reviewed in (237)). It is 
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likely that capillary flow (and thus glucose and insulin delivery) is reduced in Type 2 
diabetes, and an imbalance of fatty acid and glucose may also largely determine SM 
insulin sensitivity. 
1.1.4.1 Substrate competition 
Infusion of fatty acids in vivo causes many of the alterations seen with insulin 
resistance (including hyperinsulinaemia, hypertriglyceridaemia and hypertension) and 
may therefore be a major contributing factor to the pathophysiology of obesity and 
diabetes (239). These diseases represent a defect in the uptake and release of substrates 
by most tissues, in particular AT, SM and liver. AT resistance to insulin results in 
uncontrolled lipolysis and a large release of FFA into the blood. Released FFA may 
have adverse affects on SM insulin sensitivity and glucose uptake. Since SM accounts 
for the majority of insulin-mediated glucose uptake by the body, investigation into the 
defective mechanisms in this tissue are of fundamental importance. 
The Randle Cycle 
Mechanisms for the reduction in glucose uptake/phosphorylation and glycogen 
synthesis with insulin resistance are not well understood; FFA have largely been 
implicated as a mediator. Elevated FFA appear to be linked to the reduction in oxidative 
and non-oxidative glucose disposal in SM. In 1963 Randle (206) proposed the 
Glucose/Fatty Acid Cycle as a mechanism for increased fatty acid oxidation inhibiting 
glucose uptake/oxidation, and this has been demonstrated in both rats and humans (128) 
(300) (135) (176) (224) (220). Under the Randle hypothesis, a buildup of cellular 
glucose 6-phosphate occurs from elevated mitochondrial ratios of acetylCoA/CoA and 
NADH/NAD+ (from increased FFA uptake and oxidation) that regulate pyruvate 
dehydrogenase by pyruvate dehydrogenase kinase. The additional buildup of 
cytoplasmic citrate (an allosteric regulator of phosphofructokinase) augments this effect. 
Elevated glucose-6-phosphate levels will inhibit hexokinase and ultimately reduce 
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insulin-mediated glucose uptake. Subsequent pyruvate build-up may also increase 
lactate formation, a substrate for gluconeogenesis, thus contributing to hyperglycaemia. 
Lack of evidence for the Randle cycle in human SM 
While the Randle Cycle has gained considerable acceptance, it could not be 
demonstrated in the perfused rat hindquarter with oleate or palmitate using 
supraphysiological insulin concentrations (232). In addition, in pmi28 myotubes 
palmitate but not mysitic or stearic acid decreased IMGU (266). There appears to be 
even less evidence for its existence in humans. Despite Boden et al. (27) demonstrating 
an increase in the ratio of mitochondrial acetylCoA/CoA with elevated FFA, no increase 
in muscle citrate or glucose-6-phosphate was observed (226) (27). Moreover, FFA have 
been shown to inhibit pyruvate dehydrogenase but only modestly inhibited glucose 
oxidation (135). SM hexokinase activity was not different between lean humans and 
those with NIDDM (134). In addition, effects on glucose disposal are dependent on FFA 
concentration (26). Importantly, elevated FFA are not always reported in patient with 
NIDDM, and therefore may not be causative (202). 
Type-II diabetics have a large intracellular pool of TG in SM (73) (92) (110) 
which may cause increased rates of lipid oxidation (a key component of the Randle 
cycle). Ellis et al. (69) have published data suggesting that the intracellular 
accumulation of long chain acylCoA is as important as the blood-borne FFA (27) (227) 
in determining muscle insulin-sensitivity, which appears to be negatively correlated to 
the intramyocellular store (reviewed in (111)) and to the activation of glycogen synthase 
by insulin (197). This is despite the fact that larger intramyocellular pools also occur in 
athletes (who are highly insulin sensitive). This apparent paradox may be explained by 
the differing morphology and location of the intracellular pools, which are larger and 
more closely associated with the mitochondria in athletes (reviewed in (111)). 
While increased fat oxidation may cause some decrease in glucose disposal, an 
initial defect in glucose oxidation (as suggested by Randle) may not be the cause. 
Reports on glucose-6-phosphate levels in muscle after the infusion of TG emulsions 
such as Intralipid® have been conflicting (227) (27). It appears that the onset of glucose 
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uptake is time dependent. Boden et al. (27) reported an initial decrease in glycolysis was 
compensated for by an increase in glycogen synthesis, causing no net change in glucose 
uptake. After approximately 2 hours of Intralipid ® infusion, glycogen synthesis was also 
attenuated causing a reduction in muscle glucose uptake. In contrast, Roden et al. (227) 
however, saw an initial reduction in glucose transport/phosphorylation due to elevated 
FFA followed by reduced glycolysis and glycogen synthesis. 
Alterations in dietary FFA may modify membrane phospholipid content. 
Membrane phospholipids are indicative of insulin sensitivity and may alter insulin 
binding, and the extent of saturation of membranes lipids is also correlated to the 
amount of lipid stores within the myocyte (reviewed in (111)). Alternatively FFA may 
act indirectly to inhibit muscle glucose disposal (i.e. effects on other tissues), for 
example, alter insulin-secretion (41) and hepatic glucose and TG production. 
The Reverse Randle Cycle 
Despite Randle's proposition that enhanced FFA oxidation decreases that of 
glucose, it has been shown that SM glucose oxidation is actually higher in Type 2 
diabetics than people with normal insulin tolerance under fasting hyperglycaemia 
(reviewed in (133)). Once glucose has entered the myocyte there appears to be no 
reduction in glucose disposal with insulin resistance, suggesting that it is the transport 
that is limiting its utilization (227). 
The 'Reverse Randle cycle' was proposed in a study utilizing the 
hyperglycaemic, hyperinsulinaemic clamp in the human forearm (253). These 
researchers found that a decrease in glucose-6-phosphate impaired glucose oxidation, 
however if glucose uptake was maintained during a period of elevated FFA, FFA 
oxidation was inhibited, despite no reduction in glucose oxidation. This is in direct 
opposition to the Randle cycle and suggests this cycle may be peculiar to rat heart and 
diaphragm. 
Failure to reproduce this cycle in the perfused rat hindlimb, led Reimer et al. 
(217) to suggest that increased glucose degradation to glycerol-3-phosphate increases 
the potential for FFA esterification to form TG (instead of undergoing oxidation). 
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Moreover, glycerol-3-phosophate acyl transferase is stimulated by insulin (170), 
however with insulin resistance it would be expected that reduced stimulation of this 
enzyme would reduce the potential for FFA to deposit as intracellular TG. However, 
insulin resistance is associated with increased SM TG deposits (73) (92) (110). SM LPL 
is also reduced in type-2 diabetes (202), and is thus not likely to be contributing to the 
increased SM TG. 
Increased levels of malonylCoA increasing long chain acyl CoA with insulin 
resistance 
Increased glucose oxidation leads to the build-up of long chain acyl CoA, which 
may be the cause of insulin resistance. SM acetyl CoA carboxylase is regulated by 
phosphorylation or cytosolic citrate. A combination of insulin and glucose (and high 
fructose) have been shown to activate acetylCoA carboxylase 13, therefore increasing 
malonylCoA formation (65) (238). The phosphorylation and inactivation of acetylCoA 
carboxylase by AMP-activated protein kinase (AMPK) reduces FFA synthesis. In 
addition, malonyl CoA perturbs the passage of long chain fatty acylCoA's into the 
mitochondria via allosteric inhibition of carnitine palmitoyl transferase 1 (reviewed in 
(234) (107)). AMPK also phosphorylates and subsequently inhibits hormone sensitive 
lipase, preventing FFA release. Therefore AMPK increases FFA oxidation, but inhibits 
FFA synthesis (preventing energy-requiring processes). AMPK also phosphorylates 
glycogen synthase, resulting in increased glucose oxidation and decreased fatty acid 
oxidation (reviewed in (107)). 
By a similar mechanism it has been proposed that SM hexokinase IV 
(glucolcinase) is inhibited by long chain Acyl CoA via the hexosamine-phosphate 
pathway (275). The resulting decrease in glucose-6-phosphate, causes a build up of 
cellular glucose which has adverse affects on GLUT4 translocation (attenuating glucose 
uptake and utilization) (134). It has recently been reported that there is a colocalization 
of acylCoA synthetase-1 and GLUT4 in adipocytes suggesting direct influence of one 
over the other (256). 
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Reduced lipid oxidation may contribute to intracellular accumulation of long 
chain acylCoA's increasing diacylglycerol and activating protein kinase C (in particular 
6 and 0 isoforms) therefore inhibiting IRS-1 and insulin receptor activation (97). These 
mechanisms are outlined in the diagram below (Fig. 1). 
Amino acids may also alter the metabolism and storage of glucose. Leucine 
inactivates glycogen synthase kinase-3, therefore increasing glycogen storage (196). 
Glutamine also stimulates glycogen synthesis in addition to attenuating the rate of SM 
protein synthesis and breakdown (reviewed in (221)). 
1.1.5 Summary 
Many possible mechanisms may therefore be causal of insulin resistance. Most 
are controlled by substrate competition and availability and are likely to be greatly 
influenced by the existence of two vascular networks operating in parallel within SM. 
Altering the extent of capillary recruitment or capillary de-recruitment may provide 
some link between the inability of insulin to recruit capillaries and insulin resistance. 
Insulin Receptor 
Glucose 
	Cot:TramIste ® 
Fatty Acyl CoA'v 
Malonyl CoA 
Glucose 	 V 
Acetyl CoA 
Figure 1. Possible mechanisms for substrate-induced insulin resistance (133). 
1.2 Substrate affecting skeletal muscle blood flow 
While insulin may affect nutrient uptake by increasing muscle total flow, we 
believe that uptake is more closely correlated with capillary flow. The previous section 
discussed the potential biochemical mechanisms for SM capillary recruitment with 
insulin. Possible controlling mechanisms are shown here in Fig. 2. Two main ideas have 
been proposed. The first is that insulin may act directly on the muscle, endothelial cell, 
SM or vascular smooth muscle to produce NO. In fact, NOS is located throughout the 
myocytes and SM vasculature (250). Another possibility is that increased metabolism in 
the myocytes (from insulin infusion) results in the production of metabolites that cause 
the release of NO. The metabolites (e.g. adenosine, IC, CO2 etc) might act locally to 
hyperpolarize the capillary endothelial cell, which is then transmitted to the preceding 
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arterioles (as discussed in the first section of this chapter). Alternatively, released 
metabolites may act on more remote locations in the SM vasculature by diffusion, to 
either act directly on the smooth muscle or the endothelial cell, resulting in NO 
production. Whether the vasodilatory effect of insulin is due to direct effects on the 
endothelium (i.e. due to insulin signaling in the endothelial cell) or due to metabolic 
effects in the myocytes, will be difficult to determine. One approach will be to utilize 
substances that inhibit metabolism in muscle cells, and then subsequently determine if 
the vasodilatation with insulin is retained. 
1.2.1.1 Insulin signaling and elevated fatly acids 
In insulin resistance we believe that the ability of insulin to recruit capillaries is 
either reduced or absent. It is likely that abnormal levels of glucose, fatty acids and 
possibly amino acids play some role in contributing to this endothelial dysfunction. Any 
point in the pathways postulated in Fig. 2, may be disrupted by abnormal substrate 
levels, which may affect insulin sensitivity. 
insulin 
+ 
Metabolites (adenosine, K+, CO2 etc) 
+ NO 	 + 
Vascular smooth muscle relaxation 
	
+ NO 	Ail 	+ NO 
Muscle 	insulin 	Endothelial Cell 
+ 	 + 
insulin insulin 
Figure 2. Possible mechanisms for insulin-induced capillary recruitment 
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Glucose, amino acids and fatty acids have some effects on muscle total flow. 
Glucose itself has been shown to increase leg blood flow (49) but fructose has not (290). 
Lundholm et al. (159) infused an amino acid cocktail into the human leg which 
produced positive effects on glucose uptake, lactate efflux, leg blood flow and oxygen 
consumption. In contrast, FFA are usually reported to have adverse affects on muscle 
blood flow, in particular, FFA have been reported to effect nitric oxide-induced 
vasodilatation by insulin (261). As a result total flow is reduced. However FFA may also 
have important effects on capillary flow. By using an in vivo assay to measure 
exogenous 1-MX metabolism by xanthine oxidase (an enzyme located in muscle 
capillary endothelial cells) we can determine the effects of abnormal substrate levels on 
the extent of capillary perfusion. It is therefore of interest to determine if elevated FFA 
interfere with insulin-mediated capillary recruitment. 
Insulin has been linked to the stimulation of eNOS via activation of PKB/Akt 
(62), probably in both muscle and endothelial cells. In addition, as described in the first 
section, NOS is distributed throughout the vasculature (including the endothelial cells 
lining capillaries, arterioles and venules, and also in the vascular smooth muscle and the 
myocytes themselves (250)). Insulin can therefore activate NOS and stimulate NO 
production in any of these tissues. 
FFA have been found to attenuate endothelial dependent dilation but not 
endothelial independent vasodilatation, suggesting direct effects of the FFA on the 
endothelial cell (262) (155). Disruption of P13-Kinase affects PKB/Akt situated 
downstream from IRS-1 (the primary substrate for the insulin receptor) which directly 
phosphorylates NOS (62). Therefore, FFA and FFA derivatives (e.g. ceramide) are able 
to influence endothelium dependent vasodilatation and possibly capillary recruitment. 
Palmitic acid also decreased insulin stimulated phosphorylation of the insulin receptor, 
IRS-1 and PKB/Akt (266). Moreover, FFA have been shown to enhance the activity of 
PKC 0, which subsequently inhibits insulin signaling, in particular IRS-1 associated 
P13-Kinase (97). 
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Another possibility is that FFA are able to interfere with the NO release or 
insulin signaling in the vascular smooth muscle. Insulin has been shown to increase 3H 
2-DG uptake by perfused aortic vascular smooth muscle cells of lean Zucker rats, which 
was inhibited in the obese Zucker despite significant amounts of GLUT4 in this tissue 
(10). While these results suggest that vascular smooth muscle is an insulin-sensitive 
tissue, there is little evidence to infer that the vascular smooth muscle associated with 
SM is also. 
Knockout mice for the endothelial cell insulin receptor have been shown to have 
no deficiency in SM glucose uptake/disposal (285). From this it is reasoned that the 
muscle is the key factor regulating insulin sensitivity. These experiments, however, may 
have been more convincing if an insulin clamp was used, instead of a glucose tolerance 
test, to determine insulin sensitivity. The vascular responsiveness to insulin in these 
mice remains to be determined. However, Huang et al. (118) found in eNOS knockout 
mice that some dilation was maintained with ACh, due to the release of an unknown 
endothelial derived hyperpolarizing factor. Insulin may therefore stimulate a signal in 
SM (possibly from increased metabolism, e.g. adenosine, K+, CO2 etc) that acts locally 
on capillary endothelial cells. By a mechanism discussed earlier the metabolites may 
hyperpolarize the endothelial cell and this is conducted to the arteriole for the production 
of NO. NO may then diffuse to the underlying smooth muscle for vasodilatation, and 
capillary recruitment. Alternatively the metabolite may diffuse throughout the muscle to 
ultimately reach the endothelial cell of the preceding terminal arteriole and produce NO 
or NO may diffuse from venules adjacent to arterioles. Due to the presence of NOS in 
the myocytes (250) it is also possible that metabolites released from glucose oxidation 
may act locally to produces NO in the myocyte. 
As suggested earlier, one metabolite that may be upregulated as a result of 
glucose metabolism, is adenosine. Dela and Stallknecht (61) saw no increase in the 
interstitial concentration of adenosine with insulin (as measured by microdialysis). 
Abbink-Zandbergen et al. (1), however, showed that addition of the adenosine receptor 
antagonist theophylline, to an insulin clamp in humans, prevented the insulin-induced 
increases in total blood flow. Therefore insulin may release adenosine in a similar 
manner to exercise or hypoxia (163). During hypoxia it is thought that the release of 
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adenosine from the SM may directly affect smooth muscle or endothelial cells. 
Alternatively adenosine may act on receptors on the SM to release K + for subsequent 
vasodilatation (either directly or indirectly (163)). 
It is therefore an appealing hypothesis that metabolites released from SM may 
cause vasodilatation ('metabolic coupling'). However against this fact, fructose infusion 
with concomitant increases in carbohydrate oxidation did not increase blood flow in 
humans (290). 
A proposed mechanism for the reduction in glucose uptake with FFA has been 
shown (reviewed in (194)) where FFA inhibit P13-Kinase and IRS-1 phosphorylation. 
The inhibition of P13-Kinase by FFA does not appear to be confined to the endothelial 
cell. The inhibition of muscle P13-Kinase will also affect muscle metabolism, and 
appear to develop at the same time (i.e. after 2 hours in humans). Therefore the effects 
on the myocyte and endothelium cannot be separated. Moreover, while FFA are known 
to attenuate endothelial dependent vasodilatation, they have also been shown to reduce 
endothelial independent vasodilatation (160). 
1.3 Summary of literature and research aims 
Two vascular networks exist in SM. One is likely to consist of the muscle 
capillaries, and the other, the associated CT (septa and tendons). Insulin may therefore 
recruit capillaries by drawing flow from the CT, resulting in no change in total flow to 
the muscle. Certain vasoconstrictor agents have also been shown to alter the distribution 
of flow between the two compartments, without changing total flow. Most current 
studies to date report on the effects of increased metabolites on total blood flow, but as it 
now appears apparent that the perfusion of certain subsets of capillaries is more 
important, this effect needs to be determined. Conversely, the elevated FFA associated 
with insulin resistance may contribute to the inability of insulin to recruit capillaries 
(therefore denying access of glucose and insulin to the muscle). Clearly the effects of 
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substrate metabolism and blood flow can not be separated as each exert control over the 
other. 
Research aims: 
1. To determine how vasoactive agents affect the uptake of blood-borne metabolites 
(glucose, amino acids and fatty acids (both albumin bound and fatty acids derived 
from chylomicron-TG)) in SM. 
This will be approached by using vasoconstrictors in the perfused rat hindlimb to 
determine the uptake of radiolabeled substrate. 
2. To determine whether elevated FFA interfere with insulin-mediated glucose uptake 
and capillary recruitment? 
This will involve the use of the euglycaemic hyperinsulinaemic clamp to 
determine the effects of elevated FFA on muscle [ 3H] 2-deoxyglucose uptake 
and insulin mediated capillary recruitment (1-MX metabolism). 
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CHAPTER 2 
2 General Methods 
2.1 Introduction 
To assess the uptake of blood-borne metabolites by SM, the perfused rat 
hindlimb was used in chapters 3, 4 and 5. The surgery and general perfusion protocol is 
described below. Any deviations or other details from this method are outlined in 
individual chapters. The experiments assessing blood flow in the rat in vivo (Chapter 6) 
are outlined in the "methods section" of that chapter. 
2.2 Perfused rat hindlimb 
2.2.1 Animals 
Male hooded Wistar rats were cared for according to the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes (1990 Australian 
Government Publishing Service, Canberra). Rats were housed in the local animal house 
and kept on a 12 hour light/dark cycle maintained at 22°C. All animals were allowed 
free access to water and a standard laboratory chow (Gibson's, Hobart) of 21.4% 
protein, 4.6% lipid, 68% carbohydrate and 6% crude fiber with added vitamins and 
minerals. 
2.2.2 Krebs buffer 
Krebs Henseleit buffer consisted of 
118 inM NaC1 
4.74 mM KC1 
1.19 mM KH2PO4 
1.18 mM MgSO4 
30 
25 mM NaHCO3 
5.0 mM (Chapter 5) or 8.3 mM glucose (Chapters 3 and 4). 
2.2.3 Perfusion buffer 
The perfusion buffer used in chapters 3, 4 and 5 are outlined in the individual 
chapters and consisted of Krebs buffer containing either 6% Ficoll ® (Chapters 3 and 4) 
or a combination of bovine serum albumin (BSA) and bovine RBC (Chapter 5). After 
gassing the buffer for >30 min with either carbogen (95% 02: 5% CO2) (Chapters 3 and 
4) or a mixture of 95% air: 5% CO2 (Chapter 5), CaC12 was added to a final 
concentration of 2.54 mM. All buffers were filtered through a 0.45 1.1.1n filter before use. 
Individual recipes for each perfusion type are outlined in the methods section of each 
results chapter. 
2.2.4 Surgery for perfusion of the rat hindlimb 
An intraperitoneal injection of pentobarbitone sodium was given to anaesthetise 
rats (5-6 mg 100e body weight) before the surgical procedure. Surgery was performed 
essentially as described previously (233) (53), with minor changes outlined below. 
Ligatures were placed around various blood vessels to isolate the left hindlimb for 
perfusion (shown in Fig. 1). 
After loss of sensory perception, a string ligature was tightly tied around the left 
tarsus and the base of the tail to prevent perfusion of the left foot and tail. The 
abdominal skin was cut to gain access to the underlying midline of the body wall. An 
incision was made along the midline and extended up from the pubic symphis to the 
xyphoid process covering the sternum. Both the left and right epigastric vessels were 
ligated with cotton and a small section of the body wall between the two ligatures (upper 
and lower) was removed from either side. A ligature was tied around the left skin vessel 
(adjacent to the left femoral vein and artery). The testes were tied and removed, and the 
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Figure 1 Surgery for the perfused rat hindlimb 
Diagrammatic representation of blood vessel ligation and cannulation. Modified from 
Ross (229) and Greene (96). 
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bladder and seminal vesicles were tied together and the seminal vesicles were removed. 
Two ties were placed around the lower descending colon at a distance of approximately 
5 min and a cut was made between the two ties. A third tie was placed around the 
duodenum and the superior mesenteric vessel, just proceeding the stomach, and the 
gastrointestinal tract was subsequently removed in its entirety. A single ligature was 
placed around the left iliolumbar, ureter and the internal spermatic vessels. An identical 
ligation was performed on the same vessels of the right side. In all experiments only the 
left hindlimb was perfused, therefore flow to the contralateral limb was prevented by 
ligating the right common iliac vessel. 
The inferior vena cava was separated from the descending aorta, and two silk ties 
were placed under each at the level of the renal and iliolumbar vessels. In some 
experiments, heparin was subsequently injected (200 IU) into the vena cava above the 
renal vessel. A one-minute delay was allowed, to ensure adequate circulation of the 
heparin before commencement of the surgery. The vena-cava tie, adjacent to the renal 
vessel, was secured and an 18 Gauge Terumo Surflow cannula (with needle) was 
inserted into the vein. The needle was removed to allow blood flow and the cannula 
secured with the lower tie. The same procedure was followed for cannulation of the 
aorta, however this was achieved using a 20 Gauge Terumo Surflow cannula attached to 
a 1 ml syringe containing 0.9% saline. Insertion of this cannula was facilitated by the 
use of a small needle threader. The entire surgical procedure did not exceed 30 minutes. 
The rat was immediately placed on a water-pad heated to 37°C, and tubing was 
attached to the aorta cannula for delivery of the perfusion buffer. The hindlimb was not 
without flow for more than two minutes. A tube was attached to the venous carmula to 
allow collection of the venous effluent in a waste bucket, or for re-circulation into the 
buffer reservoir (see chapters 3, 4 and 5 for exact method). The rat was then killed with 
a lethal dose of nembutal by intracardiac injection. A string ligature was tied around the 
rat belly at the level of the L4 vertebra to impede extraneous flow. 
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2.2.5 Perfusion apparatus 
Most experiments were conducted in a non-recirculating manner (as shown in 
Fig. 2) unless otherwise indicated. The perfusion equipment was encased in a perspex 
cabinet heated to 37°C. The apparatus shown in Fig. 2 is detailed below. 
Perfusion buffer (described in each results chapters 3, 4 and 5) was aspirated 
from the buffer reservoir via a Cole-Parmer Masterflex ® pump at a constant flow (of 
either 4 or 8 ml/min). The buffer was initially pumped into a small bubble trap within a 
water-jacketed heat exchange coil maintained at 37°C. The buffer then passed through 
silastic tubing (Dow Corning) surrounded by a carbogen-gassed lung (95% 02 / 5% 
CO2), unless indicated otherwise. Finally, the buffer was pumped into a small bubble 
trap proximal to the rat (containing an infusion port (for delivery of infused substances) 
and a side-arm attached to a pressure gauge to monitor the arterial perfusion pressure 
(PP) throughout the experiment). The buffer then entered the arterial cannula for 
perfusion of the left hindlimb. The venous effluent passed through a 0.5 ml Clark-type 
electrode to measure hindlimb oxygen consumption (V02) and for venous sampling, 
before entering the waste container. The PP and V02 was continually monitored via a 
WinDaq data acquisition system on a computer adjacent to the cabinet. 
2.2.6 Vasoactive agents 
During the perfusion vasoactive agents were either added as a bolus to the 
reservoir, or infused into the port proximal to the hindlimb via an LKB Microperpex ® 
Peristaltic pump. The dose of agent used is detailed in each chapter. 
2.2.7 Perfusion Protocols 
The perfusion protocols used in Chapters 3, 4 and 5 are shown below. The 
concentrations of all infusions are outlined in the individual chapters. 
Protocol A 
34 
CHI2-DG, 1-MX, 
[14C]sucrose, palmitate 
5-HT, Vehicle 
Insulin, Vehicle 
0 	10 20 30 40 50 60 70 80 90 100 
6 4 	0 	0 	41 	0 	0 
0 indicates venous sample 
Protocol B 
[14C]palmitate, 1-MX, 
[3H]mannitol, palmitate 
5-HT, Vehicle 
, Insulin, Vehicle 
0 	10 20 30 40 50 60 70 80 90 100 
6 6 	6 	4 	6 	6 	6 
6 indicates venous sample 
Protocol C 
[14C]T0/[3 1-1]C0 
and 5-HT/vaso/vehicle 
CCh/vehicle 
recirculate 100m1 
0 	10 20 30 40 50 60 70 80 90 100 110 
4 04 6 4O 6 6 6 6 4 6 
4 venous perfusate sample 
Protocol D 
[ 14 C]AlB, AIB 
[ 3 H]mannitol 
5-HT/All/vehicle 
In  
0 	10 20 30 40 50 60 70 80 90 100 
6 6 	6 	4 	41 	6 
4 venous perfusate sample 
2.2.7.1 Protocol A - Chapter 3 
The uptake of the non-metabolizable substrate [41] 2-DG into the non-
recirculating perfused rat hindlimb was determined under the conditions described 
above. Time 0 is the beginning of hindlimb perfusion, and all other additions are 
indicated in the boxes. The following perfusion types were conducted: 
1. controls (vehicle) 
2. insulin (Ins, 75 nM) 
3. serotonin (5-HT) + Ins (3 AM and 75 nM respectively). 
After 30 min of 2-DG infusion the radioactivity in the hindlimb muscles was 
determined. 
2.2.7.2 Protocol B - Chapter 3 
The uptake of [ 14C] palmitic acid into the non-recirculating perfused rat hindlimb 
was determined as described in the protocol above. Time 0 is the beginning of hindlimb 
perfusion, and all other additions are indicated in the boxes. The following perfusion 
types were conducted: 
1. controls (no additions) 
2. Ins (75 nM) 
3. 5-HT (3 ilM) 
4. 5-HT + Ins (3 11M and 75 nM respectively). 
After 30 min of [ 14C] palmitic acid infusion the radioactivity in the hindlimb muscles 
was determined. 
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2.2.7.3 Protocol C - Chapter 4 
To determine the effects of 5-HT and vasopressin (vaso) on chylomicron TG 
hydrolysis, the following re-circulating perfusion types were conducted: 
1. controls (no additions) 
2. 5-HT (0.5-1 gM) 
3. 5-HT + carbamyl choline (0.5-1 gM and 100 gM CCh respectively) 
4. vaso (0.5 nM) 
5-HT and vasopressin were added as bolus doses to the reservoir of some 
perfusions. In some experiments the vasodilator CCh was infused to reverse the effects 
of 5-HT on PP and V02. CCh infusion commenced before the buffer was recirculated. 
After discarding the first 30 ml of perfusate (of the 130 ml perfusion medium containing 
CLE) the remaining 100 ml was recirculated through the hindlimb for 1 hour. 
2.2.7.4 Protocol D - Chapter 5 
To assess the uptake of the amino acid analogue a amino isobutyric acid (AIB), 
the following perfusion types were conducted: 
1. Controls (no additions) 
2. Ins (18 mU/m1) 
3. AII (50 nM) 
4. All + Ins (50 nM and 18 mU/m1 respectively) 
5. 5-HT (1 gM) 
6. 5-HT + Ins (1 jiM and 18 mU/m1 respectively) 
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The hindlimbs were perfused according to the protocol shown above (protocol 
D). After a 40 min equilibration period, 50 mM AIB was infused with 400 Ci [ mg AIB 
and 40 Ci [311] mannitol for 30 min at a dilution of 1/100 (final concentration 0.5 mM 
AIB). Perfusions assessing the uptake with insulin used 18 mU/m1 of Ins added as a 
bolus to the perfusion buffer. In some perfusions, either 1 [tM 5-HT or 50 nM All were 
infused 5 min prior to AIB infusion. AIB was infused for the remainder of the 
experiment (30 min). 
Oxygen 
Electrode 
Infusion 	 Heat exchange 
Pump coil 
Buffer 
Reservoir 
Bubble trap/ 
Infusion port 
Pressure 
Gauge 
WinDaq Data 
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Figure 2. Apparatus for the non-recirculating constant flow, pump-perfused rat hindlimb 
2.2.8 Calculation of oxygen consumption (V02) 
Muscle oxygen consumption was calculated using the Fick Principle: 
V02 = cPv02_12._()__ now/1000 x 60
Muscle weight (g) 
*Where fl=  calculated from the Bunsen coefficient 
a = the volume (m1) of oxygen dissolved per ml of plasma at 0°C and 760 
mmHg. a is 0.0214 in plasma at 37°C. 
fl= a 1(22.4 x 760) 
= 0.0214 ml/L / (22.4 mM x 760mmHg) 
= 1.257 i.tmol/L/mmHg 
*Where Pa02 = arterial P02 using the calibrations from the oxygen electrode for 
the arterial, air and oxygen and using their known F02. 
Pa02 cal Ar — cal Air x (PO2 at 100% - P02 in Air) + PO2 in Air 
Cal 100%02 cal Air 
Where: cal Ar = electrode arterial calibration 
cal Air = electrode air calibration 
cal 100%02 = electrode oxygen calibration 
P02 at' 100% = 760 mm Hg — 47 mmHg (H20 vapour pressure at 37°C, due to 
the use of a wet oxygen electrode). 
= 713 mmHg 
PO2 in Air = 154 mmHg 
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*Where /3,02 = venous P02 calculated the same as the 13,02 however the value 
for cal Ar was replaced by the value for the venous effluent. 
*Where flow = perfusion flow rate in ml/min, which is defined in chapters 3, 4 
and 5. 
*Where muscle weight = total perfused muscle mass, which has been previously 
been determined to be 1112th of the body weight (for a single perfused hindlimb (223)). 
2.3 Measurement of plasma glucose and lactate 
Venous samples were immediately spun in an Eppendorf centrifuge and the 
plasma eluted into another vial. Venous and arterial (from the buffer reservoir) samples 
were analysed for glucose and lactate using a YSI 2300 STAT Plus Glucose Analyser. 
2.4 Radioactivity uptake into muscle 
After all hindlimb perfusions the soleus, plantaris, extensor digitorum longus 
(EDL), gastrocnemius red (G.Red), gastrocnemius white (G.White), and the anterior 
tibialis were removed. Individual muscles were weighed and then freeze-dried overnight 
to obtain dry weight. Muscles were re-hydrated in 1 ml of distilled H20 and dissolved in 
1 ml of eSoluene (tissue solubiliser; Packard). Muscles were digested for a few days in 
a 40°C water bath before addition of 100 ill of acetic acid and 16 ml of Amersham 
Biodegradable Counting Scintillant. Dissolved muscle samples were counted for 
radioactivity using a dual label program (to detect [ 14C] and [3H]). 
As used in Protocol A, muscles were counted for [3H] 2-DG and [ 14C] sucrose, 
and in Protocol B for [ 14C]palmitic acid and [3H]mannitol in Chapter 3. In chapter 4, 
muscles were counted for [ 14C]oleic acid and [3H] CO (Protocol C). In chapter 5, 
muscles were counted for [ 14C] AIB and [3H] mannitol (Protocol D). 
2.5 Perfusate radioactivity 
In all perfusions, venous samples were taken at regular intervals and a known 
amount was added to Amersham Biodegradable Counting Scintillant for determination 
of perfusate radioactivity (using the program described above). As used in Protocol A, 
perfusate samples were counted for [3H] 2-DG and [ 14C] sucrose, and in Protocol B for 
[ 14C]palmitic acid and [ 3H]mannitol in Chapter 3. In chapter 4, samples were counted 
for [ I4C]oleic acid and [3H] CO (Protocol C). In chapter 5, samples were counted for 
[ 14C] AIB and [3H] mannitol (Protocol D). 
2.6 1-MX metabolism 
The metabolism of the exogenous substrate 1-MX by the capillary endothelial 
enzyme xanthine oxidase was determined in chapters 3 and 6. Precipitation of the 
samples with perchloric acid is outlined in those chapters. Samples were then loaded 
onto a C-18 reverse phase high performance liquid chromatography column. The 1-MX 
disappearance was calculated from arterio-venous plasma 1-MX difference and 
multiplied by femoral blood flow. More specific details are given in the individual 
chapters. 
2.7 Statistics 
All tests were performed using the SigmaStatTM statistical program (Jandel 
Software Corp.). In order to ascertain differences between treatments, the statistical 
significance of differences between groups of data was assessed by one or two way 
analysis of variance (ANOVA) for sets of experiments containing multiple groups. For 
experiments comparing only one experimental group to the controls, student's t-tests 
were used. Significant differences were recognized at P<0.05. One, two or three 
symbols were used to show significance of P<0.05, P<0.01 and P<0.001 respectively. In 
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the perfusion chapters (Chapters 3, 4 and 5) the symbols used to show significance were: 
"" (to show significance from controls), `#' (to show significance from 5-HT), '^' (to 
show significance from 5-HT+CCh), `+' (significant from insulin infusion), `8c.' (to 
show significance from All infusion) and `$' (to show significance from All and insulin 
infusion). In the in vivo experiments (Chapter 6) the symbols used were "" (to show 
significance from Ins treated group) and "1 . ' (to show significance from Lip + Ins treated 
group). 
CHAPTER 3 
3 Hormonal effects on FFA uptake by the constant flow perfused rat 
hindlimb 
3.1 Introduction 
We have previously reported that the vasoconstrictor, 5-HT is able to reduce 
capillary (nutritive) flow in SM perfused with a BSA/Krebs buffer. This was determined 
by measuring the metabolism of infused 1-MX, a substrate for the capillary endothelial 
enzyme, xanthine oxidase (211). Reduced capillary flow was associated with decreased 
muscle oxygen consumption and marked insulin-resistance with regard to insulin-
mediated glucose uptake, both in individual muscles and across the entire hindlimb 
(211). We have proposed that this is due to decreased access of insulin and glucose to 
the myocytes, and may contribute to hyperinsulinaemia and hyperglycaemia 
respectively. 
Other researchers have shown that elevated plasma FFA levels are also 
associated with insulin resistance. This may be a consequence of either reduced FFA 
uptake by limb tissues or elevated FFA release from AT. Increased FFA uptake and 
oxidation have generally been considered as the primary cause of reduced insulin-
mediated glucose uptake by muscle (206), but the exact mechanism for insulin 
resistance via substrate competition is unresolved. Recently, the SM of insulin resistant 
humans has been shown to have a reduced capacity to oxidise FFA (132). 
The perfused rat hindlimb is a widely accepted model for determining the effect 
of substrate uptake by SM, and is preferable over cultured myocytes and incubated 
muscle preparations, as the vasculature remains intact. Thus, vasoactive substances can 
be delivered through the vessels, as occurs in vivo. Using fluorescent microspheres to 
monitor blood flow distribution we have shown that as a percentage of total flow, the 
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isolated hindlimb is primarily comprised of SM, with bone, skin and fat contributing 
only minimally (208). The perfused rat hindlimb gives comparable rates of oxygen 
consumption to SM in vivo (164) (233) and perfusing the hindlimb with a Krebs 
Henseleit buffer and bovine serum albumin (BSA) produces acceptable levels of glucose 
uptake (164). Red blood cell (RBC) may also be added (304) to emulate blood in vivo. 
Additionally, we have shown that oxygen uptake is correlated with muscle or nutritive 
capillary flow (304) (208) and is thus commonly used as a surrogate indicator of 
capillary flow. While the rat hindlimb is commonly perfused with bovine serum albumin 
(BSA)/Krebs, it was found that FFA liberated from hydolyzed circulating TG 
preferentially bound the BSA rather than being taken up by the myocytes (Chapter 4). 
Trapping fatty acids generated from hydrolysis in the vasculature may be advantageous, 
due to removal of the components of uptake and oxidation. Alternatively, Ficoll®  may 
be used to measure the uptake of FFA from isolated or artificial lipid solutions. 
Whereas lipid is hydrophobic, glucose is highly water-soluble and is therefore 
readily transported in the blood stream. As a result, glucose uptake can be easily 
measured in the perfused rat hindlimb and in vivo. Glucose substrates that are both 
metabolized and not-metabolized have been used. [ 3H] glucose is often used as a 
measure of whole body glucose disposal. Constant infusion of [ 3H] glucose into the rat 
in vivo, and arterial sampling to monitor the specific activity, gives a measure of hepatic 
glucose release and whole body disposal. This substrate is however disadvantageous as 
it is both taken up and released by muscles, thus no real measure of muscle uptake can 
be made. [ 14C] glucose is also used, but is readily metabolized and measurements of 
metabolism must also be made. Fluorescent glucose analogues are also used (186) (150). 
We have commonly used [ 3H] 2-deoxyglucose (2-DG) both in the perfused rat hindlimb 
(211) and in vivo (305). This substrate is taken up by myocytes and immediately 
converted to [3H] 2-deoxyglucose- 6-phosphate, with no further metabolism. [ 3H] 2- 
deoxyglucose- 6-phosphate can then be separated from [3H] 2-DG to give a measure of 
glucose content in the myocytes and in the extracellular space (vessels and interstitial 
space) respectively. 
The present study aimed to examine the effect of low nutritive flow mediated by 
5-HT infusion in the Ficoll®-perfused rat hindlimb, on fatty acid and glucose uptake. 
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Due to the addition of extracellular [ 14C] or [3H] markers to all experiments, the uptake 
of [3H]2-deoxyglucoe (2-DG) and [ 14C] palmitic acid were determined in separate 
perfusions. To minimize variability, both perfusion buffers contained 8.3 mM glucose 
and 1.2 mM palmitic acid. As a consequence we were unable to determine whether the 
FFA had any effect on glucose uptake. Rather, focus was on assessing whether low 
nutritive flow, with expected haemodynamic insulin resistance, had any effect on the 
uptake of [ 14C] palmitic acid. 
3.2 Materials and Methods 
3.2.1 [14C] palmitic acid solution 
Palmitic acid (369.2 mg), 1.4 ml 1 M NaOH, 28 ml of distilled H20 and 80 ptCi 
,14 L C] palmitic acid (Amersham) were heated at 75-90°C for 20 min until saponified. The 
solution was then cooled to 50-60°C prior to the addition of Krebs-Ringer bicarbonate 
buffer (90.6 ml) containing 6% (wt/vol) BSA. Finally, the mixture was passed through a 
1.2 pm filter and stored at —20°C until used. 
3.2.2 Unlabeled palmitic acid solution 
Unlabeled Na-palmitate (albumin-bound) was prepared by the same protocol as 
the [ 14C] palmitic acid solution, with the omission of the [ 14C] palmitic acid. 
3.2.3 Mannitol solution 
To monitor perfusate in the interstitial and vascular space of the perfused muscle, 
a solution containing 65 mM mannitol and 401ACi [ 3H] mannitol (NEN) was prepared. 
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3.2.4 [31I] 2-Deoxyglucose solution 
A solution of 90 1.1Ci [ 3H] 2-deoxyglucose (2-DG, Amersham), 2 mM sucrose 
and 50 pCi [ 14C] Sucrose (Amersham) was prepared. [ 14C] Sucrose was used in these 
perfusions instead of [ 3H] mannitol in order to correct for volume in the extracellular 
space when infusion [ 3H]2-DG. 
3.2.5 Hindlimb Perfusions 
General protocol 
The left hindlimbs of 140-160 g rats were perfused in a non-recirculating mode 
with 6% (wt/vol) ®Fico11 (Amersham Pharmacia Biotech.) containing Krebs-Henseleit 
buffer (section 2.2.2 of the Methods chapter) and 1.27 mM CaC12 at 8 ml/min. The 
buffer was continually gassed via a sialastic tube oxygenator with carbogen (95% 02 : 
5% CO2), and the temperature was maintained at 37°C in a heat-exchanger coil. The rat 
and apparatus were in a temperature-controlled cabinet at 37°C. All other details are 
described in section 2.2 of the Methods chapter of this thesis. 
[3H]2-DG, 1-MX, 
[14C]sucrose, palmitate 
5-HT, Vehicle 
Insulin, Vehicle 
0 	10 20 30 40 50 60 70 80 90 100 
4 	e 	e 	4 
4 indicates venous sample 
Figure 1. Perfusion protocol for [3H] 2 -DG uptake 
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Perfusion protocol for PH] 2-DG uptake 
The uptake of the non-metabolizable substrate [3}1] 2-DG into the perfused rat 
hindlimb was determined under the conditions described above (Fig. 1). Time 0 is the 
beginning of hindlimb perfusion, and all other additions are indicated in the boxes. The 
following perfusion types were conducted: 
1. controls (vehicle) 
2. insulin (Ins, 75 nM, Humulin®, Aza Research Pty Ltd) 
3. 5-HT + Ins (3 gM and 75 nM respectively). 
After completion of the surgical procedure (described in section 2.2.4 of the 
Methods chapter), the rat hindlimb was perfused for 40 min with 6% eFicoll/Krebs 
buffer (sections 2.2.2 and 2.2.3 of the Methods chapter). Following this equilibration 
period, Ins (if used) was infused for the entirety of the experiment. The infusion of 5-HT 
(if used) was commenced at 50 min and continued for the entirety of the experiment. 
The effect of 5-HT infusion alone was not determined as this vasoconstrictor has 
previously been shown to have no effect on basal [ 3H]2-Deoxyglucose uptake (211). At 
60 min, the buffer reservoir was changed and the rat hindlimb then perfused (while 
maintaining the infusion of Ins and 5-HT or vehicle with medium) containing the 
following constituents: 
-26 ml unlabeled palmitic acid solution (described in section 3.2.2, 1.2 mM final) 
-1.3 ml [ 311] 2-Deoxyglucose solution (described in section 3.2.4) 
-232.7 ml gassed 6% eFicoll/Krebs buffer 
-0.65 ml 10 mM 1-MX. 
The hindlimb was perfused with this mixture for 30 mm (time 0 to 30 min in 
Figure 1) and venous samples of 1.5 ml were taken every 10 min. The total perfusion 
time was 90 min. 
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Perfusion protocol for 144 palmitic acid uptake 
[14C]palmitate, 1-MX, 
[3 H]mannitol, palmitate 
5-HT, Vehicle 
Insulin, Vehicle 
10 20 30 40 50 60 70 80 90 100 
• 	4 	4 	4 	4 	4 
indicates venous sample 
Figure 2. Perfusion protocol for [ 14C] palmitic acid uptake 
The uptake of [ 14C] palmitic acid into the perfused rat hindlimb was determined 
as described in the protocol above (Fig. 2). Time 0 is the beginning of hindlimb 
perfusion, and all other additions are indicated in the boxes. The following perfusion 
types were conducted: 
1. controls (no additions) 
2. Ins (75 nM, Humulin®, Aza Research Pty Ltd) 
3. 5-HT (3 1AM) 
4. 5-HT + Ins (3 1.1M and 75 nM respectively). 
After completion of the surgical procedure (described in section 2.2.4 of the 
Methods chapter), the rat hindlimb was perfused for 40 min with 6% ®Ficoll/Krebs 
buffer. Following this equilibration period, Ins (if used) was infused for the entirety of 
the experiment. The infusion of 5-HT (if used) was commenced at 50 mm and continued 
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for the entirety of the experiment. At 60 mm the buffer was changed and the rat 
hindlimb then perfused with medium containing the following constituents, while 
maintaining the infusion of ins and 5-HT or vehicle: 
-26 ml [ 14C] palmitic acid solution (described in section 3.2.1, 1.2 mM final) 
-2 ml mannitol solution (described in section 3.2.3) 
-232 ml gassed 6% ®Ficoll/Krebs buffer 
-0.65 ml 10 mM 1-MX. 
The hindlimb was perfused with this mixture for 30 min (time 0 to 30 mm in 
Figure 2) and venous samples of 1.5 ml were taken every 10 min. The total perfusion 
time was 90 min. 
3.2.6 Perfusate glucose and lactate determination 
The concentrations of glucose and lactate in each venous perfusate sample were 
determined as described in section 2.3 of the Methods chapter. 
3.2.7 Perfusate radioactivity measurements 
Perfusate samples containing radioactivity were immediately centrifuged to 
remove RBC. Samples (200 1.1.1) were then added to. 6 ml Amersham Biodegradable 
Counting Scintillant and counted using a dual label counting system (for the detection of 
[3H] and [ 14C]) as described in Chapter 2 section 2.5 
3.2.8 Muscle radioactivity uptake 
After perfusion, the soleus, plantaris, EDL, G.Red, G.White and tibialis of the 
left hindlimb were removed. The muscles were digested and analysed as described in the 
Methods chapter, section 2.4 of this thesis. 
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3.2.9 Calculation of muscle extracellular space 
In all perfusions either [ 14C] sucrose or [3H] mannitol was infused to determine 
the muscle extracellular space. The extracellular space (ml.g -1 ) was calculated from the 
amount of radioactivity in each muscle (dpm.g -1 ) and the specific activity of the infused 
solution (dpm.m1-1 ). 
3.2.10 Determination of 1-MX conversion 
Perfitsate samples of 100 p.1 were de-proteinised with 25 ul 2 M perchloric acid, 
centrifuged, and an aliquot of 40 1.t1 injected onto a reverse-phase HPLC column. Values 
obtained from the HPLC were used to calculate the disappearance of 1-MX. Full details 
are given in Chapter 2 section 2.6. 
3.2.11 Statistical Analysis 
Statistically significant differences for oxygen uptake (V02) and perfusion 
pressure (PP) between groups over the 30 min perfusion period were assessed using 
two-way, repeated-measures analysis of variance (ANOVA). All other tests were 
conducted using one-way ANOVA. 
P values less than 0.05 were considered to be significant. One, two or three 
symbols were used to denote P values of <0.05, <0.01 and <0.001 respectively. The 
symbols used were "" (to show significance from control perfusions), `+' (significant 
from Ins infusion), and 'ft' (significant from 5-HT infusion). 
3.3 Results 
Only the uptake of [ 14C] palmitic acid and [3H] 2-DG were determined in 
separate experiments. The other measurements (V02, PP, 1-MX metabolism, glucose 
uptake, lactate efflux, wet weight to dry weight ratios of the muscles, and the muscle 
extracellular space) were pooled and shown in Figures 3, 4, 5, 8 and 9. 
51 
Figure 3 shows the time course for the effects of 3 1.1M 5-HT, 75 nM Ins, and 5- 
HT + Ins on V02 (panel A) and PP (panel B). Maximal stimulation with 5-HT (with or 
without Ins) occurred at the beginning of perfusion with the palmitic acid perfusion 
medium (0 min on graph). 5-HT (without Ins) decreased V02 from 22.0 ± 0.5 to 9.7 ± 
0.8 gmol/g/h during maximum stimulation (P<0.001) when compared to control 
perfusions (Fig. 3, panel A). This was accompanied by increased PP from 41.6 ± 1.3 to 
167.7 ± 13 mmHg (Fig. 3, panel B, P<0.001). Using a combination of 5-HT and Ins, 
V02 and PP were also significantly different when compared with control perfusions 
(from 22.0 ± 0.5 to 9.6 ± 0.6 gmol/g/h (P<0.001) and from 41.6 ± 1.3 to 180.7 ± 7.8 
mmHg (P<0.001) respectively). Overall, the addition of 5-HT with or without Ins 
significantly reduced oxygen consumption by the perfused rat hindlimb. Since in this 
system V02 is a surrogate indicator of nutritive capillary flow, capillary flow was 
deemed to be reduced with 5-HT infusion. 
The metabolism of 1-MX, by the capillary enzyme xanthine oxidase, is a further 
indicator of capillary perfusion. The metabolism of 1-MX was also reduced when 
comparing 5-HT to control perfusions (from 5.8 ± 0.4 to 4.5 ± 0.4 nmol/min/g 
(P=0.024), Fig. 4). Furthermore, 1-MX metabolism was reduced with the co-infusion of 
5-HT and Ins, in comparison to the infusion of Ins alone (from 5.9 ± 0.5 to 3.8 ± 0.4 
nmol/min/g (P=0.004)). 
While we have established a reduction in capillary flow with 5-HT infusion in 
these experiments, insulin resistance was also tested. The total glucose uptake and 
lactate efflux by the entire perfused mass was determined from arterio-venous 
differences (Figure 5, panels A and B respectively). Glucose uptake across the total 
perfused mass was stimulated by approximately 3-fold (from 12.2 ± 0.7 to 29.2 ± 1.7 
gmol/g/h (P<0.001)). 5-HT reduced the insulin-mediated glucose uptake across the 
entire hindlimb (from 29.2 ± 1.7 to 23.1 ± 1.8 innol/g/h (P=0.005)). Lactate efflux 
(panel B) significantly increased with Ins infusion (from 37.7 + 1.4 to 48.9 + 4.1 
ttmol/g/h (P=0.01)) when compared to control perfusions. 
, A set of experiments using the non-metabolizable glucose tracer, 2-DG were 
conducted to confirm a state of ins-resistance with 5-HT in the individual hindlimb 
muscles. Ins significantly increased 2-DG uptake in all hindlimb muscles tested (Fig. 6, 
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panel A). This increase was greater than 6-fold (from 13.6 ± 1.4 to 82.1 ± 4.6 innol/g/h 
(P<0.001)) when averaging the uptake into all muscles (Fig. 6, panel B). The addition of 
5-HT to Ins perfusions however decreased 2-DG uptake in all muscles, in particular in 
the EDL and tibialis. Averaging the hindlimb muscles, panel B shows the addition of 5- 
HT reduced hindleg insulin-mediated glucose uptake from to 82.1 ± 4.6 to 41.6 ± 6.7 
gmol/g/h (P<0.001). 
Panel A of Figure 7 shows the uptake of [ 14C] palmitic acid by the hindlimb 
muscles. While the infusion of Ins tended to increase the uptake of [ 14C] palmitic acid, 
this was not significant. The infusion of 5-HT significantly reduced the uptake of [ 14C] 
palmitic acid in the EDL and the tibialis. When insulin was co-infused with 5-HT, there 
was also a significant reduction in fatty acid uptake by the muscles with predominantly 
white fibres (EDL, G.white and tibialis). 5-HT decreased insulin-mediated [ 14C] palmitic 
acid uptake from 38.3 + 2.6 to 11.2 + 4.0 ilmol/g/h in the EDL (P<0.001), 14.6 + 2.2 to 
6.0 + 1.7 imnol/g/h in the G.White (P=0.036) and 33.6 + 0.6 to 10.2 + 3.7 partol/g/h in 
the tibialis (P<0.001). When averaging the uptake across the selected muscles (Fig. 7, 
panel B), the co-infusion of 5-HT and Ins significantly reduced the uptake compared to 
insulin infusion alone (from 26.9 ± 2.3 to 13.4 ± 2.7 gmol/g/h (P=0.02)). 
The extracellular space (radioactivity in the blood vessels and interstitial space) 
of the hindlimb muscles was determined using either [ 14C] sucrose or [ 3H] mannitol as 
extracellular markers. Negligible difference was recorded between all groups within 
each muscle sampled (Fig. 8). Wet weight to dry weight ratio of the muscles was 
increased in some muscles during 5-HT infusion, however was mostly unaltered 
between experimental types (Fig. 9). 
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Figure 3. Hindlimb oxygen consumption (V02, panel A) and perfusion pressure (PP, 
panel B) in the constant flow, Ficoll® perfused rat hindlimb. Perfusions were control 
(0), 75 nM Ins (0, from -20 min), 3 1AM 5-HT (N, from —10 min), or the infusion of 
both Ins and 5-HT (V). Rat hindlimbs were perfused with [3 1-1] 2-DG solution or [ 14C] 
palmitic acid buffer (from 0 mm to 30 min). Values are means + SE (n=10-11) and 
given in gram wet weight. Significance symbols are denoted by "1" (from control) and 
`+' (from Ins), where two or three symbols represents P<0.01 and P<0.001 respectively. 
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Figure 4. Hindlimb 1-MX metabolism (a surrogate indicator of capillary/nutritive flow) 
in the constant flow, Ficoll ® perfused rat hindlimb perfused with either [ 14C] palmitic 
acid or [3H] 2-DG. Perfusions were control (white bar), 75 nM Ins (black bar), 3 [tM 5- 
HT (grey bar) or 5-HT + Ins (cross-hatched bar). Values are means + SE (n=10-11) and 
given in gram wet weight. Significance symbols are denoted by " 1" (from control) and 
`+' (from Ins), where one or two symbols represents P<0.05 and P<0.01 respectively. 
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Figure 5. Hindleg glucose uptake (panel A) and lactate efflux (panel B) during constant 
flow, Ficoll® perfusion with either [ 14C] palmitic acid or [3H] 2-DG. Perfusions were 
control (white bar), 75 nM Ins (black bar), 3 JAM 5-HT (grey bar) or 5-HT + Ins (cross-
hatched bar). Values are means + SE (n=10-11) and given in gram wet weight. 
Significance symbols are as described in the methods section of this chapter. 
Significance symbols are denoted by "" (from control), `+' (from Ins) and `#' (from 5-
HI), where one, two or three symbols represents P<0.05, P<0.01 and P<0.001 
respectively. 
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Figure 6. The uptake of [31.1] 2-DG (R'g) by the rat hindlimb perfused with 
Ficoll®/Krebs buffer containing 8.3 mM glucose and 1.2 mM palmitic acid. Perfusions 
were conducted with no extra additions (white bars), with the infusion of 12.5 mU/m1 
Ins (black bars) and with a co-infusion of 3 IAM 5-HT and 75 nM Ins (hatched bars). The 
effects of individual hindlimb muscles are shown in panel A and the average effect 
across all muscle samples is shown in panel B. Values are means + SE (n=5-6) and 
given in gram dry weight. Significance symbols are denoted by "" (from control) and 
`+' (from Ins), where two or three symbols represents P<0.01 and P<0.001 respectively. 
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Figure 7. The uptake of [ 14C] palmitic acid by the rat hindlimb perfused with 
Ficoll®/Krebs buffer containing 8.3 mM glucose and 1.2 mM palmitic acid. Perfusions 
were conducted with no extra additions (white bars), 75 nM Ins (black bars), 3 1AM 5-HT 
(grey bars) and 3 1AM 5-HT + 75 nM Ins (hatched bars). The effects of individual 
hindlimb muscles are shown in panel A and the average effect across all muscle samples 
is shown in panel B. Values are means + SE (n=5-6) and given in gram dry weight. 
Significance symbols are denoted by ' 1" (from control) and `+' (from Ins), where one or 
three symbols represents P<0.05 and P<0.001 respectively 
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Figure 8. Muscle extracellular space (comprising the vascular volume and interstitial 
space) of selected muscles of the rat hindlimb perfused with Ficoll ®/Krebs buffer 
containing either [3H] 2-DG or [ 14C] palmitic acid. Perfusions were: control (white 
bars), 175 nM Ins (black bars), 3 1AM 5-HT (grey bars) or 5-HT + Ins (hatched bars). 
Values are means + SE (n=10-11) and given as grams wet weight. Significance symbols 
are denoted by '*' (from control) and `+' (from Ins), where one or two symbols 
represents P<0.05 and P<0.01 respectively 
represents P<0.05 , P<0.01 and P<0.001 respectively. 
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The weights of all muscles were compared before and after drying to determine 
if oedema was present. Hindlimb perfusions at 37°C using a Krebs buffer containing 
BSA instead of Ficoll® usually yield a wet weight to dry weight ratio of approximately 5 
(unpublished results). These perfusions averaged approximately 5.5, which was 
indicative of marginally higher levels of oedema (Fig. 9). The infusion of 5-HT 
significantly increased the oedema in the plantaris and the red and white gastrocnemius 
muscles. 
3.4 Discussion 
The main finding from this chapter was the reduced muscle FFA uptake across 
the entire hindlimb when non-nutritive flow predominated. This corresponded with 
insulin-mediated glucose uptake also being impaired. When individual muscles were 
analysed separately this effect was only significant in those with predominantly white 
muscle fibres (EDL, tibialis and G.White). These results imply that fuel-partitioning 
responds differently in individual muscles and caution must be taken when measuring 
total uptake or release of metabolites from or into the perfusate. 
The population of adipocytes interlacing the perimysium and individual fibres. 
must also be considered when dissecting whole muscles. The results from Chapter 4 of 
this thesis imply that intermuscular AT actively contributes to muscle lipolytic activity. 
Those experiments measured the uptake of chylomicron TG into hindlimb muscles with 
predominantly non-nutritive flow (reduced capillary flow). Unlike the albumin-bound 
FFA, the uptake of FFA derived from chylomicron-TG is dependent on the exposure 
and activity of LPL. We found more hydrolytic activity (probably due to increased 
exposure to LPL) with 5-HT infusion in the red muscles. Due to the reduction in 
metabolism and increased hydrolytic activity, it was reasoned that non-nutritive flow 
increased TG access to adipocytes in the muscle CT, in particular the perimysial adipose 
tissue (which we have given the acronym `PAT'). 
Uptake of albumin-bound FFA is however not dependent on LPL activity and is 
likely to be more dependent on endothelial surface area and FFA transporters (278) 
(279). Therefore FFA uptake was expected to decrease with reduced capillary perfusion 
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(5-HT infusion). While this appears (from Fig. 7) to be apparent in only the muscles 
with predominantly white fibres, it is likely to have occurred also in the red muscles. 
The uptake into the myocytes of the red muscle is, however, probably masked by FFA 
extraction into PAT. This may also explain why the insulin-mediated uptake of 2-DG is 
not reduced to the same extent with 5-HT in the red muscles (as insulin may stimulate 
glucose uptake into PAT as a precursor for TG synthesis). 
Reduced muscle uptake of FFA during haemodynamic insulin resistance implies 
that TG deposits within the myocyte will be also reduced. Classically, it is thought that 
elevated plasma FFA during insulin resistance are re-assembled into lipoproteins in the 
liver for metabolism in the periphery, leading to increased SM TG. As expected, a 
correlation between insulin resistance and muscle TG levels (94) (144) (195) (197) and 
increased lipid oxidation (99) have been recorded. 
Despite reports of increased intramyocellular TG with insulin resistance, there 
are many emerging papers showing that FFA uptake is decreased with impaired glucose 
tolerance (281) and women with visceral obesity (51). In addition, reduced lipid 
oxidation has been recorded in subjects with NIDDM (132) and visceral obesity (51). 
The findings reported in this chapter are thus in agreement with those reported by 
Turpeinen et al. (281), showing that the uptake of FFA is reduced when insulin-
mediated glucose uptake is impaired. Therefore intracellular accumulation of TG may 
be a result of reduced lipid oxidation, rather than increased fatty acid uptake. Obese 
Zucker rats have been shown to have higher ratios of SM FFA uptake and glycerol 
release than their lean counterparts (280). It is possible that in those experiments, that 
the FFA uptake was into the PAT. Large PAT deposits may also explain why these 
obese rats have very high levels of glycerol release. 
The presence of FFA in these perfusions may have had some influence on 2-DG 
uptake into the muscles. Others have shown that FFA have no effect on basal glucose 
uptake (122) (176), but reduce insulin-mediated glucose uptake by SM. Insulin (1 
mU/m1) has been shown to increase FFA uptake by the perfused rat hindlimb (217). 
Despite this effect, no reduction in glucose uptake was seen, therefore indicating the 
absence of the Randle cycle in resting perfused SM. In addition, Ikeda et al. (122) used 
1 mU/m1 insulin in the perfused rat hindlimb and found no reduction in glucose uptake 
62 
with a combination of 1 mM oleic acid and 0.5 mM palmitic acid (122). However at 0.5 
and 0.1 mU/m1 insulin glucose uptake was decreased with the same FFA addition, with 
a concomitant decrease in insulin clearance. At the very high insulin concentration used 
in these experiments (75 nM/12.5 mU/m1) glucose uptake was most likely unaltered by 
the presence of 1.2 mM palmitic acid. In addition, the rates of 2-DG uptake in this 
chapter are comparable to those reported by Rattigan et al. (211). 
While FFA and insulin appear to influence glucose uptake, glucose and insulin 
may also influence FFA uptake. Although insulin tended to increase FFA uptake into 
most muscles, this was not significant. Ohashi et al. (188) evaluated the effects of 
different concentrations of glucose and insulin on FFA uptake by the perfused rat 
hindquarter. With high plasma glucose, FFA uptake was increased with low insulin 
concentrations, however at higher insulin concentrations (5 mU/m1) the uptake was 
reduced. At 12.5 mU/m1 insulin used in these experiments there was no significant 
change in FFA uptake. 
Capillary perfusion was determined by the activity of the capillary endothelial 
enzyme, xanthine oxidase, to convert the infused 1-MX. All perfusions contained FFA, 
which are shown to reduce insulin-mediated capillary recruitment in vivo in Chapter 6 of 
this thesis. In these perfusions there was no increase in capillary flow with insulin 
infusion and 1.2 mM palmitic acid. Without FFA in the perfusion buffer, we have 
previously shown that insulin was also unable to increase access to xanthine oxidase in 
perfusion. This is in contrast to in vivo experiments where insulin increases capillary 
flow independently of changes in total flow to the muscle (as discussed in the 
Introduction chapter of this thesis) and re-enforces the view that the perfused hindlimb is 
fully dilated in the basal state. As such, insulin is unable to further increase capillary 
perfusion as indicated by 1-MX metabolism (Fig. 4). 
In summary, the predominantly non-nutritive flow pattern induced in these 
experiments by the vasoconstrictor 5-HT resulted in significant reduction in FFA and 
insulin-mediated glucose uptake across the entire hindlimb. While these experiments 
determined the acute effects of non-nutritive flow on FFA and insulin-mediated glucose 
uptake, long term non-nutritive flow may result in a down-regulation of fatty acid 
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transporters in muscle, and ultimately contribute to significant chronic elevations in 
plasma FFA. 
64 
CHAPTER 4 
4 Effects of CT or non-nutritive flow on chylomicron TG hydrolysis by 
the constant flow perfused rat hindlimb. 
4.1 Introduction 
Chapter 3 showed the effects of predominantly non-nutritive flow on the uptake 
of albumin-bound FFA. While this is dependent on the capillary surface area, the uptake 
of FFA from circulating TG requires initial hydrolysis, and is therefore dependent on the 
distribution of lipolytic enzymes (in particular LPL). LPL is attached to the vascular 
endothelium by proteoglycans, which allow protrusion of the enzyme into the vascular 
lumen. Here it acts to hydrolyze TG from circulating TG-rich lipoproteins 
(chylomicrons and very-low density lipoproteins) into FFA and glycerol. The resulting 
FFA are taken up by tissues capable of lipid oxidation (e.g. muscle) or storage (e.g. AT, 
muscle) (55) (68). 
The hydrolysis of TG to FFA and glycerol has been found to be proportional to 
the active amount of LPL in the vasculature (157) (272) and ultimately may depend on 
whether circulating TG has access to the active form of LPL or other hydrolytic 
enzymes. The uptake of circulating TG is highest in slow twitch red fibres, medium in 
fast twitch red and least in fast twitch white (272) (161). In SM, an important 
determinant of muscle metabolism is the supply of substrate to the myocytes and is 
therefore controlled by the proportioning of flow between two distinct vascular circuits 
(48) (180). The first is termed nutritive and describes flow predominantly to the muscle 
cells. Blood flowing through the second circuit, termed non-nutritive, almost certainly 
passes through vessels of the CT associated with the muscle (181). Flow through this 
route results in the physical isolation of nutrients and hormones (including oxygen, 
glucose, TG and insulin) from the myocytes (46). As a result there is limited opportunity 
for muscle nutrient uptake. Since TG hydrolysis is dependent upon its exposure to 
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hydrolytic enzymes, it follows that the total hydrolysis of TG entering the muscle will be 
greater when the predominance of flow is through the circuit in which the majority of 
the hydrolytic activity is distributed. To date there have been no studies describing the 
location of SM TG hydrolytic activity including LPL, and its relative distribution in 
muscle nutritive capillaries or in CT vessels (non-nutritive for muscle) (181). 
It is now believed that nutritive circulation is through capillaries in close contact 
with the muscle fibres, and, as a result, the clearance of ions and oxygen is accelerated. 
When flow is largely through the non-nutritive pathway, the flow is thought to pass 
through muscle CT; in this state the clearance of ions and oxygen is decreased. 
Vasoconstrictor action to constrict vessels leading to CT vessels (Type A 
vasoconstrictors) under conditions of constant total flow will therefore re-divert flow 
into the muscle capillaries (nutritive) and consequently increase metabolism. 
Alternatively, vasoconstrictors impeding flow to muscle capillaries (Type B) will 
increase CT (non-nutritive) flow. 
To measure TG hydrolysis in the perfused rat hindlimb, lipoprotein emulsions 
can be synthesized using a mixture of radiolabeled and cold TG, cholesterol esters, and 
phospholipids and apoproteins for forming a shell around the hydrophobic TG (215). 
Alternatively, chylomicrons can be synthesized endogenously. Chylomicrons can be 
extracted from the lymph of rats fed radiolabeled palmitate and corn oil (161), however 
this method often results in very low yields of labeled TG, and is technically more 
difficult than preparing artificial emulsions. 
Thus, the present study addresses the issue of whether vasoconstrictors 
(including 5-HT (Type B) and vasopressin (Type A)) that specifically alter the 
proportion of non-nutritive and nutritive flow in the constant flow perftised rat hindlimb 
(46) (48), alter the rate of hydrolysis of circulating TG. 
4.2 Materials and Methods 
4.2.1 TG emulsion 
Chylomicron lipid emulsion (CLE) was prepared essentially as described by 
Redgrave and Callow (214) and each ml contained 7.5 mg triolein, 0.33 mg cholesteryl 
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oleate, 0.22 mg cholesteryl acetate, 2.6 mg phosphatidyl choline, 10 gmol N-[2- 
Hydroxyethyl]piperazine-N'[2-ethanesulfonic acid] (HEPES, pH 7.4), 150 punol NaC1 
and 0.25 ml heat-inactivated rat serum (HIRS) as a source of apolipoproteinCII (apoCII, 
acts as a cofactor for LPL). CLE contained either 1.25 ptCi [ 31-1]-cholesteryl oleate (CO, 
[cholestery1-1,2,6,7-3H(N)]-cholesteryl oleate, Amersham) or 0.42 pCi [ 14C]-triolein 
(TO, [carboxyl-' 4C]riolein, Amersham) and hydrolysis/uptake of each measured 
separately. The mixture was sonicated at an output frequency of 23 KHz, for two rounds 
of 1 min each. All emulsions were used on the day of preparation (using fresh HIRS). 
4.2.2 Heat-inactivated rat serum (HIRS) 
Donor animals were anaesthetized and blood collected by an intracardiac 
puncture. Blood was slowly withdrawn using a 21-gauge butterfly needle attached to a 1 
ml syringe containing 0.1 ml citrate. The syringe was changed several times during one 
collection. This procedure reduced the amount of suction and therefore the amount of 
platelet activation. Serum collected in this way was devoid of any platelet-derived 5-HT. 
Serum platelets were eliminated by clotting with thrombin (30 gl/m1). The remaining 
serum was heated at 56°C for 30 min to inactivate endogenous lipases (18). 
4.2.3 Hindlimb perfusions 
Hindlimb surgery was essentially as described in section 2.2.4 of the Methods 
chapter. Heparin was not used as an anticoagulant, as this has the potential to displace 
LPL from the vascular endothelium and distribute it throughout the perfusate. The left 
hindlimb of the rat was perfused in a recirculating mode at 37 °C with 100 ml of 
perfusion medium comprising Krebs Henseleit buffer (described in the Methods chapter, 
section 2.2.2) containing 6 % (wt/vol) Ficoll® (Pharmacia Biotech) (unless indicated 
otherwise) with 8.3 mM glucose and 1.27 mM CaC12. The buffer was continuously 
gassed with 95 % 02:5 % CO2 via a silastic tube oxygenator while maintained at 37°C in 
a heat exchanger coil. Constant flow perfusions were conducted at 8 ml/min; constant 
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pressure perfusions at 85 mmHg. After a 40 min equilibration period the buffer reservoir 
was changed to one containing 125 ml of the 6% Ficoll ® and 5 ml of CLE. 
4.2.4 Modulation of CT flow 
5-HT is one of a number of vasoconstrictors previously shown to increase non-
nutritive or CT flow at the expense of muscle nutritive flow in the constant flow 
perfused rat hindlimb (46) (48). Although other members of this group such as high dose 
NE, high frequency sympathetic nerve stimulation and high dose vanilloids give similar 
results in terms of increasing non-nutritive flow. 5-HT is the least complicated (produces 
a mono-component dose-response curve (63)) and was the model vasoconstrictor of 
choice. Thus, as shown in Fig. 1, 5-HT (Sigma) was added as a bolus into the buffer 
reservoir of the appropriate perfusions to give a final concentration of 0.5-1 ptM (to 
achieve a peak perfusion pressure of approximately 100 mmHg above basal). After 
discarding the first 30 ml of perfusate (of the 130 ml perfusion medium containing CLE) 
the remaining 100 ml was recirculated through the hindlimb for 1 hour. Samples (2.5 
ml) were withdrawn from the venous line every 15 mm. 
In some experiments the vasodilator CCh was infused at a final concentration of 
100 1.1M to reverse the effects of 5-HT on PP and V02. CCh infusion commenced before 
the buffer was recirculated. This was designed to allow the PP and V02 to return to near-
basal states before TG recirculation and prevent perfusion under predominantly non-
nutritive conditions. Infusion was continued for a further 12.5 min after recirculation. 
The type A vasoconstrictor vasopressin was added as a bolus dose (0.5 nM) to 
the reservoir of some perfusions to investigate the effects of increased V02 and PP on 
chylomicron TG hydrolysis. 
[140-0/[3H]C0 
and 5-HT/vaso/vehicle 
CCh/vehicle 
recirculate 100m1 
0 	10 20 30 40 50 60 70 80 90 100 110 
o 0 0 0 0 0 0 0 0 0 0 0 
6 venous perfusate sample 
Figure 1: Perfusion protocol for measuring chylomicron triglyceride hydrolysis by the 
perfused rat hindlimb 
4.2.5 TG hydrolysis 
,-.,- 
Perfusate samples (1 ml) from perfusions using [' 4C] -TO were added to 4 ml 
methanol:chloroform 2:1 in 10 ml glass tubes with screw caps. The tubes were vortexed 
(3 x 30 s) and maintained at room temperature (22 °C) before centrifuging at 2500 xg 
for 10 min. The entire lower layer was removed with a glass pipette into a 5 ml test tube 
and evaporated to dryness in a water bath at 40 °C under a stream of nitrogen. The 
residue was reconstituted into 10011.1 of the chloroform:methanol mixture and 15 i_t1 was 
immediately applied to a Merck silica gel 60 F254 aluminium sheet (Merck). Standards 
(10 IA of 10 mg/ml) of TO, CO, and oleic acid were also applied as spots. The plates 
were run using a mixture of n-heptane:diethyl ether:glacial acetic acid (80:20:1). Plates 
were visualized in an iodine tank and TO and oleic acid spots were scraped into separate 
plastic tubes and counted with 4 ml of Amersham Biodegradable Counting Scintillant. 
Recovery of counts after thin layer chromatography was periodically checked by 
comparing the total radioactivity scraped from one lane of the silica plate (a lane was 
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designated for each perfusate sample) with the known amount of radioactivity of the 
corresponding perfusate sample before solvent extraction. The recovery was between 90 
and 110 percent. 
4.2.6 Muscle radioactivity uptake 
After perfusion, the soleus, plantaris, G.White and G.Red, tibialis and EDL 
muscles of the perfused hindlimb were removed. Within the context of this study it is 
important to note that interfibrillar CT adipocytes are contained within each muscle. 
Excised muscles were counted for radioactivity using the method described in section 
2.4 of the Methods chapter. 
4.2.7 Statistical analysis 
The statistical significance of differences between groups of data was assessed 
by one or two way analysis of variance (ANOVA) for sets of perfusions containing 
multiple groups. For perfusions comparing only one group to the controls student's t-
tests were used. Significant differences were recognized at P<0.05. One, two or three 
symbols were used to show significance of P<0.05, P<0.01 and P<0.001 respectively. 
Symbols used were 's', `#' and '^' to show significance from controls, 5-HT and 5- 
HT+CCh respectively. 
4.3 Results 
The Clearance of chylomicron TG by perfused muscle has not previously been 
studied and it was therefore necessary to conduct a number of preliminary experiments 
to determine an optimal procedure. The commonly used albumin-containing perfusion 
medium was not entirely satisfactory as FFA released by LPL were subsequently bound 
by the albumin and little was taken up by the hindlimb. A second difficulty encountered 
was the high contamination of serum albumin by lipases. Thus lipase substrates such as 
p-nitrophenyl palmitate were rapidly hydrolysed (data not shown) causing basal rates of 
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hydrolysis to be largely attributable to these contaminants when using albumin-
containing perfusion medium. Accordingly, we chose to use Ficoll e-containing 
perfusion medium. With this medium there was no hydrolysis due to the perfusion 
medium alone and the uptake of released FFA occurred so that muscle-specific uptake 
could be compared at the completion of each perfusion. 
Figure 2 shows the time course for the effects of 0.5-1 gmol 5-HT, 0.5-1 11M 5- 
HT with 100 ptM CCh or 0.5 nM vasopressin on changes in V02 and PP in the constant 
flow, Ficoll® perfused rat hindlimb. Changes in VO2 and PP both reached a maximum at 
15 min which then declined as the vasoconstrictors were metabolised by the hindlimb 
during the recirculating perfusion. However, changes in VO2 and PP were significantly 
different (P<0.05) from controls at all time points for 5-HT and vasopressin. The 
addition of CCh blocked the pressor and oxygen effects by 5-HT. Mean values for 
muscle [ 14C]-FFA uptake (60 min), oxygen uptake (15 min) and perfusion pressure (15 
min) are shown in Table 1. VO2 was inhibited by approximately 38.9% and muscle 
[ 14C1-FFA uptake increased by approximately 227.2 % by 5-HT (Table 1). The increase 
in TG hydrolysis and the decrease in oxygen uptake due to 5-HT were each significant 
(P <0.05 and P<0.001 respectively). FFA found in the perfusate of 5-HT perfusions 
were also significantly higher than the controls (P<0.05). These high hydrolytic rates 
were reversed when 5-HT effects were blocked by CCh and thereby supporting the view 
that the effects were indicative of flow redistribution, and not due to 5-HT receptor-
mediated effects on muscle cells. 
Addition of vasopressin to the buffer reservoir produced no significant decline in 
chylomicron TG hydrolysis (Table 1), despite an increase in V02 (Table 1). However, 
the perfusate FFA with vasopressin were significantly higher than those for the control 
perfusions (Table 1). 
Constant pressure perfusions were also conducted. These confirmed the high 
hydrolytic rates with 5-HT (Table 2). Since these perfusions deliberately used BSA 
rather than Ficoll® , FFA released from TO became bound to the BSA and allowed 
measurement of its appearance in perfusate samples. Corrections due to endocytosis 
were not necessary, however basal rates of TO hydrolysis in control perfusions may 
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Figure 2. Time course for the effects of 5-HT, 5-HT with CCh and vasopressin on 
oxygen consumption (V02) and perfusion pressure (PP) in the constant flow Ficoll ®- 
perfused rat hindlimb. All perfusions were conducted at constant flow (8 ml/min) using 
a recirculating mode (total buffer volume = 100 m1). Basal values are at t = —6.25 min. 
Additions at -6.25 min were vehicle •), 0.5-1 [iM 5-HT (0), 0.5-1 1AM 5-HT + 1001AM 
CCh (V) or 0.5 nM vasopressin (V). Values are means ± SE. **,P<0.01; ***,P<0.001 
for treatment versus vehicle (n=10-12). Due to the differences among most groups, 
values were only compared to control perfusions. 
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Constant Flow Ficoll ® Perfusions 
Control 5-HT 5-HT+CCh vasopressin 
TG hydrolysis (nmolFFAII I .g-1 ) 184 ± 28 602 ± 132** 231 ± 24# 255 ± 68" 
V02 (pmol.g-1 .11-1 ) 16.7 ± 0.6 10.2 ± 1*** 19.2 ± 2.1 4" 21.3 ± 0.9*"4 
PP (mmHg) 70.6 ± 5 170 ± 27*** 62.4 ± 7 ± 8" 
Muscle FFA (nmol.g-1 .11-1 ) 161 ± 25 508 ± 133* 200 ± 6.34 169 ± 55° 
Perfusate FFA (nmol.g-1 .11 1 ) 23.5± 12 93.1 ± 15* 30.7± 19 86.3 ± 22* 
Table 1. Effect of 5-HT, 5-HT + CCh, and vasopressin on TO hydrolysis, V02 and 
PP by the perfused rat hindlimb at constant flow. 
The TO substrate was a chylomicron-lipid emulsion (214). Perfusions were constant 
flow, recirculating and set at 8 ml/min. TO and oleic acid radioactivity analyses were 
conducted on perfusate samples taken at intervals of 15 min throughout perfusions of 60 
min duration (Fig. 2). Average rates of FFA formation (perfusate FFA) over 60 min 
were measured by thin layer chromatography. Muscle [ 14g-oleic acid uptake into the 
hindlimb were at 60 min. Values for maximal changes in V02 and PP were taken 15 min 
after recirculation. Values are means ± SE (n=5-7). One symbol, P<0.05; two symbols, 
P<0.01; three symbols, P<0.001. Symbols are and `#' to show significance from 
control and 5-HT perfusions respectively. 
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have been affected by contamination of the serum albumin by lipases (as confirmed by 
the high activity of serum albumin perfusate to hydrolyse p-nitrophenyl palmitate). As 
with the Ficoll® perfusions, TO hydrolysis was however also increased with 5-HT in 
these constant pressure perfusions (Table 2). Increases in TO hydrolysis were not a 
result of 5-HT activating the enzyme (Table 3). 
The uptake of [ 14C]-FFA and [31-1]-CO into hindlimb muscles after one hour of 
chylomicron recirculation is shown in Figure 3. Panel A illustrates that perfusing the 
hindlimb with 5-HT increased the uptake of [ 14q-FFA into certain muscles. The 
increased uptake was significant in the soleus, plantaris and G.Red muscles. The 
percentage uptake of [ 311]-CO into hindlimb muscles from Fico11 ® perfusions is shown 
in Figure 3, panel B. After TG hydrolysis the chylomicron retains the CO, and therefore 
the uptake of [31-1]-CO into muscles may be due to either endocytosis of the chylomicron 
or chylomicron remnant. Even if the reported CO uptake was of the nascent 
chylomicron, the uptake of [ 14C]-FFA into the muscles of the 5-HT perfusions were still 
considerably greater than that recorded for endocytosis. Therefore the [ 14C]-FFA found 
in the muscles are likely to be attributable to TG hydrolysis. Alternatively CO uptake 
exceeded that of TO in the vasopressin perfusions. This is suggestive of uptake of the 
chylomicron remnant. If this were the case then the FFA formed from TG in the 
chylomicron must remain in the perfusate. In fact, the perfusate FFA levels with 
vasopressin are significantly higher than the control value (Table 1). 
Figure 4 is a plot of the percentage content of slow oxidative fibres against the 
uptake of [ 14C]-FFA in a hindlimb preconstricted with 5-HT for each muscle. [ 14q-FFA 
uptake when flow is predominantly non-nutritive significantly correlates (r=0.987, 
P<0.001) with the percentage content of slow oxidative fibres. 
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Constant Pressure BSA perfusions 
Control 	5-HT 
TO hydrolysis (nmolFFA.11 1 .g-1 ) 201 ± 35 421 ± 63* 
VO2 (pmol.e.h-1 ) 16.2 ±2.9 6.7± 1.8* 
PP (nunHg) 84 ± 3 91 ± 8 
Table 2. Effect of 5-HT on TO hydrolysis, V02 and PP by the perfused rat 
hindlimb at constant pressure. 
A set of BSA Perfusions were conducted at constant pressure (set at approx. 85 mmHg). 
The TO substrate was a chylomicron-lipid emulsion (214). TO and oleic acid 
radioactivity analyses were conducted on perfusate samples taken at intervals of 30 min 
throughout perfusions of 120 min duration. Average rates were calculated and means ± 
SE (n=4) for V02 (30 min) and PP (30 min) are shown. *,./3<0.05 for 5-HT vs. control. 
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LPL activity (nmol.min-l .g-1 ) 
G.Red 
	
G.White 	 Plantaris 
Vehicle 198±52 110±40 150±60 
5-HT 180±30 90±30 70±5 
Table 3. LPL activity in muscle homogenates after BSA-perfusion with vehicle or 
5-HT. 
To assess whether 5-HT activated LPL during perfusion and therefore had a direct effect 
on the rate of TG hydrolysis, perfusions were conducted in which vehicle or 5-HT was 
infused for 20 min. Muscles were then excised, homogenized and assayed for LPL 
activity using the technique of G. Bengtsson-Olivecrona and T. Olivecrona (18). No 
difference was seen in the activity of muscle LPL after perfusion with 5-HT. Values are 
means ± SE (n=4-5). 
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Figure 3. Uptake of [ 14q-oleic acid and [311]-cholesteryl oleate ([3I-1]-CO) into 
hindlimb muscles in constant flow Fico11 6-perfused rat hindlimb using a chylomicron 
lipid emulsion (CLE) and heat-inactivated rat serum (HIRS) as a source of 
apolipoprotein CII. The effects of 5-HT (0.5-1 j.tM, 5-HT, black bar), 5-HT and CCh 
(0.5-1 1AM 5-HT + 100 p,M CCh, white bar) and vasopressin (0.5 nM, hatched bar) were 
measured for each CLE type and compared to perfusions with no additions (control, 
grey bar). CLE contained either or [ 14g-triolein ([ 14C]-TO (panel A)) or [ 311]-CO (panel 
B). The values in panel B are the percentage of total circulating CO that is taken up by 
each muscle. Values are means ± SE (n=4-7). Significance from 'no additions', from '5- 
HT' perfusions or from `5-HT+CCh' perfusions, are shown by "K ',` #' and '^' 
respectively, where one symbol denotes P<0.05, two symbols, P<0.01; and three 
symbols, P<0.001. 
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Figure 4. Uptake of FFA from a synthetic chylomicron emulsion using the mean values 
for uptake with 0.5-1 i.tM 5-HT for each hindlimb muscle and their corresponding 
percentage content of slow oxidative fibres. The linear regression produces an r 2 = 0.975 
(P<0.001). The percentage content of slow oxidative fibres was taken from reports by 
Ariano et al. (5) and Armstrong and Laughlin (6). Means are values ± SE (n=5-7). 
4.4 Discussion 
The importance of SM in total circulating lipid clearance is often 
underestimated, and all previous reports have neglected the effect of flow partitioning on 
TG clearance in muscle, due to the presence of nutritive and non-nutritive routes. Here 
we report that the hydrolysis of TO was markedly increased in the perfused rat hindlimb 
when a high proportion of CT flow occurred. In contrast, increasing the proportion of 
nutritive flow (vasopressin infusion) had no effect on TO hydrolysis. The reason for this 
is not clear, however the results indicate that the hydrolytic enzyme (presumably LPL) is 
not located exclusively in the non-nutritive vessels. 
Recruitment of CT flow for these experiments was induced by the addition of 5- 
HT, a representative Type B vasoconstrictor, which has previously been reported to 
decrease oxygen uptake, lactate output, glucose uptake (211) (212) and tension 
development of aerobically contracting muscle (64). All of these changes are 
characteristic of Type B vasoconstriction (46) and are representative of decreased 
nutrient delivery to muscle, and decreased muscle metabolism secondary to increasing 
the proportion of non-nutritive or CT flow within muscle (48). 
When CT flow was increased by addition of the vasoconstrictor, 5-HT, there was 
14- a marked increase in TG hydrolysis (indicated by [ L] .. FFA uptake) in the soleus, 
plantaris and G.Recl muscles. Uptake of [ 14C]-FFA greatly exceeded that of the CO with 
5-HT. This implies that uptake due to endocytosis of the chylomicron (causing TO 
radioactivity to be found in the muscle without any detectable amounts of hydrolysis) or 
of the chylomicron remnant (where all of theco--oleic j 	acid or [ 14q-TO in the muscle 
is due to hydrolysis) could not account for the observed increase. It is important to note 
that the reported increase in TG hydrolysis occurred without any stimulation of LPL 
activity by 5-HT. This indicates that the TG hydrolysis due to 5-HT is likely to be the 
result of a vascular effect whereby the exposure of TG to TG hydrolytic activity, 
presumably LPL is increased. From this, it would also seem likely that the distribution 
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of TG hydrolytic activity is greater along the non-nutritive or CT circuit that nourish 
interlacing adipocytes than along the nutritive route supplying muscle cells. 
Evidence that the vessels of non-nutritive flow are those of the CT associated 
with muscle has been supported by direct visualisation, during various pharmacological 
intervention (95) (181). The increased TG hydrolytic activity associated with flow 
through this region implies access to LPL associated with an active population of 
interfibrillar adipocytes. This population may correspond to the interfasicular fat cells 
responsible for the marbling effect of meat. The amount of muscle marbling is reported 
to be highly variable (269), which may contribute to the large error bars for the 5-HT 
data. In addition, the amount of muscle marbling can be used as a marker for red 
oxidative (type 1) muscle fibres (301). From the present study the uptake of [ 14C]-FFA 
from TG hydrolysis correlated with the percentage of slow oxidative fibres when flow 
was predominantly non-nutritive (i.e. with 5-HT, Fig. 4). Thus increases in CT blood 
flow proposed to occur with age, hypertension and diabetes (48) (181) (242) may 
therefore allow increased fat deposition and perimysial marbling within the muscle. 
Reports of fat cells being nourished by CT vessels have been implied from 
anatomical studies by Erikson and Myrhage (72) and Lindbom and Arfors (156). In 
addition, Camps et al. (35) reported diffuse LPL mRNA levels in the CT of SM. The 
location of adipocytes in this region would be consistent with the findings herein of 
increased TG hydrolysis where flow is significantly redirected through these vessels. 
From this it follows that the non-nutritive vessels supply the CT and the closely 
associated adipocytes. 
It therefore appears likely that the vascular system plays a significant role in 
partitioning lipid and carbohydrate between muscle and CT fat cells. This type of fuel 
partitioning is likely to be under the control of the local release of vasomodulators. 
Whereas predominantly nutritive flow (such as in exercise) allows delivery of glucose 
and FFA to muscle cells, non-nutritive flow to CT adipocytes could promote either TG 
hydrolysis or the deposition of FFA to form adipocyte TG. The presence of insulin and 
glucose in this latter circuit is likely to further nourish and stimulate adipocyte TG 
enlargement by providing glycolytically-derived glycerol phosphate. Since the two 
vascular networks are in parallel, FFA and glycerol hydrolysed from TG by the LPL 
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situated along the non-nutritive circuit must first enter the venous circulation and 
redistribute throughout the body before it is presented to the myocytes. This implies a 
mechanism evolved for the storage of excess fat rather than for use by neighbouring 
myocytes. van der Vusse (283) has suggested muscle CT fat cells may be an important 
store of TG. 
Many reports on muscle TG hydrolytic activity do not discern between 
myocytes, CT and fat cells. Any measure of such activity, including LPL from a whole 
muscle sample will contain all of these components. If the TG hydrolytic activity 
described in this study is of non-nutritive origin then data from whole muscle samples 
will be more dramatically effected than has previously been recognised (67). Therefore 
assays of muscle homogenate that are significantly contaminated by CT adipocytes may 
overestimate muscle TG hydrolytic activity, including that of LPL. Similarly no 
discrimination is made between the two flow regions possible in SM. A combination of 
these factors poses further difficulty when interpreting the data of any muscle 
preparation that receives nutrient by the vascular route. 
Until recently little has been reported on the presence of perimysial adipose 
tissue (which we have given the acronym 'PAT') or 'marbling' in humans. The most 
comprehensive studies to date are carried out for the meat industry, where marbling 
affects the tenderness and palatability of a cut of steak. In cattle intramuscular adipose 
tissue occurs mainly at perimysial sites however a small amount is deposited in the 
endomysium (182) (301). The amount of muscle marbling is higher in muscles with type 
1 fibres (301) where intramuscular deposition is a combination of increased hyperplasia 
and hypertrophy (cell number and size respectively (174)). Perimysial adipocytes are 
arranged in discrete compartments (approximately 100 pri in diameter in cattle), each 
surrounded by newly synthesized CT, and supplied by blood vessels (182) (174). With 
5-HT, flow appears to be redistributed through tissue where there is higher fatty acid 
extraction but decreased metabolic capacity. The blood vessels supplying perimysial 
adipocytes (174) are therefore strong candidates for the 'non-nutritive' network. 
Continual flow through these vessels will increase fatty acid uptake to these adipocytes 
and accelerate rates of marbling. 
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Gondret et al. (88) have proposed that the deposition of PAT may be a result of 
increased lipogenic enzymes, acetyl CoA carboxylase (rate-limiting step in FFA 
synthesis) and malic enzyme and glucose-6-phosphate dehydrogenase. Despite only 
small active levels of these enzymes being present in SM (AT and liver are the main 
lipogenic tissues), their sudden increase in later life in rabbit correlates to the accelerated 
rate of muscle marbling. Mourot and Kouba (169) found increases in malic enzyme to 
be the dominant factor in PAT accretion. Increases in TG synthesis are likely to be due 
to a combination of increased fatty acid synthesis and possibly increased uptake from 
the blood. TG are synthesised from the successive esterification of fattyacylCoA units 
(pre-synthesised or from the circulation) to a glycerol-3-phosphate backbone (derived 
from ATP-dependent phosphorylation of glycerol or reduction of dihydroxyacetone 
phosphate). Only small amounts of glycerol kinase are found in AT therefore most of 
the glycerol-3-phosphate produced is thought to be from glycolytic intermediates. 
Adipose glycerol kinase is however active in certain obese individuals where glycerol 
formed from lipolysis is re-esterified (40). Therefore, uptake of glycerol and fatty acids 
from blood will increase TG synthesis, particularly in certain forms of obesity. Insulin 
has been shown to increase AT LPL and decrease or not change the levels and activity 
of SM LPL (55). The addition of insulin will further stimulate LPL in the non-nutritive 
adipocytes. 
Previously ultrasound was used to detect increases in PAT (218). Ultrasound has 
been now superceded by the better resolution capability of computed tomography, 
where lipid is recorded as a negative attenuation. Using this technique, Sipila and 
Suominen reported an increase in muscle attenuation (decreased levels of PAT) in 
elderly male and female athletes (255). In addition, perimysial fat accretion was found to 
break up the collagen network between the fibre bundles (182) resulting in a reduction 
in muscle work capacity. While an increase in muscle density is recorded with training, 
the opposite appears to be true for obesity. Reduction in muscle density has been 
correlated with age and body weight (137) (254) (236). Negative attenuation of the mid-
thigh is also inversely related to insulin sensitivity (254) (93). Despite these correlations 
computed tomography is, however, unable to distinguish between fat located within the 
muscle fibres (intramyocellular) and fat located between the muscle fibres (PAT). 
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Indeed, many studies (including muscle biopsy) may actually be measuring a 
combination of both TG stores. 
Newer methods using 1 11 NMR spectroscopy are able to distinguish the two TG 
compartments in human muscle (245) (28) (195) (269). TG methylene proton signals 
occurring at 1.4 and 1.6 p.p.m. and are thought to represent TG inside the muscle fibres 
and TG in AT between the fibres respectively. At present it is unclear why the TG in 
these two compartments resonate at different frequencies, but is likely to be due to their 
different spatial arrangement/orientation in each cell type. This may include association 
of the TG with different structures (for example perilipin in AT) or location of the 
intramyocellular lipid in a more polar environment (270). Alternatively intramyocellular 
TG is contained in a spherical droplet unlike the tubular accumulation of PAT (28). 
These methods have increased in popularity (and are preferred over muscle dissection 
and painful needle biopsy) due to non-invasive measurements of live subjects. 
Intramyocellular TG content has been positively correlated with insulin 
resistance (reviewed in (91)) despite our reported decrease in capillary blood flow. 
However it remains uncertain whether increased myocyte TG is a result of or a cause of 
insulin resistance. Most reports would suggest that an increase in intramyocellular TG is 
a major cause of insulin resistance (144) (195) (197). Studies on the off-spring of type II 
diabetics which have a high risk factor for the disease revealed an elevated 
intramyocellular TG accumulation in the soleus (195). How tissue TG modulates insulin 
secretion and action is unknown. While the deposition if intramyocellular TG is 
increased preceding or during the early stages of insulin resistance, the deposition of 
PAT appears to be later on in life (301) (174) perhaps when muscle insulin resistance 
has been established. Therefore measurement of PAT content by proton magnetic 
resonance spectroscopy in the off-spring of Type 2 diabetic parents is similar to the 
offspring of healthy adults (123). However, acceleration of perimysial adipocyte 
accretion in the muscle of humans over 60 years old (both an increased size and number) 
was accompanied by obvious changes in vessel structure (242). 
In conclusion, TG hydrolysis was enhanced in the perfused rat hindlimb by the 
addition of the model vasoconstrictor 5-HT. 5-HT had no direct effect on LPL activity 
and thus alterations in TG hydrolysis are likely to be due to the ability of 5-HT to alter 
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flow patterns within muscle. Increases in non-nutritive flow (possibly with hypertension 
and insulin resistance) may therefore enhance perimysial, endomysial and tendon fat 
deposition, leading to increases in muscle adiposity. This is more likely to occur later in 
life and result in changes that are detrimental for muscle function. 
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CHAPTER 5 
5 Effect of predominantly nutritive and non-nutritive flow patterns on 
amino acid uptake and release by the perfused rat hindlimb. 
5.1 Introduction 
Chapter 3 of this thesis examined insulin-mediated glucose and palmitic acid 
uptake by the perfused rat hindlimb with the infusion of an agent (5-HT) that increased 
the ratio of non-nutritive to nutritive flow. This resulted in the decreased uptake of these 
metabolites. Long-term reductions in capillary flow may therefore contribute to elevated 
circulating levels of FFA and glucose. While lipid and carbohydrate fulfill the majority 
of SM fuel requirements, they are also able to utilize amino acids. As with glucose, 
amino acids are soluble in water (and plasma). Solutions of radiolabeled and cold amino 
acids can thus be infused into the vasculature of the hindlimb. Non-metabolizable amino 
acids such as a amino isobutyric acid (AIB) and a methyl amino isobutyric acid 
(methAIB) are often used (29). Here we have examined the uptake of the amino acid, a 
amino isobutyric acid (AIB) by the perfused rat hindlimb. Despite the high affinity of 
MB for the muscle system A transporter, the uptake of this derivative in the perfused rat 
hindlimb is very low when compared to other amino acids such as alanine (120). This 
non-metabolizable amino acid derivative is, however, advantageous for distinctly 
studying uptake of AIB only, as it is not incorporated into protein, and provided 
intracellular levels remain low, it is not re-released into the perfusate. 
In addition, we have determined the release of an indicator of SM myofibrillar 
(actin and myosin) degradation, 3-methyl histidine (3-MH) as well as net release of 
histidine. Almost 90% of 3-MH released from the body originates from SM (295). The 
anabolic effect of insulin involves both increased amino acid uptake and decreased 
amino acid release from muscle (29). As a result, the intracellular amino-acid pool is 
elevated. While insulin has been shown to attenuate total protein breakdown (tyrosine 
release (228) (166)), myofibrillar protein breakdown (3-MH release) is unaltered in the 
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perfused rat hindlimb (228) (130). In these experiments, however, we have altered the 
proportion of capillary/nutritive flow in the perfused rat hindlimb by the addition of 
certain vasoconstrictors with or without insulin. Altering the delivery of insulin under 
these conditions may affect 3-MH or histidine release or MB uptake. 
5.2 Materials and Methods 
5.2.1 Perfusion buffer 
Bovine RBC were washed in Krebs buffer which is gassed with 95% air:5% 
CO2. RBC were filtered through muslin and packed cells were added to 1.27 times 4% 
BSA/Krebs buffer (Chapter 2 section 2.2.2), 228 1.1.1/1 heparin, 2.54 mM CaCl2, 8.3 inM 
glucose and 1.32 g/1 pyruvic acid. Throughout the perfusion, the RBC buffer was 
continuously gassed with 95% air:5% CO2, both into the medium and through the 
artificial lung of the apparatus. 
5.2.2 Perfusion protocol 
The left hindlimbs of 180-200 g male Hooded Wistar rats were perfused with 
bovine RBC in a Krebs buffer at 4 ml/min and 37°C. Surgery was performed as 
described in Chapter 2 section 2.2.4, and the perfusion apparatus used is shown in Fig.2 
Chapter 2. The Clark-type oxygen electrode was calibrated using 100% oxygen and 
100% nitrogen, and measured dissolved oxygen in the perfusate only. 
[14CJAIB, AIB 
[3H]mannitol 
5-HT/All/vehicle 
Insulin/vehicle 
0 10 20 30 40 50 60 70 80 90 100 
4 venous perfusate sample 
Figure 1. Perfusion protocol for the determination of AIB uptake by the perfused rat 
hindlimb. 
The hindlimbs were perfused according to the protocol shown above (Fig. 1). 
After a 40 min equilibration period, 50 mM AIB was infused with 400 Ci [ 14C] AIB and 
40 Ci [3H] mannitol for 30 min at a dilution of 1/100 (final concentration 0.5 mM AIB). 
Perfusions assessing the uptake with insulin used 18 mU/m1 of insulin (Ins, Humulin, 
Eli Lilly) added as a bolus to the perfusion buffer. In some perfusions, either 1 p.M 5-HT 
(5-HT) or 50 nM All (All) were infused 5 min prior to AIB infusion. AIB was infused 
for the remainder of the experiment (30 min). Venous samples were taken during basal 
conditions and 10, 20 and 30 minutes after AIB infusion. 
5.2.3 Radioactivity of hindlimb muscles 
Immediately after perfusion, the hindlimb muscles were removed and digested 
according to Chapter 2 section 2.4 for determination of radioactivity. 
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5.2.4 Radioactivity of plasma samples 
Venous samples were immediately centrifuged to remove RBC and 100 IA1 of 
plasma was added to 6 ml of Amersham Biodegradable Counting Scintillant for 
determination of radioactivity. Samples were counted for a dual-label ([3H] and [ 14C]). 
5.2.5 3-Methyl histidine release 
Derivatization of primary amines with fluorescamine (4-phenylspiro[furan-
2(3H), 1'-phthalan]-3,3'-dione) produces fluorescent fluorophors (Fig. 2). Un-reacted 
fluorescamine however, is rapidly destroyed by contact with water (282). Fluorescamine 
and all hydrolysis products are non-fluorescent (282), allowing easy detection of 
derivatized amino acids. In this chapter a modification of methods by Wasnner et al. 
(296) and Nakamura and Pisano (175) were used. Arterial and venous perfusate samples 
(taken 10 mins after the beginning of AIB infusion (70 min)) were derivatized with 
fluorescamine, and the 3-MH and histidine fluorophors were detected by C18 reverse-
phase HPLC with an in-line fluorimeter. 
Figure 2. Derivatization of primary amines with fluorescamine (modified from (282)). 
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Perchloric acid (2 M) was added to all perfusion samples to remove protein. 
Samples were then neutralized with 2.5 M K2CO 3 . Perfusate samples (501.11) were added 
to 200 pl 0.2 M boric acid buffer (pH 9) containing 10 iiM L-histidinol (Sigma) as an 
internal standard, and mixed before the addition of 250 11,1 of acetonitrile and 
fluorescamine (0.2 mg/ml, Sigma). The derivatization was performed at room 
temperature for 5 min in the dark. HC1 (250 i.t1 of 2M) was added and samples were then 
incubated at 80°C for 1 hour. After cooling to room temperature, samples were adjusted 
to pH 6.5 using 150 1.11 of 2.5 M K2CO3. Samples (100 ill) were then separated on a C18 
reverse-phase HPLC column, and run using a gradient of 10 mM sodium phosphate 
buffer in 20-40% acetonitrile (pH 7.5), as the mobile phase. Samples were run at 1.5 
ml/min and 3-MH, histidine and histidinol had retention times of approximately 10, 11 
and 20 mins respectively. Peaks were detected using a WinDaq data acquisition program 
attached to an in-line fluorimeter (excitation wavelength of 365 nm and an emission 
wavelength of 460 nm, sensitivity 100). Standards of 3-MH (Sigma) and L-histidine 
(Sigma) were conducted regularly to check the consistency of derivatization and 
separation. 
The area under the fluorescent curve for each standard concentration was 
determined (volts.$) and plotted against the standard concentration. The equations 
generated from the standard curves for 3-MH and histidine were used to calculate the 
concentration of these amino acids in the arterial and venous samples. The difference in 
venous and arterial concentration was used to calculate the release of the respective 
amino acids by the perfused hindlimb, using the equation: 
Rate = 6.3-MH or histidine (nmol/ml) 
x flow rate (ml/min) x 60 / muscle weight (g) 
= nmol/g/hr 
5.2.6 Statistics 
To determine statistically significant differences, one or two way analysis of 
variance was used (ANOVA). Significance was recognised at P<0.05. One, two or three 
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symbols were used to denote values of P<0.05, P<0.01 and P<0.001 respectively. 
Symbols used were "" (to show significance from control), `+' (to show significance 
from Ins), `#' (to show significance from 5-HT), `8,c' (to show significance from All) 
and `$' (to show significance from AII+ Ins). 
5.3 Results 
Due to the variability in basal oxygen tension (resulting from different batches of 
RBC) all differences are reported in terms of "change in oxygen consumption". The 
dissolved venous oxygen content and perfusion pressure (PP) of all experiments are 
shown in Figure 3 (panels A and B respectively). The maximal vasoconstrictor effects 
occurred at the beginning of constrictor infusion (10 min before AIB infusion). Venous 
dissolved oxygen content significantly increased by 5.8 ± 0.9 mmHg (P<0.001) during 
maximal stimulation with 5-HT, indicating decreased uptake by the hindlimb. Similarly, 
PP was significantly increased by 56.9 ± 11 mmHg (P<0.001). With the addition of 18 
mU/m1 (108 nM) Ins to the buffer, 5-HT increased venous dissolved oxygen (by 6.4 ± 
1.3 mmHg, P<0.001) and PP (by 66.9 ± 15 mmHg, P<0.001) by a similar amount. Ins 
infusion did not significantly alter dissolved oxygen content or PP from control 
perfusions. Infusion of 50 nM All significantly decreased venous oxygen content 
(indicative of increased oxygen uptake, and increased capillary flow) by 11.5 ± 1.5 
mmHg during maximal stimulation (P<0.001). This was accompanied by an increased 
PP of 41.4 ± 6.3 mmHg (P<0.01). Co-infusion of Ins with All, however, significantly 
reduced the vasoactive effect of All (venous oxygen decreased by 6.5 ± 1.4 mmHg 
(P<0.001 vs control and P=0.003 vs All), and PP increased by 18.3 ± 4.4 mmHg (not 
significant from control)). 
The uptake of AIB by the individual hindlimb muscles with all treatments is 
shown in Figure 4, panel A. Ins significantly increased AIB uptake into all muscles. 
When averaging the uptake across all muscles tested (Figure 4, panel B) Ins increased 
the uptake by approximately 2 times, from 434 ± 59 to 940 ± 87 nmo1/30min/g 
(P=<0.001). 5-HT infusion tended to decrease the uptake, however this was not 
significant (P=0.075). The infusion of 5-HT with Ins significantly decreased the uptake 
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of AIB compared to Ins infusion alone, in three of the six muscle tested (EDL, G.White 
and tibialis). This reduction in AIB uptake was significant for the average of the muscles 
tested (from 940 ± 87 to 658 ± 20 nmo1/30min/g (P=<0.05)). The infusion of MI did 
not significantly increase AIB uptake by the hindlimb. The co-infusion of Ins with An 
did not further increase AIB uptake above the uptake by ins stimulation alone. 
Very little difference was recorded between extracellular space and W.Wt. to 
D.Wt. ratio of the hindlimb muscles, with any of the treatments used (figures 5 and 6 
respectively). 
3-MH release from the tissues is an indicator of myofibrillar protein degradation. 
These values are shown in Figure 7. All infusion (50 nM) significantly increased the 3- 
MH release from the hindlimb compared to all other groups (P<0.001 for all groups vs 
All), including All + Ins (from 10.2 ± 0.7 to 3.9 ± 0.2 nmol/g/h). Ins alone did not 
significantly decrease 3-MH release compared to control perfusions. 5-HT infusion (1 
1AM) did not alter 3-MH release from control perfusions. 
Histidine release from the perfused rat hindlimb is shown in Fig.8. Histidine 
release was significantly inhibited by the infusion of 18 mU/m1 Ins (from 121 ± 15 to 55 
± 20 nmol/g/h, P<0.05). As with the 3-MH, histidine release was significantly increased 
by the infusion of All compared to all other groups, including AII+Ins (from 99 ± 12 to 
203 ± 17 nmol/g/h, P<0.001). 5-HT infusion (1 1AM) did not alter L-histidine release 
from control perfusions, however 5-HT+Ins significantly decreased histidine release 
compared to 5-HT infusion alone (from 128 ± 23 to 9.1 ± 5.8 nmol/g/h, P<0.01): 
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Figure 3. Change in oxygen partial pressure (Vp02, Panel A) and perfusion pressure 
(PP, Panel B) in the rat hindlimb perfiised with bovine RBC and BSA/Krebs buffer at 4 
ml/min, 37°C and either Ins (18mU/m1), 5-HT (1 iM), All (50 nM) or a combination of 
these agents. Insulin was added from the beginning of the experiment, while all 
vasoconstrictors were added 10 minutes before AIB infusion. At 0 min, [ 14C] AIB were 
infused in all experiments for the remaining 30 min. Symbols are 0, control; •, Ins; IN, 
All; 0, AII+Ins; V, 5-HT; V, 5-HT+Ins. Significant differences from control 
experiments are denoted by *, ** or *** to show P<0.05, P<0.01 and P<0.001 
respectively. Values are means ± S.E., n=5-6. Due to the differences between all group, 
only comparisons to control perfusions were made. 
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Figure 4. The uptake of [ 14C] AIB by the rat hindlimb perfused with bovine RBC and 
BSA/Krebs buffer at 4 ml/min, 37°C and either Ins (18 mll/m1), 5-HT (1 uM), All (50 
nM) or a combination of these agents. Insulin was added from the beginning of the 
experiment, while all vasoconstrictors were added at 10 min before AIB infusion. At 0 
min, [ 14C] AIB infused in all experiments for the remaining 30 min. The uptake into the 
individual muscles is shown in Panel A, and the average uptake for those muscles tested, 
is shown in Panel B. Bars are control (white), Ins (black), All (cross hatched), AII+Ins 
(grey), 5-HT (right hatched) and 5-HT+Ins (horizontal stripe). Significant differences 
are denoted by one, two or three symbols to show P<0.05, P<0.01 and P<0.001 
respectively. Significant differences are denoted by " 1", '+', '&', and '$' to show 
significance from control, Ins, All and AII+Ins respectively. Values are means ± S.E., 
n=5-6, for muscles after 30 minutes of AIB infusion. 
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Figure 5 Muscle extracellular space in the rat hindlimb perfused with bovine RBC and 
BSA/Krebs buffer at 4 ml/min, 37°C and either Ins (18 mU/m1), 5-HT (1 iiM), All (50 
nM) or a combination of these agents. Insulin was added from the beginning of the 
experiment, while all vasoconstrictors were added at 10 min before AIB infusion. At 0 
[ 14C] MB and [3H] mannitol were infused in all experiments for the remaining 30 
min. Bars are control (white), Ins (black), All (cross hatched), AII+Ins (grey), 5-HT 
(right hatched) and 5-HT+Ins (horizontal stripe). Values are means ± S.E., n=5-6, for 
muscles dissected after 30 mins of AIB infusion. 
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Figure 6 Muscle W.Wt:D.Wt. ratio in the rat hindlimb perfused with bovine RBC and 
BSA/Krebs buffer at 4 ml/min, 37°C and either Ins (18 mU/m1), 5-HT (1 1.IM), All (50 
nM) or a combination of these agents. Ins was added from the beginning of the 
experiment, while all vasoconstrictors were added 10 min before AIB infusion. At 0 
min, [ 14C] AIB was infused in all experiments for the remaining 30 min. Bars are control 
(white), Ins (black), All (cross hatched), AII+Ins (grey), 5-HT (right hatched) and 5- 
HT+Ins (horizontal stripe). Significant differences from AII+Ins are denoted by `$' 
(P<0.05). Values are means ± S.E., n=5-6, for muscles dissected 30 minutes after AIB 
infusion. 
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Figure 7 3-methyl histidine release by the rat hindlimb perfused with bovine RBC and 
BSA/Krebs buffer at 4 ml/min, 37°C and either Ins (18 mU/m1), 5-HT (1 iiM), All (50 
nM) or a combination of these agents. Insulin was added from the beginning of the 
experiment, while all vasoconstrictors were added 10 mm before AIB infusion. At 0 
, [ 14C] AIB was infused in all experiments for the remaining 30 min. Bars are control 
(white), Ins (black), All (cross hatched), AII+Ins (grey), 5-HT (right hatched) and 5- 
HT+Ins (horizontal stripe). Significant differences are denoted by one, two or three 
symbols to show P<0.05, P<0.01 and P<0.001 respectively. Significant differences are 
denoted by `8L', and IP to show significance from All and 5-HT respectively. Values 
are means ± S.E., n=5-6, using venous samples taken 10 min after the beginning of MB 
infusion. 
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Figure 8 Muscle histidine release by the rat hindlimb perfused with bovine RBC and 
BSA/Krebs buffer at 4 ml/min, 37°C and either Ins (18 mU/m1), 5-HT (1 gM), All (50 
nM) or a combination of these agents. Insulin was added from the beginning of the 
experiment, while all vasoconstrictors were added 10 min before AIB infusion. At 0 
min, [ 14C] AIB was infused in all experiments for the remaining 30 min. Bars are control 
(white), Ins (black), All (cross hatched), AII+Ins (grey), 5-HT (right hatched) and 5- 
HT+Ins (horizontal stripe). Significant differences are denoted by ` 4", `8,e, and `ti' 
to show significance from control, AIL AII+Ins and 5-HT respectively. Values are 
means ± S.E., n=5-6, using venous samples taken 10 min after the beginning of AIB 
infusion. 
5.4 Discussion 
This chapter demonstrated that the uptake of AIB, and the access to products of 
protein breakdown, are altered by the addition of vasoconstrictors (5-HT and AID that 
have previously been shown to modify the ratio of muscle nutritive and non-nutritive 
flow in the perfused rat hindlimb (211) (212) (180) (53). 
Insulin significantly increased [ 14C] AIB uptake into all hindlimb muscles, 
probably due to insulin's stimulatory effect on the System A transporter. Insulin has 
been shown to increase the uptake of methAIB into incubated soleus muscle (277), and 
in cultured L6 muscle cells 100 nM insulin increased AIB uptake by greater than 50% 
(165). In the perfused rat hindlimb, in this study, insulin (108 nM) increased AIB uptake 
by a similar amount. 
AIB uptake was not further increased from control perfusions by capillary 
recruitment (AII infusion). Angiotensin, however, has been shown to cause significant 
protein breakdown (33), thus, the net movement of certain amino acids out of the muscle 
by the System A transporter may inhibit the uptake of AIB, despite an increase in 
capillary perfusion, causing no net effect on AIB uptake. There was a marked dilatory 
effect of insulin against AIL that was absent during insulin or 5-HT+Ins infusions. This 
resulted in a small increase in oxygen consumption, despite no net pressure effect 
compared to control perfusions. Thus, the effect of All (with insulin) on AIB uptake 
would be less than expected if the oxygen consumption reached the same level as with 
An alone. However as insulin is also present, the effect of insulin to increase amino acid 
uptake would oppose that of All to increase amino acid release. Due to the net uptake of 
AIB in these experiments, insulin appears to have a stronger effect than All on protein 
metabolism. 
5-HT tended to decrease the uptake of AIB into all muscles, however this was 
not significant. 5-HT infusion reduced insulin-mediated AIB uptake in four of the six 
muscles tested, and significantly decreased AIB uptake across the whole hindlimb when 
compared to insulin infusion alone. This implies that the infusion of the constrictor, 5- 
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HT (shown in Chapter 3 to reduce IMGU), is likely to reduce the uptake of all amino 
acids by the muscle, contributing to muscle protein wasting. 
In addition, 3-MH and histidine release from muscle were also influenced by the 
infusion of All, 5-HT, insulin or a combination of these agents. 3-MH is an indicator of 
myofibrillar protein (myosin and actin) breakdown. 3-ME is formed through a post-
translational methylation of histidine residues of actin and myosin (reviewed in (306)). It 
is often monitored in preference to tyrosine or phenylalanine (indicators of total muscle 
protein degradation) which are not metabolized or produced by SM, but can be 
resynthesized into muscle proteins (306). Moreover, to measure these amino acids, 
protein synthesis inhibitors such as cyclohexamide must be added to the perfusate. 3- 
MH measurement is therefore preferable as it is not re-utilized for protein synthesis. 
As shown by others (228) (130), in this study insulin did not decrease muscle 3- 
MH release compared to control perfusions, however histidine release was significantly 
reduced. Histidine accounts for 2% of the total amino acids released by the perfused rat 
hindlimb (reviewed in (90)). Reduced histidine release with insulin has also been shown 
by Meek et al. (166). Thus, from this study it appears that insulin inhibits the breakdown 
of certain cellular proteins, however not actin and myosin. 
All infusion (capillary recruitment) increased the release of both 3-MH and 
histidine, which is likely to be due to either a reduction in muscle protein degradation, or 
a build-up of these amino acids in the previously-unperfused capillaries. While 
increased 3-MH release with All may be a phenomenon of washout from newly 
recruited vascular space, this was found to be unlikely, as a combination of insulin with 
All did not increase the release of 3-MH. While it is likely that the reduction in pressure 
with insulin and All, may cause some reduction in muscle amino acid efflux, Brink et 
al. (33) have shown that All has significant effects on muscle protein breakdown and 
wasting, and as is evident from this study, on both myofibrillar and other cell proteins. It 
would therefore be of interest to determine the effects of other vasoconstrictors that do 
not influence amino acid metabolism directly but alter the proportion of nutritive and 
non-nutritive flow. 
5-HT infusion alone had no effect on the release of either amino acid. Since non-
nutritive (connective tissue) flow is likely to have reduced muscle capillary perfusion, 
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along with a reduction blood access to muscle amino acid transporters, then it would be 
expected that 5-HT would decrease the efflux of histidine and 3-MH. The release of 
these amino acids however remained unaltered with 5-HT infusion, suggesting 5-HT 
may also have some metabolic effect to increase muscle protein degradation. A 
combination of 5-HT and insulin significantly reduced the release of histidine compared 
to all other perfusion types except insulin alone, however had no effect on 3-MH 
release. This re-enforces the idea that insulin has no effect on the breakdown of 
myofibrillar proteins. 
It has been shown that amino acids are able to exert control over muscle protein 
synthesis and amino acid balance (158) (268) (277). Others have shown that branched 
chain amino acids decrease the rate of protein breakdown. Kadowaki et al. (130) 
measured 3-MH release from the rat hindlimb perfused with RBC containing either 
insulin or amino acids. Neither had any effect on 3-MH release. Similarly, the inclusion 
of 0.5 mM AIB in these perfusions is not likely to affect this process, as is not 
metabolized by the myocyte. The RBC-based perfusion medium, however, contained 
small amounts of 3-methyl histidine and histidine (probably from the RBC). It is 
therefore conceivable that there was some uptake of these amino acids by the perfused 
muscle. From these experiments however there was clearly a net release of these amino 
acids into the perfusate. 
SM holds the largest pool of protein in the body (reviewed in (306)). The 
conservation of body protein is under complex control and is dependent on the degree of 
fasting and the age and fat depots of the rat (89). Older rats have been shown to have 
higher levels of protein synthesis and less proteolysis than younger rats (89). In 
incubated soleus and epitrochlearis muscles from obese Zucker rats, basal AIB uptake 
was reduced compared to their lean counterparts (80), which may be a reflection of 
down-regulation of the system A transporter, due to chronic non-nutritive flow. 
These results show that 5-HT and All are able to alter amino acid uptake and 
release by perfused muscle, which appears to be a combination of metabolic effects and 
alterations in the ratio of nutritive and non-nutritive flow. All clearly stimulates muscle 
protein degradation and 5-HT may have similar effects. Insulin appears to inhibit the 
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breakdown of histidine-containing proteins, but not myofibrillar proteins. With regard to 
amino acid transport into the myocytes, the uptake of MB was stimulated by insulin. 
However, increasing the proportion of muscle non-nutritive flow (with 5-HT infusion) 
reduced insulin-mediated AIB uptake (which is probably indicative of general amino 
acid uptake) by skeletal myocytes. Thus, non-nutritive flow may contribute to muscle 
wasting. 
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CHAPTER 6 
6 Substrate effects on hormone action: Lipid infusion impairs insulin-
mediated capillary recruitment (nutritive flow) and muscle glucose 
uptake in vivo. 
6.1 Introduction 
SM accounts for approximately 80% of the insulin-mediated glucose uptake after 
a meal (58) and becomes resistant to insulin in Type 2 diabetes (59), hypertension (129), 
obesity (57) and severe forms of stress (193). However, the mechanisms by which 
muscle insulin resistance develops are not fully understood. One factor that may be 
central is lipid availability. For example, insulin sensitivity in humans is reduced in 
obesity (57) and especially when individuals possess an abnormally high proportion of 
abdominal fat (38). In addition, lipid infusion in humans (25) (293), and in rats (140) 
gives rise to insulin resistance in muscle. Furthermore, genetically obese Zucker rats 
have elevated plasma levels of free fatty acids and show marked muscle insulin 
resistance (19) as do rats fed high fat diets (267) (264); although the type of fatty acid 
appears rather critical as oils of fish origin are protective against the effects of animal fat 
diets (265). 
Explanations to account for the link between lipid availability and muscle insulin 
resistance have until recently focused on the Randle glucose-fatty acid cycle (206) in 
which fatty acid metabolites collectively contribute to the inhibition of oxidative and 
non-oxidative glucose metabolism. Recently, there has been a number of studies (119) 
(246) (97) suggesting that fatty acids or their metabolites inhibit insulin signaling at 
points preceding activation of glycogen synthase or glucose transport. 
Insulin in vivo has haemodynamic effects additional to its well-described direct 
metabolic action on muscle. Although the precise role of the haemodynamic effects are 
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unknown, it is possible that they contribute to the overall metabolic response by 
enhancing access for both insulin and glucose to muscle (14) (303) (209). There appear 
to be two components to insulin's haemodynamic actions, one involving an increase in 
bulk flow and another involving capillary recruitment. A number of laboratories have 
reported an effect of insulin to increase bulk blood flow to muscles (14) (125) (154) (78) 
(84) (54) (222) and that this effect is impaired in states of insulin resistance (14) and 
when lipid is infused in otherwise normally responsive subjects (262). However, the role 
of the increase in total blood flow mediated by insulin is controversial. There have been 
claims that insulin-mediated changes in total blood flow relate poorly to muscle glucose 
uptake under several circumstances, including insulin dose and time course (303). In 
addition, there have been studies where total flow changes persist when glucose uptake 
is inhibited (244). Also, most vasodilators that augment total blood flow to the limbs do 
not enhance insulin action nor do they overcome insulin resistance (177) (178) (150). 
Because of techniques unique to our laboratories, we have been the first to report 
a direct effect of insulin to increase capillary recruitment (or nutritive flow) within SM 
of anaesthetized rats (209) and the forearm of humans (50). Insulin-mediated capillary 
recruitment appears to be independent of changes in bulk blood flow to the limb in both 
rats and humans, particularly if physiologic levels of insulin are used (287). 
Measurement of capillary exposure (or nutritive flow) in anaesthetized rats was assessed 
using 1-MX metabolism. Hind limb metabolism of this infused substrate targeted for 
capillary endothelial xanthine oxidase was shown to increase in the presence of insulin 
(209). In addition, if a-methyl 5-HT (a-met5HT), an agent that prevented capillary 
recruitment in the hind limb was administered (210), or if TNFa was infused (305), the 
ability of insulin to increase either total blood flow or capillary recruitment in the hind 
limb was markedly impaired and insulin-mediated glucose uptake was blocked by 50- 
60%. 
Since there appears to be a link between insulin-mediated capillary recruitment 
and insulin-mediated glucose uptake in muscle, it was considered important to explore a 
model of insulin resistance where insulin-mediated muscle glucose uptake is impaired. 
Thus the aim of these experiments was to assess whether fatty acid-induced muscle 
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insulin resistance was accompanied by impaired capillary recruitment at physiologic 
insulin. 
6.2 Methods 
6.2.1 Surgery 
Details were essentially as described previously. In brief, 250 g rats were 
anaesthetized using Nembutal (50 mg.kg -1 body weight) and had polyethylene cannulas 
(PE-50, Intramedic®) surgically implanted into the carotid artery, for arterial sampling 
and measurement of blood pressure (pressure transducer Transpac IV, Abbott Critical 
Systems) and into both jugular veins for continuous administration of anaesthetic and 
other intravenous infusions. A tracheotomy tube was inserted, and the animal was 
allowed to spontaneously breathe room air throughout the course of the experiment. 
Small incisions (1.5 cm) were made in the skin overlaying the femoral vessels of both 
legs, and the femoral artery was separated from the femoral vein and saphenous nerve. 
The epigastric vessels were then ligated, and an ultrasonic flow probe (Transonic 
Systems, VB series 0.5 mm) was positioned around the femoral artery of the right leg 
just distal to the rectus abdominis muscle. The cavity in the leg surrounding the flow 
probe was filled with lubricating jelly (H-R, Mohawk Medical Supply, Utica, NY) to 
provide acoustic coupling to the probe. The probe was then connected to the flow meter 
(Model T106 ultrasonic volume flow meter, Transonic Systems). This was in turn 
interfaced with an IBM compatible PC computer which acquired the data (at a sampling 
frequency of 100 Hz) for femoral blood flow, heart rate, and blood pressure using 
WINDAQ data acquisition software (DATAQ instruments). The surgical procedure 
generally lasted approximately 30 min and then the animals were maintained under 
anesthesia for the duration of the experiment using a continual infusion of Nembutal 
(0.6 mg.min-1 .kg-1 ) via the left jugular cannula. The femoral vein of the left leg was used 
for venous sampling, using an insulin syringe with an attached 29G needle (Becton 
Dickinson). A duplicate venous sample was taken only on completion of the experiment 
(360 min) to prevent alteration of the blood flow from the hindlimb due to sampling, and 
104 
to minimize the effects of blood loss. The body temperature was maintained using a 
water-jacketed platform and a heating lamp positioned above the rat. 
6.2.2 Experimental Procedures 
A 60 min equilibration period was allowed after surgery so leg blood flow and 
blood pressure could become stable and constant. Rats were then allocated into either of 
three protocols A, B, or C (Fig. 1). Protocol A involved 6h infusion of saline with a 2h 
euglycemic clamp (Humulin R, Eli Lilly & Co., Indianapolis, 3mU.min -1 .kg-1 ) 
commenced 4h into the saline infusion (Ins). Protocol B (Lip) involved an initial bolus 
dose of heparin (10 units) before a 6h infusion of 10% Intralipid TM / heparin (33units.ml-
1 ) at 20 1.11.min-1 with a 2h saline infusion commenced 4h into the lipid infusion. Protocol 
C (Lip + Ins) was identical to Protocol B except that a 2h euglycemic clamp replaced the 
2h saline. Volumes were matched between all three protocols (209) (210) (305). As in 
previous similar studies and since 1-MX (Sigma Aldrich Inc) clearance was very rapid, 
it was necessary to partially inhibit the activity of xanthine oxidase, particularly in non-
muscle tissues. To do this, an injection of a specific xanthine oxidase inhibitor, 
allopurinol (71) (10 imole.kg-1 ) was administered as a bolus dose 5 minutes prior to 
commencing the 1-MX infusion (0.5 mg.min -l .kg-1 ) (Fig. 1). This allowed constant 
arterial concentrations of 1-MX to be maintained throughout the experiment. 
As shown in Fig. 1, a 50 IACi bolus of 2-deoxy-D-[2,6- 3H]glucose (2-DG) 
(specific activity = 44.0 Ci.mmo1 -1 , Amersham Life Science) in saline was administered 
45 min before completion of the experiment. Plasma samples (20 p.1) were collected at 5, 
10, 15, 30 and 45 minutes to determine plasma clearance of the radioactivity and for the 
calculation of R'g. At the conclusion of the experiment, the soleus, plantaris, EDL, 
G.Red and white and tibialis muscles were removed, clamp frozen in liquid nitrogen and 
stored at -20°C until assayed for [3H]2-DG uptake. 
The total blood volume withdrawn from the animals before the final arterial and 
venous samples did not ,exceed 1.5 ml and was easily compensated by the volume of 
fluid infused. 
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All other procedures were as described previously (305), including analytical 
methods for glucose, 1-MX, allopurinol and oxypurinol assays. Free fatty acids were 
assayed using a NEFA C Colorimetric Kit (Wako). 
6.2.3 2-DG uptake assay 
The frozen muscles were ground under liquid nitrogen and homogenised using 
an Ultra TurraxTm. Free and phosphorylated [ 3H]2-DG were separated by ion exchange 
chromatography using an anion exchange resin (AG1-X8) (145) (126). Biodegradable 
Counting Scintillant-BCA, (Amersham, USA) was added to each radioactive sample and 
radioactivity determined using a scintillation counter (Beckman LS3801, USA). From 
this measurement and a knowledge of plasma glucose and the time course of plasma 2- 
DG disappearance, Rig, which reflects glucose uptake into the muscle, was calculated as 
previously described by others (145) (126) and is expressed as pg.miri l .g-lwet weight of 
muscle (126). 
6.2.4 Data analysis 
All data are expressed as means ± SE. Mean femoral blood flow, mean heart 
rate and mean arterial blood pressure were calculated from 5 second sub-samples of the 
data, representing approximately 500 flow and pressure measurements every 15 
minutes. Vascular resistance in the hind leg was calculated as mean arterial blood 
pressure in millimetres of mercury divided by femoral blood flow in ml.min -1 and 
expressed as resistance units (RUs). Glucose uptake in the hind leg was calculated from 
arterio-venous glucose difference and multiplied by femoral blood flow and expressed 
as pmol.min-I . The 1-MX disappearance was calculated from arterio-venous plasma 1- 
MX difference and multiplied by femoral blood flow (corrected for the volume 
accessible to 1-MX, 0.871, determined from plasma concentrations obtained after 
additions of standard 1-MX to whole rat blood) and expressed as nmoles.min-1. 
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6.2.5 Statistical analysis 
In order to ascertain differences between treatment groups at the end of the 
experiments (i.e. hindleg glucose uptake, R'g, and 1-MX metabolism) one way analysis 
of variance was used. Statistical differences between treatment groups for repeated 
measures throughout the 6 hours (i.e. blood pressure, heart rate, femoral blood flow, 
vascular resistance, blood glucose and GIR) were determined using two way repeated 
measures analysis of variance. All comparisons were made using the Student-Newman-
Keuls method. The correlation between 1-MX disappearance and hindleg glucose uptake 
was determined by linear regression. All tests were performed using the SigmaStat TM 
statistical program (Jandel Software Corp.). Significance was determined by P values 
less than 0.05. One, two or three symbols were used to denote P values of <0.05, <0.01, 
<0.001 respectively. The symbols used were "" (to show significance from Ins treated 
group) and T (to show significance from Lip + Ins treated group). 
6.3 Results 
6.3.1 Haemodynamic effects 
Figure 2 shows the arterial blood pressure (BP), heart rate (HR), femoral arterial 
blood flow (FBF) and hind leg vascular resistance (VR) for the three different protocols 
of saline for 6h with Ins over the last 2h (Ins), Intralipid TM/heparin  for 6h and Ins over 
the last 2h (Lip + Ins), and Intralipid TM/'heparin  for 6h and saline replacing Ins over the 
last 2h (Lip). Although there was a trend for FBF of Lip + Ins treated rats to be less than 
Ins treated rats at the closing stages of the clamp (340-360 min), this was not significant. 
There was no significant difference between Ins, Lip or Lip + Ins treated rats for any of 
• the other three parameters BP, HR, or VR. 
6.3.2 Glucose metabolism 
Blood glucose levels for the three Ins, Lip and Lip + Ins treated groups are 
shown in Fig.3. Blood glucose was allowed to set its own level during the first four 
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hours (0-240 min), and in general this remained constant at approximately 5 mM. 
However, there was some variability for Intralipid TM /heparin treated rats and for one 
group (Lip) there was a small transient fall at 120 min which then recovered, so that at 
240 min all three groups were similar. In addition, there was a rise in the blood glucose 
level in the Lip treated rats at the 360 min time point; which was significantly higher 
than both Ins and Lip + Ins treated groups. The inset shows glucose infusion rate (GIR) 
to maintain euglycemia for Ins and Lip + Ins treated groups. For Ins treated group the 
GIR increased from zero to 9.0 ± 0.3 at 250 min (10 min), then to 11.9 ± 0.6 mg.kg" 
1 .min-I at 360 min (120 min), while that for Ins + Lip group decreased from approx. 9.0 
at 250 min to 1.5± 0.6 mg.kg -1 .min-1 at 360 min. The differences in GIRs to maintain 
euglycemia became significant as early as 20 min after commencement of the Ins 
infusion. 
Measurements for arterial plasma free fatty acids were taken immediately prior 
to the commencement of the 2 hour Ins clamp. Four hour infusion of 10% Intralipid TM 
/heparin significantly increased arterial plasma free fatty acids to 3.9 ± 0.6 mM 
(P<0.001) in Lip + Ins treated animals and to 5.3 ± 0.6 mM in Lip treated animals 
(P<0.001) compared to animals receiving no lipid infusion (0.3 ± 0.1 mM). There was 
no significant difference between the free fatty acid levels in the two groups receiving 
Intralipid TM /heparin. 
Hind leg glucose uptake values for Ins, Lip + Ins, and Lip groups are shown in 
Fig. 4. Infusion of Intralipid TM /heparin alone (Lip) for 6h did not affect HGU and the 
value determined at the end of the experiment was similar to saline (basal) values 
previously reported at the end of 2h (305). However, the combination of Intralipid TM 
/heparin for 4h prior to, and during the 2h clamp significantly reduced the stimulatory 
effect of Ins from a net of 0.45± to 0.25 mol.min -1 ; an inhibition of 44%. 
6.3.3 1-3HJ 2-DG uptake 
[3H]2-DG was administered for the final 45 min of each experiment. Figure 5A 
shows uptake values for soleus, plantaris, EDL, G.Red and white, as well as tibialis 
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muscles removed at the completion of the experiment Values for soleus and plantaris 
muscles were 7.9 ± 0.7 and 4.9± 0.51Ag.miri l .g.1 , respectively, following infusion of 
Intralipid TM /heparin alone (Lip) for 6h. Ins infusion alone (Ins) increased the values for 
R'g in soleus (3.2 fold), plantaris (2.4 fold), EDL (2 fold) and G.Red (2.4 fold) when 
compared to Lip treated animals (Fig. 5). Notwithstanding the presence of the lipid in 
the control situation which may have influenced the rate of basal 2-DG uptake, the 
magnitude of stimulation by Ins at 3mU.min -l .kg-1 was less than previously reported for 
the higher dose of 10mU.min-1 .kg-1 of 6.5 fold for soleus and 7.8 fold for plantaris 
muscles (305). Intralipid TM /heparin (Lip + Ins) infusion markedly inhibited the 
stimulatory effect of Ins in three of the six muscles (soleus, plantaris and G.Red). In 
addition, Figure 5B shows that Lip + Ins significantly inhibited R'g for the combined 
muscles (aggregated on proportional weight) from a net stimulatory effect by Ins of 6.4 
to 2.0 This represents an inhibition of 69%. 
6.3.4 1-MX metabolism 
No significant difference was found between the experimental groups in arterial 
plasma concentrations of 1-MX (Fig. 6A) or oxypurinol (3.5± 0.5 pM, Ins; 4.0 ± 1.2 
p.M, Ins + Lip; 4.0 ± 0.7 1AM; Lip), the metabolite of allopurinol and inhibitor of 
xanthine oxidase. 
Ins infusion alone (Ins) significantly increased hind leg 1-MX metabolism 
relative to Lip group (P<0.01) (Fig. 6C). However, the increase in 1-MX metabolism 
with Ins was inhibited with Intralipid TM /heparin infusion (P<0.05). 
When individual data for hind leg glucose uptake were plotted against 
corresponding values for 1-MX disappearance and analyzed by linear regression a 
positive correlation was noted (Fig. 7A; r = 0.6, P = 0.014). There was no correlation 
between hind leg glucose uptake and FBF (Fig. 7C), nor between FBF and 1-MX 
metabolism (Fig. 7B). 
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Figure 1. Study design. In two (protocols A and C) the euglycemic-
hyperinsulinaemic (3mu.min-l .kg-1 ) clamp was commenced 4h after the start of saline 
(protocol A, Ins) or Intralipid TM/ heparin (protocol C, Lip + Ins) infusion. During 
protocol B (Lip) saline replaced Ins at 4h. Duplicate arterial and femoral venous plasma 
samples were collected at 360 min, as indicated by sfe) P , for HPLC analysis and plasma 
glucose determinations. Heparin, allopurinol and [ 31-112-DG were injected as indicated 
by P at 0, 295 and 315 min, respectively. Arterial samples were also taken for 
monitoring plasma [3H]2-DG radioactivity at 5, 10, 15, 30 and 45 after injection (not 
shown). Arterial samples for glucose determinations are indicated by 4. Venous 
infusions are indicated by the bars. 
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Figure. 2. Mean arterial blood pressure, heart rate, femoral blood flow, and hind leg 
vascular resistance throughout the experiments. Data were collected from 5-s 
subsamples as indicated in the text. Mean values are shown at each hour. Symbols: •, 
Ins; 0, Lip + Ins; v, Lip. 
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Figure 3. Arterial blood glucose and glucose infusion rate (GIR) for Ins (•), Lip + Ins 
(0) and Lip (•). Values are means ± SE. Significant differences from Ins are indicated 
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Figure. 4. Hind leg glucose uptake for Ins, Lip + Ins, and Lip . Values are means ± SE. 
Significant differences from Ins are indicated by *,P <0.05; ***, P<0.001 and from Lip 
+ Ins by tf, P<0.01. 
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Figure. 6. Arterial 1-MX (A), end arterial femoral blood flow (B) and hind leg 1-MX 
disappearance (C) values of Ins, Lip + Ins, and Lip groups. Values are means ± SE. 
Significant differences from Ins are indicated by *,P <0.05; and **, P<0.01. 
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116 
■••••■ 
e C 
•E 
E 
117 
6.4 Discussion 
The main finding emerging from this study was that Intralipid TM/heparin caused 
a marked decrease in insulin-mediated capillary recruitment in muscle. This was evident 
as an inhibition of 65% of the insulin-mediated metabolism of infused 1-MX and 
occurred in conjunction with insulin resistance at the whole body level characterized by 
diminished GIR and an equally marked reduction in insulin-mediated metabolic changes 
in the hind leg. These included an inhibition of 45% of the insulin-mediated glucose 
uptake by the hind leg, and an inhibition of 69% of the insulin-mediated uptake of 2-DG 
by muscles of the lower leg. The reductions in insulin-mediated changes occurred at 
physiologic insulin levels (287) and a total exposure to Intralipid TM/heparin for 6h that 
included 2h during the hyperinsulinaemic euglycemic clamp. This impairment of 
insulin-mediated capillary recruitment by Intralipid/heparin is the second 
haemodynamic defect of insulin to be reported as impaired bulk leg blood flow in 
humans (261) treated with Intralipid TM/heparin has been described. 
A second finding to emerge from this study was the positive correlation between 
hind leg glucose uptake and 1-MX metabolism (Fig. 7A). This contrasted with hind leg 
glucose uptake and femoral arterial blood flow, where there was no significant 
correlation. The absence of a correlation between leg glucose uptake and FBF resulted 
from the absence of a difference for FBF between any of the three treatment protocols, 
Ins, Lip or Lip + Ins. This was despite individual animal differences for hind leg glucose 
uptake and 1-MX metabolism. 
The present study represents yet another where we have documented a close 
relationship between glucose uptake and capillary recruitment under hyperinsulinaemic 
euglycemic clamp conditions. Previously this has been described for a-methyl 5-HT 
(210). Other studies with TNFa (305), and exercise-trained rats (213) also show parallel 
adjustments between insulin-mediated hind leg glucose uptake and capillary 
recruitment. A recurring correlation between insulin-mediated glucose uptake and 
insulin-mediated capillary recruitment, implies but does not necessarily prove causality. 
In one of the prior studies, we reported a marked inhibition of insulin-mediated glucose 
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uptake when insulin-mediated capillary recruitment was blocked pharmacologically by a 
peripherally acting serotonergic agonist, a-methyl 5-HT (210). This intervention was 
based on experiments using the isolated pump-perfused rat hind leg where the 
vasoconstrictors, a-methyl 5-HT or 5-HT were found to redirect flow from nutritive to 
the non-nutritive route (179). Indirect evidence that serotonergic agonist-mediated 
insulin resistance did not result from a direct effect on muscle glucose uptake and 
metabolism was obtained using isolated incubated muscle preparations (211) where the 
vascular distribution of insulin and glucose is not involved. In that preparation, 5-HT 
had no effect on insulin-mediated glucose uptake (211). Thus, it would appear likely that 
insulin-mediated glucose uptake becomes partly inhibited by denying access for insulin 
and glucose to regions of the muscles of the perfused hind leg or the hind leg in vivo. 
Similarly, an increase in nutritive blood flow whether mediated in perfused muscle by 
vasoconstrictors (48), or in vivo by insulin (209), leads to increased muscle glucose 
uptake. However, even if insulin-mediated capillary recruitment contributes in part to 
the increase in muscle glucose uptake by this hormone in vivo by acting to enhance 
access for itself and glucose, no information emerges from the present or previous 
studies (209) (210) (305) as to mechanism. Given that an increase in bulk blood flow is 
not involved, increased capillary (nutritive) flow must then result from a redistribution 
of flow from the non-nutritive route. That being so, a net vasodilatation of sites 
controlling entry of blood to the nutritive route mediated by insulin is likely. We know 
that insulin-mediated capillary recruitment is NO-dependent (289) and there are a 
number of possible mechanisms to account for the effect. Firstly, insulin may act at 
insulin receptors on endothelial cells to produce NO, which in turn permeates adjacent 
vascular smooth muscle cells to lower the vascular tone of pre-capillary sphincters. In 
favor of this mechanism is that this process is NO-dependent and is thus consistent with 
our preliminary data (289), that eNOS knock-out mice are insulin resistant (66) and 
there are data that TNFa interrupts insulin signaling to eNOS in this cell type (139); 
against, is the fact that to do so insulin must access the sites that it is going to dilate. 
This requires that some flow is occurring before insulin arrives at these sites. Also 
against this possibility is the preliminary report that vascular endothelial insulin receptor 
knock-out mice are not insulin resistant (286). Secondly, insulin may act at insulin 
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receptors on the vascular smooth muscle cells (131) to cause vasorelaxation. This 
mechanism would also be NO-dependent (289), but free of endothelial cell involvement 
in signaling. However, accessing is also a key issue as it is for a direct endothelial effect. 
The mechanism has some attraction as TNFa is known to inhibit insulin signaling in 
vascular smooth muscle cells, although to date this has been restricted to the ERK1/2 
activation step (85). Thirdly, insulin may act at insulin receptors on SM to activate 
glucose transport and metabolism to produce a metabolite (e.g. adenosine) that 
permeates adjacent tissue to react with appropriate receptors on endothelial and/or 
vascular smooth muscle cells to result in vasorelaxation. Such a mechanism would 
resemble that occurring in exercise where vasodilatory metabolite(s) are released by 
working muscle to facilitate local blood flow. This mechanism would not necessarily be 
NO-dependent, but would be inhibited by agents that inhibit muscle glucose 
metabolism. A variant of this third mechanism is where a form of NOS is activated in 
SM independently of glucose metabolism. NO could then permeate neighboring tissue 
as above. The terminal half of this mechanism (82) might be simulated by AMPK 
activation with AICAR addition. Regardless, all mechanisms will be sensitive to 
inhibitors of insulin signaling. 
From the present study it is clear that elevated plasma free fatty acids resulting 
from the infusion of Intralipid TM/heparin has led to an inhibition of insulin-mediated 
capillary recruitment and glucose uptake in muscle. The question now arises as to how 
this has occurred. Until recently, the focus has been on the metabolic effects of the fatiy 
acids on muscle glucose metabolism. In 1963 Randle et al. (206) proposed the notion of 
competition between glucose and free fatty acids as oxidative fuel sources in muscle 
(glucose-fatty acid hypothesis). Despite a number of studies (74) (77) (153) examining 
the effect of fatty acids on SM glucose metabolism, it is still controversial whether 
insulin resistance in diabetes and obesity result from increased plasma fatty acids. A 
number of sites in glucose metabolism have been reported to be inhibited by fatty acids 
and it is generally agreed that raising free fatty acids increases fatty acid oxidation at the 
expense of carbohydrate oxidation. Sites in glucose metabolism include inhibition of 
hexokinase by long-chain acyl CoA (275), which by reducing glucose 6-phosphate 
concentrations could lead to the inhibition of glycogen synthesis and glycolysis. 
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However, this may not be the explanation as plasma free fatty acid concentrations of 
approx. 0.75 mM in humans, give rise to an increase in intramuscular glucose 6- 
phosphate concentrations (26). There have been independent reports that glycolysis 
(128) and glycogen synthesis (41) are inhibited. Some have found inhibitory effects on 
glucose uptake (274) (75) but most did not (20) (300) (30) (21). A complication in 
identifying the precise site(s) is that the effects of fatty acids on insulin-stimulated 
glucose metabolism are time-dependent (27) (227). Roden et al. (227) claim that the key 
event is glucose transport. Non-invasive NMR of stable isotope-enriched fuels in the 
muscle of healthy humans showed that the reduction in glycogen synthesis by elevated 
plasma free fatty acids was preceded by a fall of muscle glucose 6-phosphate 
concentrations starting at approximately 1.5h (162). However, This could not be 
explained by changes in the amount of insulin-regulatable glucose transporter protein in 
either oxidative or glycolytic muscle. In view of this, recent studies have focused on 
insulin signaling. A particularly valuable approach has been to assess signaling in 
muscle in vivo. With this approach, Griffin et al. (97) reported a decrease in IRS-1 
associated P13-Kinase activity, and a blunting in insulin-stimulated IRS-1 
phosphorylation. Since this was accompanied by a marked increase in protein Icinase C 0 
activity, Griffin et al. (97) propose that activation of PKC 0 is responsible for the 
decrease in insulin signaling, glucose transport and dependent metabolism including 
glycolysis, glucose oxidation and glycogen metabolism. 
If capillary recruitment is a consequence of glucose metabolism and mediated by 
a generated product, then impairment of glucose metabolism by fatty acids acting via 
PKC 0 would be expected to curtail the component of 1-MX metabolism increased by 
insulin. However, if we assume insulin signaling mechanisms are similar in most tissues, 
then impairment of insulin signaling in vascular tissue by any of the mechanisms 
discussed above could also inhibit insulin-mediated capillary recruitment. On balance, 
existing data would favor the latter direct mechanism to affect vascular tissue. There is 
some data that helps this argument. Thus Lind et al. (155) have demonstrated 
impairment in endothelial function by free fatty acids in human forearm in terms of a 
reduced response to local intra-arterial methacholine relative to nitroprusside. In 
addition, Steinberg et al. (261) have shown that free fatty acid elevation impairs insulin- 
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mediated vasodilatation and NO production in the legs of insulin-sensitive subjects 
undergoing euglycemic-hyperinsulinaemic (40mU.m-2 .min-1 ) clamps. 
In conclusion, elevation of plasma free fatty acid levels for 6h during a 
hyperinsulinaemic-euglycemic clamp at physiologic insulin, leads to whole body insulin 
resistance with impaired insulin-mediated muscle glucose uptake and capillary 
recruitment. We propose that the fatty acids induce an impairment of insulin signaling in 
vascular tissue. The reduction of insulin-mediated muscle glucose uptake may in part be 
due to reduced access for insulin and glucose. 
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CHAPTER 7 
7 General discussion 
7.1 Summary of thesis results 
This thesis primarily investigated the interplay between hormone and substrate to 
influence muscle fuel uptake, by altering regional muscle blood flow. A key approach 
involved the uptake of metabolites by perfused rat SM when a high non-nutritive to 
nutritive ratio was maintained pharmacologically. During hyperinsulinaemia and a high 
non-nutritive to nutritive ratio, the uptake of palmitic acid, a amino isobutyric acid 
(AIB) and glucose were reduced. This paralleled reduced oxygen uptake and lactate 
efflux previously reported by this laboratory (46) (211). The reduced uptake is likely to 
be a combination of reduced insulin and substrate access to the muscle cells, thus 
creating an acute state of haemodynamic insulin resistance. Chronic effects of non-
nutritive flow may therefore contribute to the elevation of these fuels in the plasma. 
Moreover, the reduction in uptake of fuels by myocytes (if maintained for extended 
periods) may alter muscle oxidative capacity and long-term insulin sensitivity. In 
contrast, the hydrolysis of chylomicron-TG was increased with predominantly non-
nutritive flow. This was attributed to an increased exposure of the chylomicrons to 
lipolytic enzymes (probably LPL) located in non-nutritive vessels adjacent to CT 
adipocytes. Continual nourishment of non-nutritive adipocytes may lead to fat accretion 
between the muscle fibres. A further effect studied concerned the influence of FFA on 
glucose uptake by muscle, and on muscle's action to augment this process by increasing 
access for itself and glucose in vivo. Thus, the latter part of this thesis showed elevated 
FFA to attenuate the vasodilatory action of insulin on capillary recruitment. Elevated 
FFA may therefore augment non-nutritive flow and the associated adverse metabolic 
effects. This inability of insulin in the presence of fatty acids to shift flow from the non-
nutritive vessels may be an innate protective mechanism by the muscle to prevent excess 
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FFA uptake into the myocytes. FFA may therefore indirectly modulate capillary flow, 
thus exerting some control over fuel partitioning in SM. 
7.2 Implications of this work 
Combined results from chapters 3 and 5 showed that the infusion of 5-HT with 
insulin reduced muscle uptake of glucose, fatty acids and amino acids. As this was 
common to all fuels tested (with the exception of chylomicron TG), it appears that this 
drug causes a defect in bulk clearance, which is most likely due to changes in muscle 
blood flow distribution and capillary recruitment. The high proportion of non-
nutritive/nutritive flow stimulated by 5-HT may adversely affect fuel partitioning within 
the muscle. It is likely in a healthy human there is considerable oscillation between 
blood flow in the nutritive and non-nutritive networks. For example, during rest, flow is 
likely to predominantly partition into the non-nutritive network in parallel with a 
reduced metabolic requirement. However during periods of exercise, flow to the 
nutritive capillaries increases. Low physical activity and fat rich diets may impinge 
sufficiently to create a state where the magnitude of these oscillations is reduced and 
flow predominantly occupies the non-nutritive vessels. This will result in less uptake 
and release of metabolites from the muscle and may produce adverse metabolic effects, 
including acute haemodynamic insulin resistance, and in the longer term phenotypic 
characteristics of chronic insulin resistance. 
Chronic insulin resistance is associated with reduced oxidative capacity of 
muscle, which may be a reflection of chronic non-nutritive flow (as above). Obese and 
diabetic muscle have been shown by others to have reduced oxidative enzyme activity 
(succinate dehydrogenase) and increased glycolytic capacity (a-glycerol-phosphate 
dehydrogenase) despite no significant difference in muscle fibre type (110). Such results 
suggest that the impairment in oxidative metabolism chronologically precedes the 
change of fibre type (which has previously been suggested as the cause of insulin 
resistance. Hernandez et al. (112) showed that in SM biopsies of hypertensive men there 
was a significant decrease in beta-hydroxy-acyl-CoA dehydrogenase, citrate synthase 
and hexokinase, but no change in muscle TG or FFA, suggesting reduced oxidation and 
124 
reduced FFA uptake. Reduced oxidative enzymes in SM has also been positively 
correlated with insulin resistance (22). In some animal models the relationship is less 
clear. For example, Pujol et al. (204) reported increased activity of citrate synthase and 
beta-hydroxy-acyl-CoA dehydrogenase in SM of obese Zucker rats, while Ide et al., 
(121) showed that the SM of obese Zucker rats had reduced ability to oxidize palmitic 
acid. 
Chapter 4 of this thesis reported that increased non-nutritive or CT flow at the 
expense of muscle capillary (or nutritive) flow using the model vasoconstrictor 5-HT (5- 
HT), increases chylomicron TG hydrolysis in muscles with predominantly slow-
oxidative fibres. Therefore vessels diverting flow away from muscle capillaries with 5- 
HT (and reducing oxygen uptake) are probably accessing a highly active perimysial 
adipose tissue (PAT). Since the perimysium is the major site of intramuscular fat 
accretion in red muscles (182) the vessels running through the perimysium are likely to 
be those of the non-nutritive network. Therefore SM blood flow has the potential to 
deliver unesterified fatty acids to the muscle for oxidation, or to the adjacent CT for 
storage. As shown by Rattigan et al. (209), when non-nutritive flow predominates to 
create an acute state of insulin resistance, there is a breakdown of control over this 
partitioning whereby insulin is unable to recruit muscle capillary flow. Therefore it 
would be expected that excess glucose and lipid would be delivered to the muscle CT. 
The presence of insulin in this circuit would stimulate glucose uptake into PAT and 
provide the glycerol-3-phosphate backbone needed for subsequent TG synthesis. By this 
mechanism, insulin should further stimulate fatty acid uptake and storage into non-
nutritive adipocytes of red muscles. Altering the access of lipoprotein-TG to LPL 
enables fuel partitioning between the SM fibres and the adipocytes interlaced between 
them. Healthy muscle may contain small amounts of PAT between the muscle fibre 
bundles. With insulin resistance however, continual deposition may force the fibres 
apart, or fat cells may enlarge in conjunction with fibre atrophy as a consequence of 
reduced muscular activity. PAT probably evolved as a storage depot for excess TG 
adjacent to the myocytes. Adipocyte accretion within SM is therefore more likely to be 
the result rather than the cause of insulin resistance. Whether these cells contribute to 
insulin resistance once it has been established remains to be determined. The release of 
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factors such as TNF a, leptin and adipocyte related protein (ACRP) from PAT may 
contribute to the general systemic (paracrine?) signals that affect metabolism and insulin 
sensitivity in SM. 
Excess TNFa secretion clearly has adverse effects on insulin action (305). It is 
primarily secreted by adipocytes to regulate size of fat cells (reviewed in (205)), but has 
recently also been shown to be produced by SM (183). A number of reports have shown 
that TNFa release is increased with insulin resistance (191) (183). Excessive PAT may 
contribute to this increased TNFa production with insulin resistance. Reports on the 
action of TNFa to inhibit IMGU by SM however have been conflicting. While Del 
Aguila et al. (60) reported that TNFa decreases IMGU by muscle cells in culture, Storz 
et al. (266) showed no decrease in IMGU by cultured differentiated muscle cells despite 
significant reductions in early events in the insulin-signaling cascade (i.e. reduced 
tyrosine phosphorylation of IR and IRS1 and P13-Kinase). However, in these 
experiments it is possible that the activity of GLUT1 had increased to compensate for 
the reduced GLUT4 activity. Nolte et al. (184) however saw no decrease in the 
phosphorylation of the insulin receptor, IRS-1 and the association of P13-Kinase (thus 
no decrease in IMGU) in isolated SM acutely pretreated with very high levels of TNFa 
for extended periods (e.g. up to 8 hrs) before insulin stimulation. However, TNFa may 
exclusively interrupt insulin-signaling to produce NO in endothelial cells in vivo (139), 
in which case, effects of TNFa in in vitro preparations may not be expected. 
Leptin is another paracrine signaling molecule secreted from fat cells which has 
been shown to have beneficial effects on SM fatty acid uptake and metabolism (259) in 
addition to its well documented action on the central nervous system (reviewed in 
(216)). Leptin receptors are situated in SM, and leptin promotes lipolysis and lipid 
metabolism, thus decreasing SM TG (151). Yaspelkis III et al. (302) showed that leptin 
administration to rats fed a high fat diet ameliorated the decrease in IMGU by SM, by 
increasing GLUT4 translocation to the plasma membrane. Excessive release of leptin in 
humans (87), from large fat deposits (possibly including PAT) can cause leptin 
resistance contributing to both decreased FFA oxidation by muscle (259) and increased 
appetite (reviewed in (216)). 
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Recently another signaling molecule released exclusively from adipocytes, 
adipocyte related protein (ACRP or AdipQ), was discovered. Fruebis et al. (81) 
produced a recombinant form of ACRP that was found to increase both SM fatty acid 
uptake and oxidation. It also decreased plasma glucose by an unknown mechanism. The 
release of ACRP has been shown to be reduced in obesity (117). Excess PAT may 
contribute to this phenomenon, resulting in decreased FFA uptake. 
Chapter 6 of this thesis showed that the infusion of IntralipidTM and heparin 
during a euglycaemic/hyperinsulinaemic clamp in rats prevented insulin-mediated 
capillary recruitment. It will be of considerable interest to determine if the signal for 
insulin-induced capillary recruitment originates from the muscle, endothelial cell, or 
smooth muscle, and where FFA interfere with this signal. Some evidence comes from 
experiments by Baron and coworkers involving FFA-impaired endothelial dependent 
vasodilatation (as measured by total leg blood flow (262)). NO production was 
attenuated (261), but no evidence could be found for NOS inactivation within isolated 
aorta (251). If endothelial cells lining SM blood vessels react in a similar manner to 
isolated aorta, then it is of interest to determine how FFA act to indirectly inhibit eNOS. 
One possibility is that elevated FFA induce a signaling molecule that interferes with 
eNOS. Alternatively, FFA may inhibit the release of a molecule that normally acts on 
the endothelium for NO production, which is released directly or indirectly from SM 
glucose metabolism. Alternatively, FFA may inhibit insulin signaling in the myocytes, 
endothelium or both. As discussed in chapter 6, FFA have been shown by others to 
inhibit events earlier in the insulin signaling cascade such as at PKC theta (97) or 
phosphorylation of the insulin receptor, IRS-1 and PKB/Akt (266). 
There seems little doubt that FFA therefore interfere with endothelial dependent 
vasodilatation (262) (261). Whether FFA interfere with capillary recruitment during 
exercise by the same mechanism is unknown, and unlikely. Insulin-mediated capillary 
recruitment is generally thought to be endothelial NO dependent (289), however with 
exercise-induced dilation this remains contentious. In exercise, NO may be released by 
the muscle, as discussed earlier. Acute exercise increases NOS (e and nNOS) in SM 
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myocytes (225). Regardless, elevated FFA do not attenuate exercise increases in blood 
flow (187) as they do with insulin (261). 
7.3 Future considerations 
Reduced nutritive capillary flow with insulin resistance will reduce oxygen, 
insulin glucose, amino acid and lipid availability to the muscle fibres and contribute to a 
decline in metabolic capacity. This thesis underscores the importance of regional muscle 
blood flow in fuel partitioning and insulin sensitivity, which can be manipulated through 
diet, exercise or possible pharmacological agents. 
Determining the cellular mechanism for capillary recruitment will help to 
develop drugs to increase muscle metabolism and insulin sensitivity. Insulin is initially 
detected by the extracellular domain of the insulin receptor that is located on both the 
endothelial plasmamembrane and the sarcolemma. This causes a conformational change 
that stimulates autophosphorylation of certain residues on the intracellular domain of the 
insulin receptor, then attracting and causing phosphorylation of the downstream IRS 1. 
This allows association of IRS! with P13-Kinase to activate PKB/Akt. PKB/Akt is now 
thought to be involved with both GLUT4 translocation (reviewed in (114) (133)) and 
NOS activation (62) through divergent pathways. In SM this would provide a direct 
coupling of metabolism to dilation. If we are able to determine where FFA interfere with 
this signal we may be able to initiate mechanisms to prevent it. Moreover, the 
administration of drugs that enhance signalling effects at an early point in insulin 
signaling (i.e. before PKB/Akt) are likely to be beneficial. Alternatively, substances that 
increased SM glucose metabolism may also enhance capillary recruitment, particularly 
if the dilatory signal emanates from skeletal muscle. 
Controlling dietary intake may be beneficial in the prevention and treatment of 
insulin resistance. In addition to their protective effects against muscle insulin resistance 
(263), n-3 polyunsaturated fats have been shown to have beneficial affects on blood 
flow (23). In addition, cod protein extracts have recently been shown to enhance IMGU 
in cultured muscle cells and isolated muscles (152). This effect could be simulated by 
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the addition of the same mixture of amino acids (152). A mixed cocktail of amino acids 
has also been shown to have positive effects on muscle blood flow (159). 
The most beneficial treatment for NIDDM is exercise. Exercise has been shown 
to have positive effects on IMGU by muscles, and reductions in TG in fat depots. 
Exercise also has positive effects on eNOS (225). Unlike visceral fat, PAT has been 
shown to be very resistant to stimuli such as exercise. For example, regular walking 
does not reduce the amount of fat infiltrating SM (255). For many people however drugs 
targeted at enhancing capillary recruitment will need to be administered during periods 
of low activity because the same individuals who are insulin resistant are also almost 
always obese, and either unable to exercise or non-compliant. 
One potential substance that may be beneficial in improving nutritive flow is 
tetrahydrobiopterin (BH4). BH4 is a cofactor for NOS dimerization and is synthesised 
from guanosine triphosphate (reviewed in (173)). Intravenous administration of BH4 
significantly increased myocardial blood flow, as assessed by positron emission 
tomography in healthy volunteers (294). Recently BH4 has also been shown to improve 
arginine uptake into rat cardiomyocytes, probably through upregulation of arginine 
transporters (247). It has also been shown that BH4 is released from endothelial cells, 
and it is likely to diffuse to underlying smooth muscle as a cofactor for NOS in this 
tissue (reviewed in (243)). Importantly, BH4 incubation improved endothelial dependent 
vasodilator in aortic strips of fructose fed rats, suggesting a deficiency in these rats 
(252). Moreover, administration of a pteridine derivative (6-methyl-5,6,7,8 
tetrahydrobiopterin) abolished endothelial dysfunction in aortic rings of streptozotocin 
diabetic rats (198). 
Vitamin C treatment of cultured human umbilical vein endothelial cells 
increased the activity of eNOS without increasing the expression of this enzyme. The 
increased activity was thought to be due to augmented levels of BH4 (8). This effect was 
also seen with the administration of the BH4 precursor sepiapterin but not another 
scavenger of superoxide anions, Mn (III) tetra kis (4-benzoic acid) porphyrin chloride 
(8), and it was concluded that vitamin C increased the delivery of BH4 to eNOS 
independently of its antioxidant effect. Another beneficial effect of vitamin C is the 
antioxidant property of scavenging free radicals, which drastically reduce the half-life of 
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NO (271). Vitamin C improved endothelial dysfunction in the forearm of type II 
diabetics (276). 
Oxidative stress is associated with a reduction in PKB/Akt and GLUT4. This 
effect can be prevented by the administration of lipoic acid, which induces marked 
dilator responses with insulin in diabetic aorta. Lipoic acid also stimulates PKB/Akt and 
glucose transport in 3T3-L1 adipocytes by reducing oxidative stress (235), and 
stimulates P13-Kinase and PKB/Akt and glucose uptake in L6 myotubes (143). 
Statins (HMGCoA reductase inhibitors) also have the ability to increase eNOS 
independently of their effect to lower cholesterol. Two week administration of 
mevastatin increased coronary blood flow by 30% \(reviewed in (3)). 
S-acyl cysteine sulfoxide (SACS) isolated from garlic was shown to be 
beneficial in alloxan diabetic rats (7). Inducible NOS (iNOS) is upregulated as an 
inflammatory response by TNFa but is shown to be down-regulated by SACS, while 
SACS activated eNOS and suppressed hydroxyl radical production (141). Another 
substance isolated from garlic, Alliosan, has also been shown to be beneficial in 
augmenting the skin microcirculation of healthy volunteers (as assessed by Laser-
Doppler fluxometry) (299). 
The effects of these substances on capillary recruitment (and dissociation of total 
flow effects) may be assessed using currently established methods in our laboratory or 
the laboratory of our collaborators in the USA. The metabolism of the capillary 
endothelial enzyme, xanthine oxidase, can be assessed by the metabolism of 1-MX as 
used in this thesis. Alternatively, contrast enhanced ultrasound could be employed, 
where circulating albumin microbubbles depict areas of capillary blood flow. 
While increased FFA may produce some reduction in total flow, it is likely that 
capillary recruitment is also affected. Insulin effects on capillary recruitment in vivo 
occur after 30 minutes of infusion (287). If insulin was acting directly on the endothelial 
cell, myocyte or vascular smooth muscle to produce vasodilatation then we may expect 
recruitment earlier on. Ultimately this can be tested by infusion of a substance that 
interfere with the translocation of GLUT4. By disrupting a signal further downstream in 
the cascade from PKB/Akt (which has effects on NOS), the effects may be separated, as 
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vasodilatation may remain, but metabolism may not. If neither occurs, then it is likely 
that the metabolism caused the vasodilatation. Recently it has been shown that the 
protease inhibitors (indinavir, ritonavir and amprenavir) significantly reduce IMGU by 
directly inactivating GLUT4 (171). Indinavir inhibited insulin-mediated GLUT4 
transport to the plasmamembrane and glucose uptake of incubated rat muscles, however 
did not decrease insulin stimulation of P13-Kinase activity or PKB/Akt phosphorylation 
(185). However, Caron et al. (39) incubated differentiated 3T3-F442A cells with 
Indinavir and found reduced insulin binding to the insulin receptor, and reduced MAP 
Kinase activity, but no reduction in IRS-1 phosphorylation. The effect of these 
substances however needs to be determined on capillary recruitment in vivo. 
7.4 Summary of conclusions 
In vivo, the elevated FFA associated with insulin resistance will prevent capillary 
recruitment with insulin, probably by interfering with endothelial cell insulin signaling. 
Flow will therefore favorably partition into the non-nutritive (likely to be perimysial) 
vessels and affect the uptake of blood-borne nutrients. Due to the denial of insulin and 
glucose to the myocytes, non-nutritive flow will induce a state of muscle insulin-
resistance for glucose. The uptake of fatty acids and amino acids will be similarly 
affected. Hydrolytic activity for circulating chylomicron TG, however, could be 
expected to be more active in the non-nutritive vessels of the red muscles, thereby 
elevating FFA levels. Moreover, the elevated FFA (from increased TG hydrolysis, and 
decreased muscle uptake) will magnify the high non-nutritive to nutritive muscle blood 
flow. FFA may thus be indirect mediators for non-nutritive flow, a mechanism 
preventing their excessive FFA uptake by SM. Ultimately, continual elevation of fatty 
acids will increase non-nutritive flow and contribute to the inability of muscle to take up 
amino acids, fatty acids and glucose in the presence of insulin, and accelerate adipocyte 
accretion (human marbling) associated with muscle fibres. Finally, an important case for 
the future will be determining the role of PAT in contributing to the production of both 
endocrine and other signaling factors in SM. 
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Increased chylomicron triglyceride hydrolysis by 
connective tissue flow in perfused rat hindlimb: 
implications for lipid storage 
L. H. Clerk, M. E. Smith, S. Rattigan, and M. G. Clark' 
Division of Biochemistry, Medical School, University of Tasmania, Hobart, Australia 7001 
Abstract Skeletal muscle has two circulatory routes, nutri-
tive (in contact with muscle) and non-nutritive (part of 
which is located in the connective tissue), and the balance 
of flow between the two is controlled by neural input and 
circulating vasomodulators. The purpose of this study was 
to assess muscle triglyceride hydrolysis given that the two 
circuits may have a differing vascular distribution of hydro-
lytic activity. The isolated rat hindlimb was perfused with 
6% Ficolle and a radiolabeled chylomicron-lipid emulsion 
containing apolipoprotein C-I!. Serotonin (0.5-1 .LM), a 
model vasoconstrictor previously shown to preferentially in-
crease connective tissue flow, inhibited hindlimb oxygen up-
take (from 16.7 ± 0.6 to 10.2 -± 1.0, mean ± SE, n = 7 
(P <0.001)) and stimulated [HQ-labeled fatty acid uptake 
into muscles (from 184 ± 28 to 602 ± 132, mean -1- SE, 
n = 7 (P = 0.009)). These effects were reversed by the 
vasodilator carbamyl choline. Vasopressin resulted in in-
creased oxygen consumption but no change in triglyceride 
hydrolysis. Cholesteryl oleate uptake (an indicator of en-
docytosis of the chylomicron or remnant particle) was unal-
tered by serotoninal It is concluded that chylomicron tri-
glyceride hydrolysis is enhanced by vasoconstrictors that 
increase connective tissue flow in the perfused .rat hind-
limb. Increased hydrolysis appears to be primarily due to an 
increased access of triglyceride to hydrolytic enzymes, pre-
sumably lipoprotein lipase associated with the fat cells com-
monly observed interlaced amongst bundles of muscle 
fibers.—Clerk, L. H., M. E. Smith, S. Rattigan, and M. G. 
Clark. Increased chylomicron triglyceride hydrolysis by con-
nective tissue flow in perfused rat hindlimb: implications 
for lipid storage. J. Lipid Res. 2000. 41: 329-'335. 
Supplementary key words lipoprotein lipase • nutritive flow • non-
nutritive flow • oxygen consumption • perfusion pressure 
The uptake of lipoprotein triglycerides (TG) into target 
tissues requires initial hydrolysis and this is thought to be 
facilitated by the enzyme lipoprotein lipase (LPL). LPL is 
attached to the vascular endothelium by proteoglycans 
which allow protrusion of the enzyme into the vascular lu-
men. Here it acts to hydrolyze TG from circulating TG-
rich lipoproteins (chylomicrons and very low density lipo-
proteins) into free fatty acids (FFA) and glycerol. The  
resulting FFA are taken up by tissues capable of lipid oxi-
dation (e.g., muscle) or storage (e.g., adipose tissue, mus-
cle) (1, 2). 
The hydrolysis of TG to FFA and glycerol has been 
found to be proportional to the active amount of LPL in 
the vasculature (3) and ultimately may depend on 
whether circulating TG has access to the active form of 
LPL or other hydrolytic enzymes. In skeletal muscle an 
important determinant of muscle metabolism is substrate 
supply to the myocytes and is controlled by the propor-
tioning of flow between two distinct vascular circuits (4, 
5). The first is termed nutritive and describes flow pre-
dominantly to the muscle cells. Blood flowing through the 
second circuit, termed non-nutritive, almost certainly 
passes through vessels of the connective tissue associated 
with the muscle (6). Flow through this route results in the 
physical isolation of nutrients and hormones (including 
oxygen, glucose, TG, and insulin) from the myocytes (7). 
As a result there is limited opportunity for muscle nutri-
ent uptake. As TG hydrolysis is dependent upon its expo-
sure to hydrolytic enzymes, it follows that the total hydrol-
ysis of TG entering the muscle will be greater when the 
predominance of flow is through the circuit in which the 
majority of the hydrolytic activity is distributed. To date 
there have been no studies describing the location of skel-
etal muscle TG hydrolytic activity including LPL, and its 
relative distribution in muscle nutritive capillaries or in 
connective tissue vessels (non-nutritive for muscle) (6). 
The concept of a dual vascular system in skeletal muscle 
was proposed as early as the 1940s. Experiments done by 
Pappenheimer (8) showed that norepinephrine adminis-
tration to the gastrocnemius nmscle of dogs resulted in an 
increase in oxygen consumption while stimulation of vaso- 
Abbreviations: 5-HT, serotonin; 	apolipoprotein C-II; CO, 
cholesteryl oleate; LPL, lipoprotein lipase; HMS, heat-inactivated rat 
serum; V0 2 , oxygen consumption; PP, perfusion pressure; CLE, chylo-
micron lipid emulsion; TO, triolein; FFA, free fatty acid (unesterifiecl); 
TG, triglyceride; BSA, bovine serum albumin; HEPES, N12-hyclroxy-
ethyl] piperazine-N' [2-ethanesulfonic acid]; CCh, carbamyl choline. 
I To whom correspondence should be addressed. 
Journal of Lipid Research Volume 41, 2000 	329 
160 
28 
24 
20 
16 
12 V
02
  (
p
m
o
l.g
'1
.0
)
  
8 
125m1 buffer + 5mICLE + vasoconstrictor 
recirculate 100m1 
Irk* 
40 
choice. Thus 5-HT (Sigma) was added as a bolus into the buffer 
reservoir of the appropriate perfusions to give a final concentra-
tion of 0.5-1 p.M (to achieve a peak perfusion pressure of ap-
proximately 100 mm Hg above basal). After discarding the first 
30 ml of perfusate (of the 130 ml perfusion medium containing 
CLE) the remaining 100 ml was recirculated through the hind-
limb for 1 h. Samples (2.5 ml) were withdrawn from the venous 
line every 15 min. 
In some experiments the vasodilator CCh was infused at a final 
concentration of 100 p.i to reverse the effects of 5-HT on PP and 
V09. CCh infusion commenced before buffer was recirculated. 
This was designed to allow the PP and VO2 to return to near-
basal states before TG recirculation and prevent perfusion under 
predominantly non-nutritive conditions. Infusion was continued 
for a further 12.5 min after recirculation. 
The type A vasoconstrictor vasopressin was added as a bolus 
dose (0.5 nm) to the reservoir of some perfusions to investigate the 
effects of increased V09 and PP on chylomicron TG hydrolysis. 
Triglyceride hydrolysis 
Perfusate samples (1 ml) from perfusions using [ 14C1TO were 
added to 4 ml methanol—chloroform 2:1 in 10-ml glass tubes 
with screw caps. The tubes were vortexed (3 X 30 s) and main-
tained at room temperature (22 °C) before centrifuging at 2500 g 
for 10 min. The entire lower layer was removed with a glass pi-
pette into a 5-ml test tube and evaporated to dryness in a water 
bath at 40°C under a stream of nitrogen. The residue was recon-
stituted into 100 ill of the chloroform—methanol mixture and 15 
p.1 was immediately applied to a Merck silica gel 60 F254 alumin-
ium sheet (Merck). Standards (10 pi of 10 mg/ml) of TO, CO, 
and oleic acid were also applied as spots. The plates were run using 
a mixture of n-heptane—diethyl ether—glacial acetic acid 80:20:1. 
Plates were visualized in an iodine tank and TO and oleic acid 
spots were scraped into separate plastic tubes and counted with 4 
ml of Amersham Biodegradable Counting Scintillant. Recovery 
of counts after thin-layer chromatography was periodically 
checked by comparing the total radioactivity scraped from one 
lane of the silica plate (a lane was designated for each perfusate 
sample) with the known amount of radioactivity of the corre-
sponding perfusate sample before solvent extraction. The recov-
ery was between 90 and 110%. 
Muscle radioactivity uptake 
After perfusion, the soleus, plan taris, gastrocnemius white and 
red, tibialis and extensor digitorum longus muscles of the per-
fused hindlimb were removed. Within the context of this study it 
is important to note that interfibrillar connective tissue adipo-
cytes are contained within each muscle. Excised muscles were 
freeze-dried overnight to obtain dry weight and later re-hydrated 
with 1 ml of water and 1 ml of Soluene® (tissue solubiliser; Pack-
ard). When digestion was complete, 100 ill of acetic acid was 
added together with 14 ml of Amersham Biodegradable Count-
ing Scintillant. 
Statistical analysis 
The statistical significance of differences between groups of 
data was assessed by unpaired, two-tailed Student's 1-test. Signifi-
cant differences were recognized at P.< 0.05. 
RESULTS 
Clearance of chylomicron TG by perfused muscle has 
not previously been studied and it was therefore necessary 
to conduct a number of preliminary experiments to deter- 
mine an optimal procedure. The commonly used albit-
min-containing perfusion medium was not entirely satis-
factory as FFA released by LPL were subsequently bound 
by the albumin and little was taken up by the hindlimb. A 
second difficulty encountered was the high contamina-
tion of serum albumin by lipases. Thus lipase substrates 
such as p-nitrophenyl palmitate were rapidly hydrolyzed 
(data not shown) causing basal rates of hydrolysis to be 
largely attributable to these contaminants when using 
albumin-containing perfusion medium. Accordingly, we 
chose to use Ficollkcontaining perfusion medium. With 
this medium there was no hydrolysis due to the perfusion 
medium alone and the uptake of released FFA occurred 
so that muscle-specific uptake could be compared at the 
completion of each perfusion. 
Figure 1 shows the time course for the effects of 0.5-1 
p,mol 5-HT, 0.5-1 Rm 5-HT with 100 Rim CCh or 0.5 nm va-
sopressin on changes in V0 2 and PP in the constant flow, 
Ficoll® perfused rat hindlimb. Changes in V0 2 and PP 
both reached a maximum at 15 min and then declined as 
the vasoconstrictors were metabolized by the hindlimb 
during the recirculating perfusion. However, changes in 
V0 2 and PP were significantly different (P < 0.05) from 
controls at all time points for 5-HT and vasopressin. The 
0 	15 	30 	45 	60 
Time after recirculation (min) 
Fig. 1. Time course for the effects of serotonin (5-HT), 5-HT with 
carbamyl choline (CCh), and vasopressin on oxygen consumption 
(V02) and perfusion pressure (PP) in the constant flow Ficolle-
perfused rat hindlimb. All perfusions were conducted at constant 
flow (8 ml/min) using a recirculating mode (total buffer volume = 
100 ml). Basal values are at t = —6.25 min. Additions at —6.25 min 
were vehicle (•), 0.5-1 jim 5-HT (0), 0.5-1 p.M 5-HT + 100 p. 
CCh (•) or 0.5 nm vasopressin (V). Values are means ± SE. ** P< 
0.01; *** P< 0.001 for treatment vs. vehicle (n = 10-12). 
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Fig. 2. Uptake of [ 14Cloleic acid and [ 3 1-1]cholesteryl oleate ([ 3 1-1] 
CO) into hindlimb muscles in constant flow Fico11 6-perfused rat hind-
limb using a chylomicron lipid emulsion (CLE) and heat-inactivated 
rat serum (HIPS) as a source of apolipoprotein C11. Hindlimb mus-
cles dissected include the soleus (Sol.), plantaris (Plant.), extensor 
digitorum longus (EDL), gastrocnemius red (GR), gastrocnemius 
white (GW) and tibialis (Tib.). The effects of serotonin (0.5-1 p.m, 
5-1-1T, black bar), 5-HT and carbamyl choline (0.5-1 p.m 5-HT + 
100 p.m CCh, white bar) and vasopressin (0.5 nm, hatched bar) were 
measured for each CLE type and compared to perfusions with no 
additions (control, grey bar). CLE contained either [ 14C]triolein 
([ 14C1TO (panel A)) or [ 3 HICO (panel B). The values in panel B 
are the percentage of total circulating CO that is taken up by each 
muscle. Values are means -1- SE (n = 4-7) * P< 0.05; ** P< 0.01; 
*** P< 0.001 for treatment versus vehicle. 
micron must remain in the perfusate. In fact, the perfu-
sate FFA levels with vasopressin are significantly higher 
than the control value (Table 1). 
Figure 3 is a plot of the percentage content of slow oxi-
dative fibers against the uptake of [ 14C1FA in a hindlimb 
preconstricted with 5-HT for each muscle. [ "C] FA uptake 
when flow is predominantly non-nutritive significantly 
correlates (r = 0.987, P< 0.001) with the percentage con-
tent of slow oxidative fibers. 
DISCUSSION 
The importance of skeletal muscle in total circulating 
lipid clearance is often underestimated, and all previous 
reports have neglected the effect of flow partitioning on 
TG clearance in muscle, due to the presence of nutritive 
and non-nutritive routes. Here we report that the hydroly-
sis of TO was markedly increased in the perfused rat hind- 
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Fig. 3. Uptake of FFA from a synthetic chylomicron emulsion us-
ing the mean values for uptake with 0.5-1 p.m serotonin (5-HT) for 
each hindlimb muscle and their corresponding percentage content 
of slow oxidative fibers. The linear regression produces an r2 = 
0.975 (P < 0.001). The percentage content of slow oxidative fibres 
was taken from reports by Ariano, Armstrong, and Edgerton (31) 
and Armstrong and Laughlin (32). 
limb when a high proportion of connective tissue flow oc-
curred. Recruitment of connective tissue flow for these 
experiments was induced by the addition of 5-HT, a repre-
sentative type B vasoconstrictor, which has previously been 
reported to decrease oxygen uptake, lactate output, insu-
lin-mediated glucose uptake (21, 22), and tension devel-
opment of aerobically contracting muscle (23). All of 
these changes are characteristic of type B vasoconstriction 
(7) and are representative of decreased nutrient delivery 
to muscle, and decreased muscle metabolism secondary 
to increasing the proportion of non-nutritive or connec-
tive tissue flow within muscle (5). 
When connective tissue flow was increased by addition 
of the vasoconstrictor, 5-HT, there was a marked increase 
in TG hydrolysis (indicated by[ 4C]FA uptake) in the 
soleus, plantaris and gastrocnemius red muscles. Uptake 
of [ 14CiFA greatly exceeded that of the CO with seroto- 
nin. This implies that uptake due to endocytosis of the 
chylomicron (causing TO radioactivity to be found in 
the muscle without any detectable amounts of hydrolysis) 
or of the chylomicron remnant (where all of the [14C1 
oleic acid or [ 14C]TO in the muscle is due to hydrolysis) 
could not account for the observed increase. It is impor-
tant to note that the reported increase in TG hydrolysis 
occurred without any stimulation of LPL activity by 5-HT. 
This indicates that the TG hydrolysis due to 5-HT is likely 
to be the result of a vascular effect whereby the exposure 
of TG to TG hydrolytic activity, presumably LPL, is in-
creased. From this, it would also seem likely that the dis-
tribution of TG hydrolytic activity is greater along the 
non-nutritive or connective tissue circuit that nourishes in-
terlacing adipocytes than along the nutritive route supply-
ing muscle cells. 
Evidence that the vessels of non-nutritive flow are those 
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Nutritive and non-nutritive blood flow: rest and exercise 
M.G. CLARK, S. RATTIGAN, L.H. CLERK, M.A. VINCENT, A.D.H. CLARK, 
J.M. YOUD and J.M.B. NEWMAN 
Division of Biochemistg, Medical School, University of Tasmania, Hobart, Australia 
ABSTRACT 
There is growing evidence to support the notion of two vascular routes within, or closely associated 
with skeletal muscle. One route is in intimate contact with muscle cells (hence is known as 'nutritive') 
and the other functions as a vascular shunt (and has had the interesting misnomer of 'non-nutritive'). 
Recent findings suggest that the 'non-nutritive' route may, in part, be those vessels in closely 
associated (interlacing?) connective tissue that nourishes attached fat cells, and may form the basis of 
'marbling' of muscle in obesity. In addition, embolism studies using various size microspheres indicate 
that the 'non-nutritive' vessels are likely to be capillaries fed by terminal arterioles that branch from the 
same transverse arterioles as those supplying terminal arterioles of the muscle capillaries (i.e. two 
vascular systems operating in parallel). The proportion of flow distributed between the two routes is 
tightly regulated and controls muscle metabolism and contraction by regulating hormone and 
substrate delivery as well as product removal. Because a high proportion of nutritive flow may elevate 
the set point .for basal metabolism, a low proportion of nutritive flow in muscle at rest confers an 
evolutionary advantage, particularly when food is scarce. In addition, the proportion of flow that is 
carried by the non-nutritive routes at rest affords a flow reserve that can be switched to the nutritive 
route to amplify nutrient supply during exercise. Alternatively the non-nutritive route may allow flow to 
escape when active muscle contraction compresses its nutritive capillaries. Thus rhythmic oscillation 
of blood flow between the non-nutritive and nutritive networks may aid the muscle pump. 
Keywords amplification of nutrient delivery, connective tissue adipocytes, connective tissue flow, 
microsphere embolism, muscle capillary flow, resting muscle metabolism. 
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The metabolic needs of the muscle are met by changes 
in blood flow that are in turn tightly regulated by central 
neural mechanisms, local reflexes, circulating mediators 
and locally produced vasoactive substances. The 
microcirculation of muscle plays a major role in the 
control of metabolism and it now seems probable that 
muscle metabolism at rest and during exercise may be 
controlled by the distribution of blood flow within 
muscle, albeit between nutritive and non-nutritive 
routes. The reader is directed to our previous reviews 
on this topic (Clark et al. 1995, 1997, 1998a, b). The aim 
of this article is to throw some new light on the identity 
and function of the so-called 'non-nutritive' vascular 
route of skeletal muscle at rest and during exercise. 
Concept of nutritive and non-nutritive flow routes in muscle 
The concept of two vascular routes, one nutritive and 
the other 'non-nutritive' in muscle presents serious 
implications for some commonly held theories. For 
example, because the two routes operate in parallel, 
changes in the proportion of flow distributed between 
the two routes as mediated by adrenaline or other 
vasoactive substances, inevitably results in arteriove-
nous extraction fractions that differ although the total 
blood flow does not change. Indeed it has been 
observations of this kind that have given rise to the 
concept of two routes. Thus, these have involved 
studies where total blood flow into muscle did not 
correlate with (a) metabolic or heat transfer responses 
or (b) the clearance of intramuscular injected or infused 
'radioactive substances. We have recently reviewed the 
earlier literature (Clark et aZ 1998b) and the reader is 
referred therein for references. 
The key observations that impact on our present 
interpretations are those of Zweifach & Metz (1955), 
Barlow et al. (1958, 1961), Grant & Wright (1970), 
Lindbom & Arfors (1984, 1985) and Borgstrom et al. 
(1988). Barlow et al. (1961) simultaneously recorded 
clearance of radioactive ions (either 24Na, 42K or 131 1) 
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is. Indeed they have shown that the vascular arrange-
ment of the tenuissimus muscle exists as a basic unit in 
hind leg musculature generally. Moreover, vascular 
connections between the muscle tissue proper and 
adjacent connective tissue septa have also been 
reported as a feature in several muscles of different 
species [e.g. rat (Eriksson & iNilyrhage 1972, Grant & 
Wright 1970), cat (Myrhage & Eriksson 1980) and 
monkey (Hammersen 1970)]. Importantly, these same 
connective tissue vessels have been variously associated 
with the interlacing fat cell deposits, and thus may be 
nutritive for connective tissue and the associated 
adipocytes although they are clearly 'non-nutritive' for 
muscle. As both connective tissue and adipocytes 
would have considerably lower metabolic activity than 
muscle, the overall oxygen extraction and lactate 
production would very likely fall when flow is switched 
from the nutritive capillaries of muscle to these 
connective tissue vessels. 
RECENT EVIDENCE FOR 
NON-NUTRITIVE ROUTES IN MUSCLE 
The mechanically pumped constant flow perfused rat 
hindlimb has proved to be a useful in vitro model system 
to investigate haemodynamic effects on skeletal muscle. 
It has provided important new information concerning 
the regulation of flow within muscle. In particular, we 
now know that vasoactive agents can control skeletal 
muscle metabolism and performance by their effects on 
the vasculature (Clark et al. 1995, 1997). Thus, our 
studies have shown that vasoconstrictors, which 
increase the perfusion pressure in the constant-flow 
perfused rat hindlimb, can be categorized into two 
types depending on their metabolic actions in the 
hindlimb. One type A results in an increase in oxygen 
consumption (Colquhoun et al. 1988), lactate (Hetti-
arachchi et al. 1992), glycerol (Clark et al. 1994), urate 
(Clark et al. 1990) and uracil (Clark et al. 1990) efflux. 
These type A vasoconstrictors include a radrenergic 
agonists, angiotensins, vasopressin, vanilloids and low-
frequency (< 2Hz) sympathetic nerve stimulation (Hall 
et al. 1997). Angiotensin II, one of the type A vaso-
constrictors, was found to increase aerobic tension 
development, contraction-mediated oxygen uptake and 
2-deoxyglucose uptake by plantaris and gastrocnemius 
red and white muscles during electrical tetanic stimu-
lation of the hindLimb (Rattigan et al. 1996). Type B 
vasoconstrictors which can produce identical pressure 
to type A result in decreased oxygen consumption 
(Dora et al. 1991), lactate (Hettiarachchi et al. 1992), 
glycerol (Clark et al. 1995), urate and uracil efflux (Clark 
et al. 1995). These vasoconstrictors include serotonin 
(5-H1), high-dose noradrenaline, high-frequency 
(>5 Hz) sympathetic nerve stimulation and high-dose 
© 2000 Scandinavian Physiological Society 
vanilloids (Clark et al. 1995) and act opposite to type A 
to decrease insulin-mediated glucose uptake (Rattigan 
et al. 1993, 1995), aerobic tension development and 
contraction-mediated oxygen uptake (Dora et al. 1994). 
All effects of both types of vasoconstrictors occur 
while total flow is held constant and are caused by their 
vascular actions and not owing to direct actions on the 
skeletal muscle as all of the effects could be reversed by 
vasodilators (Colquhoun et al. 1988, 1990, Hetti-
arachchi et al. 1992, Rattigan et al. 1993), regardless of 
the mechanism of action of the vasodilators. In addi-
tion, none of the vasoconstrictors had any effect upon 
contractility or insulin-mediated glucose uptake of 
isolated incubated muscles where supply of nutrients 
was by diffusion and not dependent upon the vascu-
lature (Dora et al. 1994, Rattigan et al. 1993, 1995). It is 
also important to note that the sites responsible for 
types A and B vasoconstriction could be distinguished 
by their metabolic requirements for constriction. Thus 
removal of extracellular calcium or inhibition of oxi-
dative metabolism (cyanide, azide or by anoxic perfu-
sion) prevented type A but not type B vasoconstriction 
(Dora et al. 1992, Clark et al. 1994). 
The controversial nature of the non-nutritive route 
A major stumbling block in the acceptance of non-
nutritive flow in skeletal muscle has been the anatom-
ical identity of a discrete route associated with muscle 
that essentially denies nutrient exchange but is capable 
of high flow. The first stage in shedding some light on 
their location came from the use of flow measurement 
using fluorescent microspheres. The aim was to assess 
whether flow redistributed between muscles of 
differing fibre composition, or between muscle and 
non-muscle tissue when vasoconstrictors such as 
noradrenaline or serotonin acted to vasoconstrict in the 
constant-flow perfused rat hindlimb and stimulate or 
inhibit metabolism, respectively. Thus microspheres of 
15 urn  were infused under conditions of steady-state 
with or without noradrenaline or serotonin. Muscles, 
including soleus, plantaris, gastrocnemius red, gastroc-
nemius white, tibialis, extensor digitorum longus, 
remaining calf muscles, vastus, remaining thigh and 
trunk muscle, as well as bone, skin and subcutaneous 
white adipose tissue of the perfused leg were dissected 
free. In addition, tissues were collected from unper-
fused regions to check for leakage. For each sample, 
wet weight and microsphere content were determined. 
The results of Fig. 2 show that when compared with 
control (vehicle), neither noradrenaline nor serotonin 
infusion altered microsphere recovery in muscle, spine, 
skin, white adipose tissue or tissues of the lower 
abdomen. Of the muscles, only two, soleus and tibialis, 
showed a significant change and this was a decrease 
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Figure 3 Plot of tendon vessel flow as a function of oxygen uptake 
modified by vasoconstrictor addition. Experiments were conducted 
using the isolated constant-flow perfused rat hindlimb where oxygen 
uptake, an indicator of relative nutritive flow in this preparation, was 
altered systematically by addition of various doses of either 
noradrenaline (411), serotonin (N) or vehicle (0). Tendon vessel flow 
was determined from fluorescence signal strength of infused fluo-
rescein isothiocyanate-labelled dextran (M. 150 000) over the tibial 
tendon region of the biceps femoris muscle. Data are from Newman 
et al. (1997). 
micron emulsion. Quite unexpectedly we found that 
clearance was increased under conditions of predomi-
nantly non-nutritive flow (Clerk et al. 1999) (Fig. 4), 
indicating that lipoprotein lipase was more concen-
trated in the non-nutritive than the nutritive route. As 
lipoprotein lipase is synthesized in fat and muscle cells 
and secreted into neighbouring capillaries and adipose 
tissue contains more activity of lipoprotein lipase than 
muscle, the higher clearance of triglyceride during non-
nutritive flow would suggest an active presence of 
adipocytes on this route. Indeed adipocytes have been 
reported on connective tissue vessels in muscle, 
particularly on the vessels that pass through the 
perimysium and epimysium (Myrhage & Eriksson 
1980). Figure 5 shows such an arrangement where 
adipocytes can be seen attached to the connective tissue 
vessels on the superoanterior border of the rat biceps 
lemons muscle. It is also apparent from this picture 
that blood is supplied to both muscle and adipocytes by 
a common vessel (i.e. two systems are operating in 
parallel). 
As foreshadowed earlier, it would now seem likely 
that the so-called 'non-nutritive' vessels of muscle are 
connective tissue vessels that are closely associated with 
each muscle and which can be viewed as separate 
entities on relatively exposed thin tendons such as the 
0 2000 Scandinavian Physiological Society 
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soleus plant. EDL G.red G.white tib. 
Figure 4 Effects of serotonin (0.5-1 pm) on the uptake of oleate 
from triolein-containing chylomicron emulsions into muscles of the 
perfused rat hindlimb. Hindlimb muscles dissected were soleus, 
plantaris (plant.), extensor digitorum longus (EDL), gastrocnemius 
red (G. red), gastrocnemius white (G. white) and tibialis (tib.). Data 
are from Clerk et al. (1999) and show effects of no addition (N) or 
serotonin (0); significant differences are marked by *. These effects 
were not the result of increased pinocytotic uptake by 5-HT (data not 
shown). 
tibial tendon of the rat biceps lemons (Grant & Wright 
1970). In addition, it is likely that these vessels are 
interspersed between fibre bundles and constitute loci 
where fat accretion can take place to possibly give rise 
to the 'marbling' of meat. There are sufficient available 
data to suggest that these vessels are high capacitance 
and low resistance and therefore capable of carrying 
high flow when muscle is at rest. Finally, although they 
may be larger than the nutritive capillaries nourishing 
muscle cells, these connective tissue adipocyte vessels 
do not allow the passage of 15-rim microspheres [i.e. 
when non-nutritive flow is high (Rattigan et al. 1997a)]. 
Figure 5 Photomicroscopy of blood vessels of the superoanterior 
border of the rat biceps femoris muscle showing connective tissue 
adipocytes adjacent to the muscle. Blood is supplied to both muscle 
and adipocytes by a common vessel. 
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involving a selective increase in muscle nutritive flow 
consistent with our observations using the constant-
flow perfused rat hindlimb. The vasodilator, isopro-
terenol would appear to have selectively increased flow 
to the non-nutritive pathway at the expense of nutritive 
flow. In our experience (Colquhoun et al. 1990) 
isoproterenol opposes type A vasoconstrictor effects in 
the constant-flow perfused hindlimb by relaxing 
constricted sites in the vasculature that are reducing 
flow to non-nutritive routes. As already indicated above 
microspheres probably do not allow the discrimination 
between nutritive and non-nutritive routes of muscle 
and we know that agents such as serotonin do not alter 
the distribution of 15-pm microspheres, yet have a 
marked inhibitory effect on oxygen uptake and 
metabolism generally (Rattigan et al. 1997a). 
From our point of view the study of Kuznetsova 
et al. (1998) suggested that LDF measured nutritive 
flow in muscle. Accordingly, we have recently 
conducted a series of studies aimed at comparing 
muscle LDF signal during various states of nutritive 
flow in the constant-flow blood perfused rat hindlimb. 
In this work a single LDF probe was positioned over 
the mid region of the exposed biceps femoris. The LDF 
signal strength was found to directly relate to the extent 
of oxygen consumption when total flow was constant 
(Clark et al. 1999). Thus type A vasoconstrictors that 
increased metabolism in this preparation increased the 
LDF signal. Conversely, type B vasoconstrictors that 
decreased metabolism, also decreased LDF signal 
(Clark et al. 1999). These findings, although welcome in 
terms of paving the way for nutritive flow measurement 
in humans, raise a major question concerning the ana-
tomical location of the non-nutritive vessels and their 
relative invisibility to LDF detection when probes are 
placed over the muscle body. Initial consideration 
might suggest the data to be entirely consistent with the 
notion that the type B vasoconstrictors have acted to 
redirect flow from capillaries within muscle (and 
therefore the region of LDF measurement) to vessels 
outside the region in connective tissue. However, other 
possibilities cannot be ignored. For example, from LDF 
signal measurements (which are non-vectorial) made on 
blood cell-perfused isolated polymer tubes of single 
pass and triple pass (zigzag) configurations, each with 
identical flow rates, it was found that the LDF signal 
strengths were low and high, respectively (Clark et al. 
1999). This might imply that decreases in LDF signal 
caused by the type B vasoconstrictors in perfused 
muscle result from switching of flow from long zigzag 
capillaries that pass several times under the detector and 
give a high LDF signal, to short capillaries that pass 
fewer times under the detector and give a low LDF 
signal. Type A vasoconstrictors would have the reverse 
effect and with this model of the microvasculature, only 
© 2000 Scandinavian Physiological Society 
the length and therefore surface area available for 
nutrient exchange would distinguish nutritive from 
non-nutritive route. At the moment we favour a model 
consistent with the observations of Myrhage & 
Eriksson (1980) where the connective tissue vessels that 
operate in parallel to the muscle capillary networks and 
are visible on the distal edge of flat muscles such as the 
tenuissimus, are internalized to run between the fibres 
in the cylindrical bulk muscles. 
Site-dependent effects of microiphere embolism: 
clues to the nature of nutritive and non-nutritive routes 
As indicated above, vasoconstriction of the constant-
flow perfused rat hindlimb can either increase or 
decrease skeletal muscle metabolism possibly owing to 
flow redistribution through nutritive or non-nutritive 
flow routes, respectively. In a recent unpublished study, 
we have used microspheres of different size and 
number to assess whether specific occlusion of either 
flow route was possible, as well as to determine the 
largest average diameter at which flow can be redis-
tributed from one to the other route by microsphere 
embolism. Microspheres of 5.4, 11.8, 23.4 or 93.6 pm, 
with one size allocated for each series of experiments, 
were injected and their effects on flow recruitment and 
metabolism assessed. Injections were conducted during 
angiotensin II (high nutritive: non-nutritive flow) or 
serotonin (low nutritive: non-nutritive flow), or under 
control conditions and the effects on oxygen uptake, 
perfusion pressure and venous flow rate monitored. 
The effects were very much dependent on the size of 
the microspheres. Thus, the inhibitory effects of sero-
tonin on oxygen uptake were partly reversed by 5.4 or 
11.8 pm microspheres but not by the larger sizes (23.4 
and 93.6 pm). Similarly, only the smaller sizes (5.4 and 
11.8 pm) increased oxygen uptake during vehicle 
infusion. The stimulatory effect of angiotensin II on 
oxygen uptake was reversed by all four sizes of micr-
ospheres. Most importantly, the particular number of 
microspheres used in these experiments did not 
significantly affect the venous flow rate. The larger size 
microspheres of 23.4 and 93.6 pm were inhibitory 
during serotonin, angiotensin II and vehicle infusions 
with increased perfusion pressure. Interestingly, the 
number of the smaller microspheres required to reverse 
the inhibitory effects of serotonin differed. Thus 
1.5 X 107 of the 5.4 pm were equivalent to 3.0 x . 106 of 
11.8 pm in recovering -=1.6 pmol 11 -1  g  oxygen 
uptake previously inhibited by serotonin. Taken 
together, it would appear likely that the 5.4 and 
11.8 pm but not the 23.4 and 93.6 pm microspheres 
were capable of occluding the flow route recruited by a 
specific vasoconstrictor and re-diverting this flow 
through the opposite flow route. The size-dependent 
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There are two schools of thought concerning the origin 
of the oxygen deficit. Traditionally, it was thought to be 
the result of a delay in skeletal muscle blood flow and 
thus oxygen delivery to skeletal muscle. Recently, this 
view has been challenged (Grassi et al. 1996, Sahlin et al. 
1988) and attributed to a lag in mitochondrial meta-
bolism owing to poor substrate supply to the mito-
chondria. Two experimental approaches support this 
latter notion. In one, administration of dichloracetate, 
an activator of the pyruvate dehydrogenase complex, 
resulted in increased acetyl group availability and 
attenuation of creatine phosphate breakdown and 
lactate accumulation in human skeletal muscle during 
exercise (Timmons et al. 1998). In the second, increased 
fatty acid availability and enhanced muscle oxidative 
capacity (following a period of short-term training) 
were shown to attenuate creatine phosphate degrada-
tion, glycogenolysis and lactate accumulation during 
exercise (Chesley et al. 1996, Dyck et al. 1996). 
However, at this point of time it is unknown whether 
dichloracetate could affect microvascular flow, partic-
ularly the proportion of nutritive/non-nutritive flow 
within skeletal muscle. There are indications that a 
period of short-term training or prior muscle contrac-
tions (Matsuhisa et al. 1998) could very well increase the 
proportion of nutritive flow and could account for the 
observations (Chesley et al. 1996, Dyck et al. 1996) that 
creatine phosphate degradation, glycogenolysis and 
lactate accumulation were attenuated. 
Our view is that the presence of a secondary (non-
nutritive) route or shunt within muscle affords a 
distinct advantage in terms of amplification for nutrient 
delivers , during exercise. This is over and above the 
proportionate increase in total blood flow to muscle. 
The extent of the amplification depends on the ratio of 
nutritive/non-nutritive flow for resting muscle, which 
is unknown at present. Best estimates are based on the 
data of Lindbom & Arfors (1984) for the tenuissimus 
muscle receiving an approximate arterial oxygen tension  
of 70 mmHg and suggest that the ratio nutritive/non-
nutritive could be as low as 30/70, although the authors 
(Lindbom & Arfors 1984) claim a more conservative 
position of 80/20. There is also indirect data from 
hydrogen clearance measurements (Harrison et al. 1990) 
that nutritive/non-nutritive flow is low (i.e. 16% of 
total flow). 
It is claimed that at rest not all muscle capillaries are 
perfused (Harrison et al. 1990) and thus even with no 
change in non-nutritive flow the ratio nutritive/non-
nutritive could have the potential to increase when total 
flow to muscle is increased in exercise. However, at a 
maximum exercise rate it is likely that flow in nutritive 
pathways becomes maximal and that flow in non-
nutritive pathways becomes minimal. Harrison et al. 
(1990) were perhaps the first to recognize that the non-
nutritive pathway provides a flow reserve to be 
recruited during muscular contractions. Thus, if the 
ratio of nutritive/non-nutritive flow at rest is 0.3 then 
the combination of increased sympathetic nervous 
system vasoconstrictor activity, a 3-fold increase in total 
blood flow to muscle and the release of metabolic 
vasodilators is an increase of 9.5-fold for blood flow to 
muscle nutritive vessels (Clark et al. 1998b). Excessive 
(high frequency; >6 Hz) sympathetic vasoconstrictor 
activity is thought to increase non-nutritive flow at the 
expense of nutritive flow (Hall et al. 1997). In addition, 
vasoconstrictors of this nature decrease aerobic muscle 
contractility (Dora et al. 1994) and thus excessive 
sympathetic vasoconstrictor activity in combination 
with exercise would lead to a decrease in nutritive blood 
flow and a probable decline in performance. Further-
more, the sites of vasoconstriction that have this 
deleterious effect are not affected by metabolic vasod-
ilators (Dora et al. 1994). 
Until precise figures are available for oxygen uptake 
by individual muscles at rest and during exercise the 
relationship between blood flow and oxygen uptake 
(Vo2) for muscles of different fibre type cannot be 
Table 1 Oxygen/flow ratios for muscle at rest and during exercise 
Isolated dog gastrocnemius 
 
Perfused rat hindlimb in vitro 
   
Rest 
Exercise 
Rest Rest + All Exercise Exercise + All 4.46 6.69 
,Q„ (mL • min -I 	• 100 g-I ) 12.9 39.0 81.0 92.0 92.0 92.0 92.0 
V02 (pmol • min-I • 100 g-I ) 31.2 178.6 535.7 53.6 93.8 102.7 133.9 
I/02/g. (mot • mL-I ) 2.4 4.6 6.6 0.58 1.02 1.12 1.46 
Modified from Clark et al. (1998b). Data are from Cerretelli et at (1984) for isolated autoperfused dog gastrocnernius muscle and from Rattigan 
et at (1996) for constant-flow blood cell perfused rat hindlimb at 37 °C. For the former (Cerretelli et at 1984) values are given at constant 
arteriovenous 02 difference of 4.46 and 6.69 pmol 0 2 mL-I blood. In the latter (Rattigan et al 1996), the sciatic nerve was stimulated resulting in 
much of the calf muscle group (•,--20% of the hindlimb muscle mass) being active; addition of the vasoconstrictor, angiotensin (All) increases 
V0 2/Q, both at rest and during exercise. 
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were essentially capillary-like. This and the inability 
to account for physiological data (Pappenheimer 
1941, Walder 1953, 1955, Barlow et al. 1958) provided 
the impetus for a search for vessels that would fulfill 
the role as a non-nutritive route in muscle. Zweifach 
& Metz (1955) were probably the first to realize that 
these non-nutritive vessels may be outside the capil-
lary bed of the muscle fibrils. In 1955 these authors 
described "preferential capillary channels at the edge 
of the spino-trapezius muscle of the rat". Barlow and 
colleagues (1959, 1961) added to this notion by con-
cluding that the secondary non-nutritive route was 
located in the septa and tendons. Their findings, 
along with others that preceded them, were based on 
clearance kinetics of 24Na± administered either intra-
venously or intramuscularly. In 1970 Grant & Wright 
noted that blood vessels in the tibial tendon of the 
biceps femoris muscle could be readily viewed and 
also claimed them to be the non-nutritive vessels of 
skeletal muscle (Grant & Wright 1970). These vessels 
were dilated by acetylcholine or histamine and con-
stricted by noradrenaline or adrenaline, but did not 
respond to changes in body temperature and were 
thus unlikely to be involved in thermoregulation. 
As yet, there have been no attempts to integrate 
metabolic data with anatomical studies. This is sur-
prising as the intravital microscopy studies of the rab-
bit tenuissimus muscle by Lindbom, Arfors and their 
colleagues (Lindbom & Arfors 1984, 1985, Borgs-
trom et al. 1988) would appear to provide key infor-
mation that could explain much of the metabolic data 
obtained by us and others with the perfused rat hind-
limb preparation. Most importantly, the microvas- 
Fig. 1. This illustration is adapted from Borgstrom et al. (1988) 
and shows a transverse arteriole of the rabbit tenuissimus 
muscle supplying both capillaries in muscle tissue and adjacent 
connective tissue. 
culature of the tenuissimus muscle shows two vascu-
lar compartments that could very well provide an 
anatomical basis for the notion of nutritive and non-
nutritive routes in muscle. 
The tenuissimus muscle is a muscle that is access-
ible and transparent, thereby allowing both the de-
tailed illustration and study of changes that affect 
flow in each of the two routes. Although this muscle 
may be considered by some as atypical in being rela-
tively flat, the vascular arrangement of the 
tenuissimus muscle is proposed to exist as a basic unit 
in all hind leg muscles (Myrhage & Eriksson 1980). 
The vasculature of the rabbit tenuissimus muscle is 
shown in Fig. I. Transverse arterioles supply both 
capillaries in muscle tissue proper and adjacent con-
nective tissue. Using intravital microscopy, Lindbom, 
Arfors and their colleagues measured microvascular 
blood flow at two points on several transverse arteri-
oles in the tenuissimus muscle of anesthetized rabbits 
(positions A and B, Fig. 1) while studying the influ-
ence of environmental (muscle bathing solution) oxy-
gen tension as well as perfusion pressure, isoproter-
enol, epinephrine, functional hyperemia (exercise in-
duced) and reactive hyperemia (Table 1). Under 
resting conditions the proportion of total flow pass-
ing into the connective tissue was approximately 44%. 
This dramatically increased to 91% if the bathing 
oxygen concentration was increased to 20 kPa even 
though total muscle flow dropped by 46%. Topically 
applied isoproterenol, a 13-adrenergic agonist and po-
tent vasodilator, also markedly increased the pro-
portion of connective tissue flow. Thus, despite total 
flow increasing from 0.73 to 2.65 n1 • s — I, an increase 
of 263%, most of this flow (97%) was carried by the 
connective tissue vessels. It is important to note that 
this particular result emphasizes the potential ca-
pacity of the connective tissue route for flow, as under 
the conditions of isoproterenol-mediated vasodilation 
the connective tissue vessels carry 3.5-fold the total 
basal flow rate. Exercise induced functional hyper-
emia increased muscle capillary flow at the expense 
of connective tissue flow. Thus, capillary flow in-
creased from 56% to 76% of total flow with a corre-
sponding decrease in connective tissue flow from 44% 
to 24%. Lowering of the perfusion pressure also 
tended to favor muscle capillary flow at the expense 
of connective tissue flow. In contrast, neither epine-
phrine, nor reactive hyperemia (in response to oc-
clusion) altered the proportion of connective tissue to 
muscle flow, even though total flow was decreased and 
increased, respectively. 
Reciprocal control of flow between connective tissue 
and muscle 
Our studies using the constant-flow perfused rat 
hindlimb were initially intended to investigate the ef- 
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Control of hindlinnb metabolism from a redistribution of 
flow between muscle and connective tissue 
Several recent studies, particularly from our own lab-
oratory, suggest that the perfused rat hindlimb is a 
two compartment model and that changes in met-
abolism mediated by vasomodulators result from a 
redistribution of flow between these two compart-
ments. There is also strong evidence to suggest that 
the second compartment of muscle is that of connec-
tive tissue. Table 2 summarizes the data and shows 
that type A vasoconstrictors that act to increase met-
abolism of the hindlimb overall decrease the flow vol-
ume in tendon vessels, which can be viewed in an area 
essentially free of capillaries. 
Measurements were made in the constant flow per-
fused rat hindlimb using 6 mm pulse infusions of 
fluorescein isothiocyanate (FITC)-labeled dextran 
(Mr 150 000) while positioning a fluorescence sensor 
over exposed vessels of the tibialis tendon of the bi-
ceps femoris (Newman et al. 1997), the same vessels 
claimed by Grant & Wright to be representative of 
the non-nutritive route of muscle (Grant & Wright 
1970). Readings were taken during vehicle infusion 
and again under constant infusion of a type A (nor-
adrenaline), or type B (serotonin) vasoconstrictor 
(Newman et al. 1997). The intensity of the signal at 
steady state was inversely related to V02, the surro-
gate indicator of muscle nutritive flow. In addition, 
photomicroscopy of the vessels following injection of 
India ink clearly showed that the change in signal was 
due to the relative filling of the vessels. To our knowl-
edge, this was the first report of vasoconstrictors 
selectively directing flow to, or away from tendon ves- 
Table 2. Effects of type A and B vasoconstrictors on perfused rat hind-
limb characteristics likely to result from the redistribution of flow be-
tween skeletal muscle capillaries and connective tissue vessels of tendon 
and septa 
Type A 	Type B 	Ref. 
Metabolism (including V02, Ji_ac, ciciy etc.) 	T a 
Parameter 
Tendon vessel volume 
Vascular volume perfused 
Arterial cast (30 pal acrylate) 
Weight 
Volume 
Passage of microspheres (11.8 01) 	1.1±0.1 2.2±0.2 
Microsphere embolism (11.8 1.1M) 
1-Methylxanthine metabolism 
Chylomicron triglyceride hydrolysis 
Abbreviations: V02, oxygen uptake; J uc, lactate efflux, Jmy, glycerol ef-
flux. For microsphere embolism "—" and "+" indicate inhibition and 
stimulation of metabolism, respectively. Values for the passage of micro-
spheres are percent of total injected, which in each case was 2x10 6 . 
Refs: a, Clark et al. 1995; b, Newman et al. 1997; c, Newman et al. 1996; 
d, Vincent et al. 1998; e, Rattigan et al. 1997; f, Clerk et al. 2000. 
sels (Newman et al. 1997). Interestingly, Grant & 
Wright in their anatomical study of these vessels, 
noted that they were about twice the diameter of 
muscle nutritive capillaries (Grant & Wright 1970). 
According to Poiseulle's Law (Q=kPr4/1, where Q= 
flow; k=constant; P= pressure; r=radius; and 1= 
length of vessel), at the same vessel length and per-
fusion pressure, these functional shunts could be cap-
able of carrying 16 times the flow of a typical muscle 
capillary. Applying this reasoning, the potential ratio 
of flow rates was approx. 1:12 for norepineph-
rine:serotonin. These calculations combined with the 
fact that the vessels in question are located in a tissue 
of low metabolic activity makes the hypothesis of a 
significant non-nutritive flow pathway through ten-
don highly plausible. 
Another approach (Table 2) was the assessment of 
perfused vascular volume. In these experiments, 
again using the perfused rat hindlimb at constant 
total flow, the effects of each vasoconstrictor were 
compared in terms of vascular entrapment of fluor-
escein-labeled dextran (Fx) (Newman et al. 1996). Fx 
was infused at a constant rate and during this in-
fusion norepinephrine was also infused (if a new vas-
cular region was being recruited .then this would fill 
with Fx). Subsequently, infusion of the Fx was halted 
and a few minutes allowed for the material remaining 
to wash out. A second infusion of norepinephrine 
succeeded in releasing the previously entrapped Fx.. 
By varying the time between each infusion of nor-
epinephrine it was possible to deduce that approxi-
mately 31% of the pre-norepinephrine vascular vol-
ume had been recruited. Although there was no evi-
dence that norepinephrine had acted to derecruit a 
previously perfused vascular volume, recruitment of 
an additional vascular volume under conditions of 
constant total flow must have been at the expense of 
flow elsewhere (presumably from the non-nutritive 
connective tissue route). For serotonin, a type B vaso-
constrictor that inhibits metabolism, a new space was 
not recruited, but rather, vasoconstriction by this 
agonist resulted in the closing off of a space. Presum-
ably the de-recruited space represented a portion of 
the previously perfused muscle nutritive route. Again, 
since the total flow was kept constant, this would 
mean that flow has been directed to the non-nutritive 
route, consistent with the observed increase in tendon 
vessel volume induced by serotonin and discussed 
previously. 
The third piece of evidence in support of vasocon-
strictor-mediated redistribution of flow between skel-
etal muscle capillaries and connective tissue vessels 
comes from a comparison of the extent of arterial 
vascular tree filling for control (vehicle only), nor-
epinephrine and serotonin (Newman et al. 1996). For 
these experiments, corrosion casts were made using 
30 1..im spheres of methyl methacrylate. Whereas nor- 
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nutritive flow could be made, so it is unknown 
whether this changed. 
We have proposed elsewhere (Clark et al. 1998) 
that the presence of a secondary (non-nutritive) route 
or shunt within muscle affords a distinct advantage 
in terms of amplification for nutrient delivery during 
exercise. This is over and above the proportionate in-
crease in total blood flow to the muscle. The extent of 
amplification depends on the ratio of nutritive/non-
nutritive flow for resting muscle, which is unknown 
at present but could be as low as 16% of total (Harri-
son et al. 1990). We would argue that if this were the 
case then vasoconstriction from increased sym-
pathetic outflow during exercise could act to switch 
blood flow from the non-nutritive to the nutritive 
route, thereby amplifying nutrient delivery. Depend-
ing on the extent of vasoconstriction and the pro-
portion of nutritive/non-nutritive flow at rest, the am-
plification could approach 5-fold. Data from Takemi-
ya and colleagues (Takemiya et al. 1982) reported 
that tendon/muscle blood flow ratio of rabbit hind- 
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Fig. 2. Effect of flow rate on oxygen uptake, perfusion pressure 
and relative tendon flow in the pump perfused rat hindlimb. 
Animals were housed in cages with or without access to a 1 m 
circumference running wheel. Exercise-trained rats ran a mini-
mum of 10 km per week. Technical detail can be found else-
where (Newman et al. 1997). Significant difference between 
trained (0) and untrained (•) indicated by asterisk (P<0.05). 
Values are means -±SEM for n=7 in each group. 
limbs was greater than 2:1 and implications from a 
later paper from the same group (Takemiya & Maeda 
1988) showing that infused noradrenaline preferen-
tially decreased tendon blood flow, adds support to 
the notion that increased sympathetic outflow in exer-
cise may well act to redirect blood flow from tendon 
to muscle. 
The editors of Gray's Anatomy regard the non-nu-
tritive route as a route through which the blood pass-
es when the flow in the endomysial capillary bed is 
impeded, e.g. during contraction (Gray's Anatomy 
1973). Thus, rhythmic oscillation of blood flow be-
tween the non-nutritive and nutritive routes may aid 
the muscle pump. If this were so, then this would rule 
out the afore-mentioned possibility for flow amplifi-
cation. However, evidence from Lindbom (1986) from 
studies on the rabbit tenuissimus muscle and from 
Takemiya & Maeda (1988) would suggest that during 
exercise flow is proportionately increased to the 
muscle capillaries in preference to the connective 
tissue or tendons. This may mean that there is an 
active recruitment of flow from non-nutritive to nutri-
tive route. 
Unfortunately, most attempts to measure tendon 
vessel flow during exercise have not compared it to 
muscle blood flow and have invariably chosen to 
measure tendon vessel flow in the midportion or pen -
tendinous area. rea. Thus, direct comparisons with data 
from the rabbit tenuissimus muscle above and direct 
assessment of our amplification proposal cannot be 
made. However, it is interesting to note that from the 
few studies conducted, exercise was found to both de-
crease (Astrom & Westlin 1994) and increase (Lang 
berg et al. 1998, 1999) tendon blood flow. Differences 
may relate to methodology, as Astrom & Westlin 
(1994) used laser Doppler flowmetry and Langberg 
et al. (1998, 1999) used clearance of injected 133Xe. 
There are also findings from rabbits where tendon 
blood flow was found to increase in exercise (Landi 
et al. 1983). In addition, a study by Bulow and Tond-
evold (1982) using radioactive 15 jim microspheres in 
dogs showed that exercise increased Achilles tendon 
blood flow aproximately 3-fold. However, blood flow 
to muscle was likely to have increased much more 
than this, and so there is still the possibility of blood 
flow being recruited to muscle at the expense of con-
nective tissue and tendon. Further experiments are 
clearly required to resolve this, avoiding the possi-
bility that tendon vessel flow in exercise is not re-
stricted due to mechanical effects. 
Effects of physical training on intrinsic resistance and 
capacitance of tendon vessels 
As indicated above, we have developed a technique 
for monitoring tendon vessel flow/volume during rat 
hindlimb perfusion when total flow is held constant 
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